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 I 
Abstract:  
 
Endothelium forms an interface between vasculature and cellular sub 
endothelial environment. It sits in a vulnerable position responding to 
the changes in the immediate environment in health and disease. 
During vasculitic glomerulonephritis (VGN), autoantibodies raised 
against neutrophil serine proteases (SP) activate the neutrophils 
resulting in the release of neutrophilic products onto the endothelial 
surface changing its ability to support neutrophil recruitment and 
leading to its damage. We have hypothesized that endothelial 
functions are modulated by intra and extracellular environments of the 
vasculature and that the glomerular epithelial cells (podocytes) 
regulate glomerular endothelial cell (GEnC) functions.  
To address this, firstly we have investigated the effects of SP on EnC 
phenotype and demonstrated that endothelium presents proadhesive 
phenotype prior to the development of injury. Proteinase-3 (PR3) and 
human neutrophil elastase (HNE) induced neutrophil recruitment to 
viable endothelial cells under static conditions at 1µg/ml, whilst PR3 
also increased neutrophil recruitment to HUVEC under flow. At 1µg/ml, 
neither PR3 nor HNE altered endothelial viability, whilst high 
concentrations (10µg/ml) and prolonged exposure (24hours) of 
endothelium to either protease caused detectable damage. Most of the 
effects were inhibitable by the presence of α1-antitrypsin (α1-AT).  
Further, using an in vitro static co-culture system, the role of 
podocytes in modulating neutrophil recruitment by GEnCs was 
 II 
investigated in health and disease with anti-neutrophil cytoplasmic 
autoantibodies (ANCA) and puromycin aminonucleoside (PAN) injured 
podocytes.       
Co-culture of GEnCs and podocytes stimulated with higher 
concentrations of TNF-α (100U/ml), demonstrated a protective role by 
significantly reducing neutrophil recruitment by up to 50% when 
compared to GEnC mono-cultures. The inhibition of neutrophil 
recruitment was mediated by inteleukin-6 (IL-6), demonstrated by 
neutralising IL-6 in co-cultures and addition of exogenous recombinant 
IL-6 in GEnC mono-cultures. The neutrophil interactions in co-culture 
seem to be mediated by CXCR2 and ENA-78. The ability of ANCA to 
enhance neutrophil recruitment by minimally activated GEnC mono-
cultures (TNF-α 2U/ml), was mitigated in co-cultures and the effect 
was reversed in highly activated endothelium (TNF-α, 10 & 100 U/ml). 
PAN injured podocytes in co-culture with GEnCs, lost their protective 
role and therefore resulting in elevated neutrophil recruitment with 
TNF-α stimulation, both in the presence and absence of ANCA. PAN 
injured podocytes demonstrated the consequences of a disease state. 
Overall, these studies elucidate that GEnC presents an adhesive 
phenotype attracting neutrophils under the influence of inflammatory 
cytokines. During disease conditions as in VGN, exposure of 
endothelium to SPs results in a pre-activation stage leading to damage 
with high and/or prolonged exposures. Podocytes modulate glomerular 
endothelial responses to cytokine stimulation in health and disease.  
 III 
Thus, endothelial functions are tightly regulated by interacting cells 
and their molecules and could be an important phenomenon in the 
disease process of VGN where neutrophil recruitment plays a central 
pathogenic role.  
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Chapter-1: The role of neutrophil serine proteases and 
podocytes in glomerular inflammation 
 
1.1 Introduction 
 
Vasculitic diseases are characterised by the presence of inflammation in blood vessels. 
Primary causes in disease occurrence may be intrinsic to the organ, genetic abnormalities 
or autoimmune conditions whilst secondary causes are associated with certain infections 
such as Hepatitis B, Hepatitis C or HIV, drugs, connective tissue diseases or Hcancers . 
Several subgroups have emerged under vasculitis which were predominantly classified at 
the Chapel Hill Consensus Conference, on the basis of site or size of the inflamed blood 
vessels or distinct clinical pathologies (Jennette, 1994; Scott et al., 1994). These diseases 
share a common pathology with the development of focal necrotizing lesions, which affect 
many different vessels and organs.  
The small-vessel vasculitides (SVV) that affect vessels smaller than arteries (i.e., 
arterioles, venules, and capillaries), are the focus of the present studies and in particular 
anti-neutrophil cytoplasmic antibodies (ANCA) -associated SVV (ASVV), which includes 
Granulomatosis Polyangiitis (formerly known as Wegener’s Granulomatosis) 
2011(Jennette), Microscopic Polyangitis and Churg-Strauss Syndrome. ANCA are mostly 
immunoglobulin (Ig) G antibodies directed against molecules of human neutrophils and 
monocytes (Davies et al., 1982; Van Der Woude, 1985).  Evidence have also 
demonstrated the presence of IgM ANCA (without IgG) alone or in conjunction with IgG 
ANCA presenting pulmonary haemorrhage (Esnault et al., 1992). There is a frequent 
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involvement of kidneys targeting the glomerular, tubular and vascular structures and thus 
damage leading to renal failure. Glomerulonephritis (GN) is often a prominent component 
of vasculitis, causing iInflammation of the Hglomeruli H. Glomerular crescent formation is a 
feature where recruited inflammatory cells and proliferating epithelial cells form a ‘crescent’ 
in Bowman’s space and surround the glomerulus leading to impaired glomerular function 
(Huang et al., 1994). The disease incidence is increasing, with more than 20 per million 
and is most often seen in elderly population (peak age, 55 to 70 yr). Survey figures in the 
United Kingdom in 2008 showed an estimated incidence of 2 cases per 100,000 persons 
(Watts et al., 2008).  
My thesis concentrates on the VGN associated with ANCA and the role of ANCA and their 
antigens in damaging the vascular endothelium. The role played by the extra vascular cells 
in supporting or provoking the endothelium during the process is also described. 
In the introduction, I aim to explore the autoimmunity associated with ANCA, the 
inflammatory process in the presence of ANCA, the role of SP that are released by 
neutrophils in activating or damaging the endothelium, natural inhibitors of SP and 
synergistic relationship of glomerular endothelial and epithelial cells in neutrophil 
recruitment during inflammation, including mechanisms and the mediators involved.  
 
15B 
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1.1.1 ANCA in vasculitis and its antigenic targets 
 
ANCA vasculitis is an autoimmune disease where ANCA IgG are directed against 
proteinases 3 (PR3) (Gross et al., 1986) or myeloperoxidase (MPO) (Falk and Jennette, 
1988a) and uncommonly human neutrophil elastase (HNE)  (Lüdemann J, 1990 ; Tervaert 
et al., 1993) contained in cytoplasmic granules of neutrophils and monocytes. ANCA were 
first reported by Davies et al., 1982 (Davies et al., 1982), although the first report on the 
importance of these autoantibodies as a diagnostic marker of granulomatosis polyangiitis 
was by Van der Woude et al., (Van Der Woude, 1985). Since then, two major ANCA 
patterns have been recognized by Falk et al., in 1988 (Falk and Jennette, 1988b) using 
indirect immunofluorescence of ethanol-fixed neutrophils: cytoplasmic staining (c-ANCA) 
with 90% specificity to PR3 (Goldschmeding et al., 1989; Jennette et al., 1990; Niles et al., 
1989) and a perinuclear staining pattern (p-ANCA), 90% specific for MPO (Falk and 
Jennette, 1988b). In addition, atypical c- and p-ANCA were also described in inflammatory 
bowel disease and rheumatoid arthritis patients (Savige et al., 2003).  
Figure 1: Immunofluorescence staining patterns of ANCA on neutrophils 
(pictures taken from colleague Hamad Al Nuami) 
 
Figure 1: ANCA binding pattern on neutrophils: (A) Cytoplasmic staining pattern, C-ANCA 
targets proteinases 3 and (B) perinuclear pattern, p-ANCA targets myeloperoxidase. 
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The occurrence and severity of ANCA IgG differ within the IgG sub-classes. The most 
frequently represented are IgG1 and IgG4, whereas the IgG2 sub-class is infrequent  
(Locke et al., 1999). IgG3 or IgG4 are associated with disease severity or relapse and 
there are controversies with some investigators finding no association at all (Brouwer E, 
1991b; Esnault VL, 1991; Jayne DR, 1991; Nowack et al., 2001). Pankhurst et al recently 
published about the variability in the pathogenicity of IgG subclasses and reported that 
IgG3 is the most pathogenic than other IgG followed by IgG1 and IgG2 and last IgG4 in 
regulation of neutrophil recruitment on endothelium under flow conditions (Pankhurst et 
al.).   
The interaction of ANCA with the neutrophil may occur in the circulation or after the 
margination of a primed neutrophil to the endothelium, causing it to degranulate and 
transmigrate through the vessel wall. ANCA stimulated neutrophils may undergo 
premature degranulation of lytic enzymes and toxic metabolites which may promote the 
recruitment and activation of other leukocytes. ANCA also interferes with the resolution of 
inflammation through dysregulated neutrophil apoptosis and preventing apoptotic cell 
removal leading to secondary necrosis (Harper et al., 2001a) . ANCA is a pathological 
mediator and thus projected as an important diagnostic tool and marker in systemic 
vasculitis. ANCA is also found in non-vasculitic conditions including infection and 
inflammatory bowel disease where the antibody specificities may be directed towards a 
range of antigens other than PR3 or MPO (Jayne et al., 1995; Tervaert et al., 1989).  
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1.1.1.1 ANCA binding to antigens expressed on neutrophils 
 
Falk et al in 1990 described the capability of anti- PR3/MPO antibodies in activating TNF-α 
primed neutrophils in vitro. Reumaux et al., demonstrated additional effects of TNF priming 
on signal transduction by activating nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase and involvement of β2 integrins (Reumaux et al., 2006). Studies from 
our lab have shown that the F(ab)2 portion of ANCA IgG engages with target antigens on 
the cell surface of neutrophils and that the Fc portion interacts with Fc receptors (FcγRIIIb 
(CD16) and FcγRIIa (CD32)) (Ben-Smith et al., 2001). This engagement of both Fab and 
Fc portions of the antibody is a prerequisite for full ANCA-induced neutrophil activation 
inducing a respiratory burst as measured by superoxide assay (Ben-Smith et al., 2001; 
Kettritz et al., 1997; Porges et al., 1994; Williams et al., 2003). Even though the signaling 
process is not fully understood, signaling through Fcγ receptors is followed by tyrosine 
kinase dependent activation of phospholipase C, independent of G-protein activation 
(Santana et al., 1996), and an increase in calcium levels are reported (Hundt and Schmidt, 
1992; Vossebeld, 1995). ANCA also bind to endothelial-bound antigens, inducing antibody 
dependent cellular cytotoxicity (Ewert et al., 1991). The promoted neutrophil adherence to 
EnCs and neutrophil migration into the tissues increase the likelihood of injury to 
endothelium during the process. The leukocyte recruitment to the glomerular capillary bed 
is thought to be a crucial step in the development of disease process (Huang et al., 1994; 
Huang et al., 1997).  
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1.1.1.2 Possible reasons for the development of ANCA: 
 
It still remains unclear why autoimmunity occurs and why ANCA develop in the first place. 
There are several theories: 
First, under normal conditions, PR3 and MPO that are released will be quickly scavenged 
or neutralised by naturally occurring inhibitors eg. α1-antitrypsin (α1-AT). However the 
molecules that are expressed on the cell surface cannot be neutralised by the inhibitors 
due to the steric hindrance (Campbell et al., 2000; Charles et al., 1991; Csernok et al., 
1994a), and therefore could be exposed to the non-tolerized immune system resulting in 
the production of autoimmune antibodies. In patients with ANCA associated vasculitides 
(AVV), α1-AT can be inactivated by ROS which would lead to an acquired localized 
protease/antiprotease imbalance which could be further enhanced by PR3-ANCA 
interactions. The deficient PIZ α1-AT phenotype is also associated with AAV as well as a 
poorer prognosis for ANCA-positive systemic vasculitis (Segelmark et al., 1995). Recently 
published findings from our lab indicated that the Z but not the S allele is associated with 
AAV and also found polymers of α1-AT in the patient’s serum and glomeruli of at least 
some patients with the Z allele, which may promote inflammation through priming of 
neutrophils (Morris et al.), 2010). 
The other factors that contribute to the initiation of the ANCA autoimmune response 
include environmental pressures, including silica exposure (Hogan et al., 2001). Genetic 
susceptibility of certain individuals to develop autoimmune diseases along with infection 
becomes sufficient stimuli in the development of widespread vasculitis in a patient with 
ANCA (Lawyer et al., 1994; Stegeman et al., 1994). 
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Other possible explanations include:  
There is the concept of molecular mimicry which suggests that there are similarities 
between human proteins and bacterial or viral proteins that result in the development of 
autoantibodies.  Studies by the Chapel Hill group have provided evidence that vasculitis 
patients with ANCA specificity for PR3, also develop antibodies to a peptide translated 
from the antisense DNA strand of PR3 (complementary PR3) or to a mimic of this peptide. 
This theory of formation of antibodies against antigens which are complementary in their 
peptide sequence to autoantigens is referred as inverted hydropathy (Pendergraft et al., 
2004). 
Another possible contributing factor to the development of autoimmune responses is the 
improper deposition of PR3 and MPO due to dysregulated apoptosis of neutrophils 
(Harper et al., 2001a; Utz, 1998) on the EnC and subsequent presentation to immune 
cells.  Further, the Witko-Sarsat group suggested that the bimodal expression of 
membrane PR3 on the neutrophil surfaces and the proportion of expression within a given 
donor is  a possible key in the development of ANCA and may provide a risk factor for 
vasculitis, as well as being associated with relapse (Halbwachs-Mecarelli et al., 1995). 
Work by the Csernok group demonstrated occurrence of PR3 on the surface of the 
neutrophil in addition to an intracellular pool on resting neutrophils (Csernok et al., 1994b).  
At the cellular level, neutrophil activation also results in the formation and release of 
neutrophil extracellular traps (NETs) that contain chromatin, MPO and SP, including PR3 
and HNE (Brinkmann et al., 2004), which have been detected in affected human glomeruli. 
Kessenbrock et al. demonstrated that NETs perpetuate the autoimmune response against 
neutrophil components in patients with AAV (Kessenbrock et al., 2009).  
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1.1.1.3 In vitro and In vivo studies – a proof that ANCA are pathogenic 
Evidence that ANCA are pathogenic is provided from both in vitro and in vivo studies. 
There are many in vitro studies which have provided strong evidence that both MPO and 
PR3-ANCA are directly involved in causing the glomerular and vascular inflammation in 
ASVV. Important in vitro evidences from the studies by Savage group and Jennette group 
showed that ANCA binds to cytokine primed neutrophils and monocytes resulting in 
functional activation with elevated respiratory burst and degranulation leading to the 
endothelial damage (Ewert et al., 1995; Ewert BH, 1992; Kettritz et al., 1997; Lu et al., 
2006; Lu et al., 2004; Mulder et al., 1994; Radford et al., 1999). Falk et al., first observed 
that ANCA could stimulate leukocytes to undergo degranulation and respiratory burst (Falk 
et al., 1990b).  In vitro findings lead to the ANCA-cytokine sequence theory of 
inflammatory injury to the vessel wall which is triggered by neutrophil recruitment to the 
endothelium and release of auto-aggressive neutrophil constituents (Gross et al., 1986). 
The argument that all the in vitro studies were laboratory artefacts was addressed by 
advancements with in vivo models that provided compelling evidence that ANCA are 
pathogenic. During the 1990s, various rodent models were developed to investigate the 
effect of anti-MPO antibodies in renal injury. Qasim et al., (Qasim et al., 1993) reported the 
development of necrotizing vasculitis in Brown Norway rats treated with MPO-ANCA along 
with lower doses of mercuric chloride. Brouwer et al., (Brouwer et al., 1993) immunized 
Brown Norway and Lewis rats with human MPO and reported development of anti-human-
MPO antibodies that cross-react with rat MPO. They also induced crescentic GN in Brown 
Norway rats by infusing a lysosomal extract directly into the renal artery of animals 
immunized with human MPO and replicated human autoimmune vasculitis (Brouwer et al., 
1993). Sub-nephritogenic doses of antiglomerular basement membrane (anti-GBM) and 
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anti-MPO antibodies given to animals developed necrotizing and crescentic 
glomerulonephritis, whereas animals that received only anti-GBM antibodies developed 
only minor disease (Heeringa et al., 1996). However, murine models developed by Xiao 
and colleagues in 2002 documented a definitive evidence for pathogenicity of MPO-ANCA 
(Xiao et al., 2002).  They passively infused high-affinity anti-MPO antibodies raised in 
MPO knockout mice, into immune-deficient or immune- competent mice which resulted in 
the development of crescentic GN. This facilitated further studies looking at the role of 
neutrophils as key effector cells (Xiao et al., 2005), TNF-α (Huugen et al., 2005)  and 
complement  (Xiao et al., 2007) in the pathogenesis of vasculitis. 
Little group induced anti-MPO antibodies in WKY rats by immunizing with human MPO 
and developed systemic anti-MPO-associated vasculitis resembling human ASVV by 
exogenously administering human MPO adjuvant (Little et al., 2005b).  They also 
demonstrated the cross reactivity of induced anti-MPO antibodies with rat neutrophils and 
augmenting leukocyte-endothelial interaction, inducing microvascular injury in vivo (Little et 
al., 2005b). The same model formed the basis of intra-vital microscopy where interaction 
of MPO-ANCA with leukocytes is directly observed in mesenteric venules along with the 
development of micro haemorrhages (Little et al., 2005a). 
All these models convincingly demonstrate the pathogenic potential of MPO-ANCA with 
clear limitations. These cannot be considered as autoimmune models due to the reliability 
on active immunization depending on use of adjuvant for disease induction. The renal 
phenotype in these models is mild and thus limits the testing for novel therapies. 
In vivo evidence on the pathogenicity of PR3 ANCA is very limited as rodents lack PR3 
expression on murine neutrophil surface and with little homology for the ANCA epitopes 
between human and murine PR3. Pfister et al in 2004 developed ANCAs against 
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recombinant murine PR3 in PR3/HNE double deficient mice, but the raised PR3-ANCA did 
not induce vasculitis when transferred into wild type mice due to the lack of expression of 
antigen on the surface of mouse neutrophils unlike human neutrophils. However these 
antibodies did induce a local inflammatory response following the administration of 
subcutaneous TNF-α in supporting PR3-mediated tissue damage (Pfister et al., 2004). Van 
der Geld and colleagues immunized mice and rats with chimeric human-mouse PR3 which 
elicited an antibody response to mouse PR3 and rat granulocytes with no signs of 
developing vasculitis (van der Geld and 2007). Recently published work from Little group 
was successful in inducing PR3-ANCA associated vasculitis in mice with a human immune 
system (Little et al 2011). MPO-ANCA SVV animal models have laid road in understanding 
the unique pathogenic mechanisms involved in ANCA-mediated vasculitis which will lead 
to new routes in developing therapeutic strategies. Yet the questions remain concerning 
the pathogenesis and immunogenesis of ANCA associated diseases. The development of 
PR3- ANCA SVV in vivo model elucidating more facts of that end is still awaited. 
 
1.1.1.4 Other Antibodies involved  
In addition to ANCA, there are reports about involvement of other autoantibodies in ASVV, 
including antibodies directed against EnC specific antigens called anti-endothelial cell 
antibodies (AECA) (Frampton, 1990; Lauren et al., 1989). AECA are a heterogeneous 
family of autoantibodies reacting with several antigen determinants in various diseases. In 
1990, Frampton et al.,reported that 50% of ANCA positive patients with WG and MPA 
showed positivity for AECA IgG (Frampton, 1990). These antibodies are detected in vitro 
using cellular ELISA with cultured HUVEC (Belizna et al., 2006; Rosenbaum J, 1988 ). 
AECA can activate the EnC and induce apoptosis (Bordron, 2001). In vitro and in vivo 
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studies have shown direct and indirect cytotoxicity of these antibodies in promoting 
vascular damage (Matsuda, 1988; Tannenbaum et al., 1986). There is clinical evidence 
that these antibodies have possible pathogenic role in the disease (Belizna et al., 2006; 
Dulce et al., 1999; Leung et al., 1986; Rosenbaum J, 1988 ). However, it is possible that 
AECA may not be the cause of disease rather may follow EnC damage. Altogether, these 
antibodies could be directed against constitutively expressed or cytokine induced cryptic 
antigens along with adhesion molecules, extracellular matrix components (Belizna C, 
1997; Direskeneli et al., 1994). 
Anti glomerular basement membrane antibodies are another group of auto antibodies, 
often seen coexisting with ANCA (Harris AA, 1998), more often accompanied by MPO-
ANCA than by PR3-ANCA. These antibodies react with non collagenous domain of type IV 
collagen and nearly all the patients with these antibodies have shown necrotizing lesions 
and crescents associated with GN, alveolar necrosis and accumulation of immunoglobulin 
accumulation along the GBM (Hellmark et al., 1997; Wilson CB, 1973 ). The studies by 
Hellmark et al., showed the specificity of anti GBM antibodies was same in patients with or 
without ANCA (Hellmark et al., 1997). In vivo studies have documented the pathogenic 
potential of these antibodies (bolton, 1996). The pathogenic mechanism of anti-GBM 
antibodies involves binding to its antigenic target, fixation of complement leading to 
neutrophil and monocyte recruitment which results in destruction of glomerular capillary 
walls thereby initiating crescent formation.  
Anti laminin antibodies are raised against laminin which is a connective tissue matrix 
component of glomerular basement membrane. These antibodies are found in various 
diseases including ASVV, especially those with MPO specificity (Hellmark et al., 1997; 
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Vecchi et al., 2000). Circulating anti-entactin antibodies were also found in patients with 
GN and SLE (Saxena, 1994; Saxena et al., 1991).  
Other antibodies which have taken importance on the GN stage recently are a new 
subtype of ANCA against lysosomal membrane protein-2 (LAMP-2) (Kain, 1995). The anti 
LAMP-2 antibodies were found in the majority of patients with focal necrotizing GN. LAMP-
2 is an abundant protein on neutrophil and endothelial cell surfaces and shuttles between 
lysosomes and the cell membrane. In vivo evidence has shown that antibodies to LAMP-2 
cause pauci-immune FNGN when injected into rats, and apoptosis of human 
microvascular endothelium in vitro (Kain et al., 2008). A human LAMP-2 epitope 
(designated P41–49) has been shown to have 100% homology to the bacterial adhesion, 
FimH, and rats immunized with this protein developed pauci-immune FNGN and also 
develop antibodies to rat and human LAMP-2. These studies suggest that infection with 
fimbriated pathogens could be an aetiological factor in the development of focal 
necrotizing GN. The presence of anti-LAMP-2 antibodies in ASVV awaits confirmation by 
other groups. 
 
1.1.2 Neutrophils and their role in ASVV: 
Neutrophils form part of the polymorphonuclear cell family (PMN) together with HbasophilsH 
and Heosinophils, and are most abundant leukocytes in the bloodstream. They act as the 
first line of defense at sites of bacterial infection or injury. Neutrophils phagocytose and 
eliminate foreign microorganisms by undergoing activation and release of oxygen 
dependent and independent antimicrobial cytotoxic molecules from secretory granules. 
Neutophilic granules undergo exocytosis and release their constituents cruicial for 
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neutrophilic functions (Faurschou and Borregaard, 2003). The process of Exocytosis is 
Ca2+ dependent and involves fusion of vesicular membranes to the plasma membrane 
resulting in the expression of the vesicular constituents on the surface of the cell (Miller LJ, 
1987). The controlled mobilisation of the cytoplasmic organelles of the neutrophil 
transforms it from a passively circulating cell to an effector cell of innate immunity. 
Neutrophils respond quickly to tissue injury and are the hallmark of acute inflammation. 
 
1.1.2.1 Neutrophil activation by ANCA: Degranulation and Respiratory burst. 
Neutrophilic granules consist of SP, components of the respiratory burst, a wide range of 
membrane-bound receptors for endothelial adhesion molecules, extracellular matrix 
proteins, bacterial products and soluble mediators of inflammation. Specific granules are 
suggested to be involved in inflammatory responses and azurophilic granules with the 
antimicrobial functions of neutrophils (Faurschou and Borregaard, 2003). Neutrophil 
antimicrobial actions include the generation and release of reactive oxygen species (ROS) 
and release of SP from the intracellular granules. In ASVV, neutrophil activation by ANCA 
results in the generation of release of ROS and is important in triggering neutrophil 
apoptosis (Charles et al., 1992; Falk et al., 1990b; Jacobson, 1996). During inflammatory 
episodes, activated leukocytes are recruited from the blood stream onto the endothelium 
and migrate into the tissue. The adhesive interaction of neutrophils with endothelium 
triggers the mobilisation of secretory vesicles and subsequent exocytosis of the granules 
from neutrophils (Borregaard et al., 1994) resulting in the expression of receptors and 
release of additional matrix-degrading enzymes, including collagenase and SP, which 
facilitate migration. 
 17 
The respiratory burst of neutrophils involves release of ROS (superoxide radicals and 
hydrogen peroxide) and hypochloric acid. HNADPH oxidaseH produces Hsuperoxide H, which 
spontaneously recombines with other Hmolecules H to produce reactive Hfree radicals H.  
Oxygen burst: 2O2  2O2
- + NAD++H+ (Catalysed by NADPH oxidase) 
Superoxide production: 2O2+ 2H
+  2O- (superoxide) + H2O2 (Catalysed by superoxide 
dismutase) 
Respiratory burst and degranulation occurs simultaneously from the leukocytes. Under 
normal conditions these processes occur in a controlled fashion, but under unusual 
circumstances they may be uncontrolled leading to adverse effects.  
 
1.1.2.2 Neutrophil SP (PR3 and HNE), role in endothelial activation and injury 
in ASVV 
PR3 and HNE are two SP stored in azurophilic granules in the cytoplasm of neutrophils, as 
well as monocytes. PR3 is a 29-kd SP and was first reported in 1978 by Baggiolini et al., . 
HNE is of ≈25-kd SP (Navia et al., 1989). PR3 shares 60% sequence homology with HNE 
in the first 40 residues and identical first four N-terminal residues. HNE, unlike PR3, is 
strictly localized in azurophilic granules and does not have an extra granular localization in 
neutrophils. PR3 was discovered as a major antigen of c-ANCA in WG and detection of 
these autoantibodies has been helpful in diagnosis and follow up of the disease 
(Goldschmeding et al., 1989; Gross et al., 1986; Niles et al., 1989). ANCA against HNE 
have also been discovered in patients with a p- ANCA pattern (Tervaert et al., 1993).  
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The physiological concentrations of these enzymes in a healthy individuals are, 3.24 U+U 
SD0.24 pg/neutrophil (Campbell et al., 2000) and 1.59 pg/neutrophil (Campbell et al., 
1989; V. V. Damiano, 1988) for PR3 and HNE respectively. It is shown by Campbell et al., 
that brief priming and activation of neutrophils by proinflammatory mediators alone induces 
a rapid and persistant 5 to 6 fold increase in surface expression of PR3 and minimal free 
release. Significantly raised circulating levels of PR3 have been observed in plasma of 
SVV patients, in the range of 110-3940, median 560 µg/l, (n=59) compared to healthy 
donors 350 µg/l, 110-580 range, (n=30) (Ohlsson et al., 2003).  
SP help the migration of neutrophils by activating endothelium and further leads to its 
detachment by degrading several constituents of the extracellular matrix proteins like 
elastin, fibrinogen, collagen type IV, fibronectin, heparan sulfate proteoglycans, laminin, 
vitronectin (Campanelli et al., 1990; Rao et al., 1991b; Rao et al., 1991c). Yang et al have 
shown that internalisation of PR3 and MPO may occur but only PR3 leads EnCs towards 
apoptosis. Other in vitro studies also demonstrated the direct detachment and cytolysis of 
EnCs by SP (Brouwer et al., 1994; Yang et al., 1996; Yang et al., 2001). The C- terminal 
domain of PR3 has an apoptotic function. Active PR3 induces apoptosis via direct 
cleavage of p65 NF-kB, resulting in its reduced transcriptional activity (Preston et al., 
2002). PR3 also has functional similarities to caspase-1 and processes inactive cytokine 
precursors to their active forms. In fact PR3 has been shown to mimic functions of 
caspases 1, 2 and 3. PR3 acts like caspase-2 and -3 to cleave the Sp1 transcription factor 
(Piedrafita and Pfahl, 1997) and like caspase-1 to process IL-1β (Coeshott et al., 1999) 
which is involved in leukocyte recruitment.  
These enzymes are potent and play a key role in digesting phagocytosed microorganisms 
and cell debri (Campbell et al., 2000). The microbicidal property of SP is shown to be 
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independent of their enzyme activity and operates depending on charged interactions 
between SP and bacterial cell membrane (Odeberg and Olsson, 1976; van der Geld et al., 
2001). Similarly, the cationic nature of the enzymes also allows them to bind non-
covalently to the anionic endothelium to which ANCA then binds, and triggers antibody-
dependent cellular cytotoxicity (Ballieux et al., 1994). Their physiological roles explain their 
toxicity when these enzymes are released in excessive concentrations during disease 
conditions. PR3 may also play a role in enhancing IL-8 production by EnCs (Berger et al., 
1996a), which further acts as a strong chemotactic factor and activates neutrophils.  
Sibelius et al., reported presence of PR3 messenger RNA in HUVEC detected by the PCR 
method. Contrary to these findings, others were unable to detect PR3 in resting or cytokine 
activated HUVEC (King et al., 1995; Pendergraft et al., 2000). Mayet et al., reported the 
PR3 expression by cytokine activated human EnC’s in the cytoplasm which increase the 
pathological consequences of WG (Mayet et al., 1993). Deposition of PR3 has been 
detected on the glomerular basement membrane and endothelium in kidney biopsies from 
patients with WG (Ballieux et al., 1994; Berger et al., 1996b).  
The mechanism by which PR3 interacts specifically with EnC is not clearly understood. In 
vitro studies by Taekema et al., suggested that PR3 binds to 111kD membrane protein on 
EnC’s. EnC’s also express protease-activated receptors (PAR) (Cupit et al., 1999), which 
are believed to be the receptors for binding of PR3. PR3 is presented by CD177 (NB1 
glycoprotein) on circulating neutrophils which has been shown to co-localise with 
membrane bound PR3 and was proposed to be a receptor for PR3. In patients with ASVV, 
elevated levels of CD177 was detected on circulating neutrophils (Hu et al., 2009). 
However, it is to be noted that neutrophils lacking CD177 have been shown to express 
membrane PR3 and are susceptible to ANCA induced activation. Thus the interactions 
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between CD177 and PR3 and its importance in disease pathogenesis have not been fully 
characterized.  
 
1.1.2.3 Inhibitors of SP:  
Under normal conditions, the proteolytic action of PR3 and HNE is always precisely 
regulated by the presence of endogenous antiproteases also called serpins (serine 
protease inhibitors). The most important of protease inhibitor is α 1-anti trypsin which 
physiologically acts on both PR3 and HNE (Bergenfeldt et al., 1992; Rao et al., 1991a). 
There are other inhibitors which include elafin (Wiedow et al., 1991), α2-macroglobulin 
(Rao et al., 1991a), glycosaminoglycans (Bergenfeldt et al., 1992). 
PR3 complexed with α1-AT, as well as free circulating PR3, has been detected in plasma 
of WG patients and healthy controls (Baslund et al., 1994; Timothy et al., 1994). Under 
some pathological conditions, an imbalance of protease and inhibitor may occur at the site 
of inflammation due to deficiency inhibitors or abnormal α1-AT phenotypes or phenotype 
variants (Callea 2003; Segelmark et al., 1995). There is evidence that PR3- ANCA-positive 
vasculitis patients are more likely to have a Z allele that is associated with a deficient 
phenotype (Esnault et al., 1993; Griffith et al., 1996; Savige JA, 1995). The release of 
oxygen radicals can reduce the association of α1-AT with SP and thereby increasing the 
local activity of SP (Esnault, 1997). Thus, it may be that deficiency of serpins may 
contribute to the autoreactivity of SP by determining the local ratio of SP and their 
inhibitors and the final proteolytic damage by neutrophils and monocytes. 
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1.1.3 Other Leukocytes in ASVV: 
Monocytes and macrophages are the predominant infiltrating cells during the 
development of GN (Ferrario F, 1999; Rastaldi MP, 2000, 1996). Previous human and 
experimental models have revealed the involvement of monocytes and macrophages in 
the formation of glomerular crescents and lesions at interstitial level and playing a vital role 
in inflammatory process leading to renal injury. They participate in crescent formation by 
infiltrating into Bowman’s space, interstitium and periglomerular space causing their 
rupture with further accumulation. They also synthesize and secrete a variety of 
chemokines, chemoattractants and growth factors. PR3 and MPO as constituents of 
monocytes may have direct effect of ANCA on monocytes/macrophages along with 
neutrophils. (Kobold et al., 1999; Sven et al., 2001; Tay SP, 1998) In vitro studies also 
reported that ANCA promotes monocyte recruitment (Casselman et al., 1995; Ralston et 
al., 1997). 
 
T and B lymphocytes are also shown to be strongly involved in the disease process of 
ASVV. T lymphocytes are a large component of infiltrating leukocytes in vasculitic lesions 
and granulomas, thus may have a role in the pathogenesis (Griffith ME, 1996). Circulating 
T cells with Th1- type cytokine profile were evident in ASVV patients during active disease 
and remission. T cells are particularly necessary in production of epitope specific 
responses and class switching of ANCA IgG. Renal biopsies from vasculitic dependent 
crescentic GN patients shows the presence of CD4+ T cells (Bolton WK, 1987; Muller, 
1988). CD4+ T cells, specific for ANCA antigens, are shown to proliferate in response to 
exposure to PR3 or MPO in patients with AAV (Brouwer E, 1994; Griffith ME, 1996; King 
WJ, 1998). Increased levels of soluble IL-2R is seen in active disease (Brouwer E, 1991a; 
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Schmitt W, 1992). A study by Popa et al., demonstrated that activation of T-cell persists 
during disease remission (Popa ER, 2002). Giscombe described a high prevalence of 
CD28 cells within the activated T-cell subset in vasculitis patients and suggested that they 
could be the effector arm of the T-cell response in ASVV (Giscombe et al., 1998). An 
increased percentage of activated T cells measured by the expression of CD25 and D-
related human leukocyte antigen on CD4+ and CD8+ cells are found in patients in 
remission (Ludviksson et al., 1998). The role of T cells is also suggested by the partial 
success of anti T cell therapy. Treatment with rabbit anti-lymphocyte globulin showed 
some efficacy in patients by depleting autoreactive T cells (Hagen EC, 1995). 
B-cells occupy centre stage in vasculitis as precursors of plasma cells that produce ANCA. 
They interact with and act as antigen presenting cells themselves providing co-stimulatory 
support to T-cells. Abnormal B cell function is evident in autoimmunity and particularly in 
the pathogenesis of T-cell auto reactivity (Takemura et al., 2001). Also abnormal T cell 
regulation is dependent on B cells in AAV and B cell proliferation may be amplified by T 
cell derived cytokines like BLyS (B lymphocyte stimulator) and APRIL (a proliferation 
inducing ligand) . Nasal biopsies of AAV patients have shown abnormal B cell clusters 
adjacent to PR3 ANCA positive cells (Voswinkel J, 2006). Renal biopsies have also been 
shown to have B cell infiltrates. Low surface expression of CD19 by B cells results in 
reduced transmembrane signaling and may allow auto reactive B-cells into peripheral 
circulation as seen in ASVV and be associated with the breakdown of tolerance to ANCA 
antigens (Culton DA, 2007). The effective use of rituximab, the B cell depleting agent, has 
provided a valuable insight into the importance of B cells in vasculitis. 
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1.1.4 Role of cytokines and chemokines in neutrophil recruitment 
Endothelium is the source and the target to inflammatory mediators called cytokines that 
play a vital role in inflammation and immunity. EnCs stimulated by inflammatory cytokines, 
produce chemo attractants or chemokines to recruit and activate leukocytes. Different 
cytokines have different functions in mediating inflammation and immunity.  
 
1.1.4.1 Tumor necrosis factor (TNF-α) in neutrophil priming: 
In inflammatory diseases, TNF-α is a principle mediator and functions primarily in 
regulating immune cells. It is produced by a variety of cells such as neutrophils, 
macrophages and T-cells. All cells involved in inflammation have TNF-α receptors, and are 
activated by it to synthesize more of their own TNF-α. Dysregulated TNF-α production has 
been implicated in variety of diseases such as ischemic renal disease, WG and MPA 
(Ludviksson et al., 1998; Noronha et al., 1993; Tomer et al., 1999). Interaction of TNF-α 
with vascular endothelium renders it hyper-adhesive by increased expression of adhesion 
molecules which attract neutrophils (Briscoe et al., 1992; Pober et al., 1986). It plays a 
crucial role in cell-cell interactions both in vitro and in vivo (Falk et al., 1990b, c; Kunkel et 
al., 1991). During active ASVV, upregulation of TNF- mRNA expression and cytokine 
release results in neutrophil priming which facilitates an ANCA-induced respiratory burst, 
degranulation and dysregulated neutrophil apoptosis (Falk et al., 1990a, b; Mulder et al., 
1994; Porges et al., 1994). 
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1.1.4.2 Interleukin -6: 
Cytokines such as IL-6 are vital modulators of immune and inflammatory responses. IL-6 
is secreted by different cells including fibroblasts, endothelial cells, monocytes and 
macrophages, lymphocytes, podocytes and other different cell types (Weissenbach, 1980); 
(Corbel and Melchers, 1984);(Aarden et al., 1987; Vansnick et al., 1989). IL-6 is not 
produced constitutively by normal cells, but can be induced by infections and by other 
cytokines such as TNF-α and/or IL-1 or in the presence of IFN-γ (Shalaby et al., 1989; 
Vandamme et al., 1987). IL-6 interacts with its ligand-binding receptor IL-6R (CD126) and 
the signal transducing transmembrane receptor subunit gp130 (Hirano T, 1992; L Syners, 
1989) promoting the initiation of intracellular signalling (Rose-John et al., 2001; Taga et al., 
1989). IL-6R expression is limited to hepatocytes, neutrophils, monocytes/macrophages 
and certain other leukocytes and gp130 is expressed on almost all cells of the body. 
Trans-signalling of IL-6 occurs by the interaction between soluble form of IL-6 receptor 
(sIL-6R) and IL-6 stimulating the cells by binding to gp130 ligand (Mackiewicz et al., 1992; 
Taga et al., 1989). IL-6 affects T and B lymphocytes and the production of acute-phase 
proteins by liver.  IL-6 switches innate immunity to acquired immunity, being responsible 
for the transition from neutrophil recruitment to mononuclear cells by trans-signalling 
(Topley et al., 1996). IL-6 deficient mice have shown that  neutrophil accumulation is 
blocked by IL-6 at inflammatory sites (Xing et al., 1998). In the resolution of innate 
immunity, trans-signalling of IL-6, not only blocks pro-inflammatory cytokines and 
suppresses IL-8 and GRO, but also promotes release of ENA-78 and CXCL-6 (Hurst et al., 
2001; McLoughlin et al., 2004; McLoughlin et al., 2003; Modur et al., 1997). IL-6 is a 
resolution factor balancing pro- and anti inflammatory outcomes and thus acts as an 
immunological switch. IL-6 interacts with other inflammatory mediators and there is 
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interplay between IL-6 mediated signals. The raised levels of IL-6 were shown to correlate 
with the disease activity in diseases such as rheumatoid arthritis and sepsis (Hack et al., 
1989; Houssiau et al., 1988). The high titers of IL-6 can result in amplification of the 
inflammatory process by involving IL-1 and TNF-α (Brouckaert et al., 1989). In chronic 
diseases, IL-6 blocking is therapeutic (Mihara et al., 1998; Shinkura et al., 1998; Yoshizaki 
et al., 1998). Over production of IL-6 is also linked to variety of diseases such as 
proliferative mesangial GN, acting in an autocrine fashion (Kishimoto, 1989).  
 
1.1.4.3 Chemokines: 
The quiescent circulating neutrophils are actively recruited onto the endothelium by 
chemotactic agents. CXC chemokines mainly act on neutrophils and CC chemokines are 
inactive on neutrophils and stimulate monocytes, basophils, eosinophils and T 
lymphocytes. Chemokines act by signalling leukocyte migration, working in association 
with selectins and integrins (Reviewed by (Baggiolini, 1998)).  
To induce stable attachment of neutrophils, EnCs synthesize, secrete and display CXC 
chemokines, like interleukin-8 (IL-8 /CXCL8) and several analogs GRO, epithelial cell-
derived neutrophil-activating protein (ENA-78/CXCL5), neutrophil-activating protein-2 
(NAP-2/CXCL7) and platelet activating factor (PAF) on luminal surface induced by 
inflammatory cytokines (IL-1 or TNF or both) and by LPS (Breviario et al., 1988; Prescott 
et al., 1984; Warner et al., 1987; Zimmerman et al., 1990). All these chemokines share 
properties of IL-8 as neutrophil chemoattractants and the effects were also tested during in 
vivo studies (Colditz et al., 1989; Vanzee et al., 1991). Interleukin-8 and GRO-α (CXCL1) 
are active on neutrophils and IL-8 rendered neutrophils adhere to endothelium and, in 
contrast, there are findings which show that EnC derived IL-8 inhibits binding of 
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neutrophils to activated EnC. The transmigration of neutrophils is partially dependent on 
the local production of IL-8. It was shown that the timing in the presentation of these 
chemotactic agents is very important for the successful neutrophil transmigration (Luu et 
al., 2000). CXC chemokines were shown to have high affinity for two receptors: CXCR2 
with high affinity for all CXC chemokines and CXCR1 with high affinity for IL-8 only (Ahuja 
and Murphy, 1996; Moser et al., 1991; Schumacher et al., 1992). It was shown that both 
receptors function independently by mediating similar responses to different CXC 
chemokines (Loetscher et al., 1994). 
 
1.1.5 Glomerular Endothelium and its role in the course of a disease 
process: 
Endothelium forms the inner cell lining of blood vessels and has many functions. EnC 
phenotype is considered heterogeneous between different sites of origin. The specialized 
characteristics, the unique structure and functions of endothelium in the glomerular 
microcirculation and are also considered to be some of the contributing factors of its 
damage in ASVV. The ultra-structural variation of renal endothelium is non-diaphragmed 
fenestrations which potentially increase exposure of the basement membrane and may 
give rise to a propensity for damage. GEnCs are exposed to high numbers of circulating 
cells and high shear stress, thus express specific EnC adhesion molecules in response to 
injury (Maria Pia et al., 1996). The special features of glomerular endothelium may be 
accounting in placing kidneys as major target of vasculitic diseases (reviewed by (Little 
MA, 2008; Pankhurst et al., 2009)).  
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1.1.5.1 Endothelial Cell activation and damage 
Activation of endothelium in response to cytokines (e.g. TNF, IL-1), mechanical stress, 
circulating autoantibodies, local inflammatory mediators (e.g. histamine, thrombin) and 
bacterial products (e.g. endoxin) are pivotal in acute and chronic inflammation. Endothelial 
activation induce release of proinflammatory cytokines and upregulation of cell adhesion 
molecules promoting leukocyte endothelial interactions. At some inflammatory sites, apart 
from the involvement of known classical adhesion molecules, a novel molecule like VAP-1 
also seems to play a role in different conditions (Holmen et al., 2005) and strong 
expression of VCAM-1 induced by IL-4 is specific for glomerular endothelium in vasculitis 
patients (Maria Pia et al., 1996). ANCA stimulated neutrophils are also shown to increase 
glycoprotein Von-Willebrand factor (vWF) release, a circulatory cofactor for factor VIII on 
endothelium which is a measure of endothelial cell activation / stress (Lu et al., 2006). 
Recent studies by Bevins et al., from our lab, also demonstrated the increased release of 
vWF by SP treated EnC showing the possibility that vWF release also represents 
endothelial activation.  
Primed neutrophils associating with ANCA become activated resulting in antigen 
presentation, free radical generation, cytokine production, adhesion with resident 
glomerular cells. Many in vitro studies have demonstrated potential for the endothelial 
injury in course of the disease process (Büschenfelde, 1993 ; Ewert et al., 1995; Ewert BH, 
1992; Keogan MT, 1993; Savage et al., 1992). To prevent inappropriate tissue damage 
during neutrophil extravasation, EnC has been shown to be protected by initial integrin-
mediated downregulation of ROS through temporary suppression of NADPH oxidase 
activity (Zhao, 2003). However, Lu et al., have shown that superoxide generation from 
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fMLP and ANCA-activated neutrophils is inhibited in the presence of EnC, but SP release 
was not inhibited  (Lu et al., 2006).  
The highly cationic neutrophilic ANCA antigens bind non-covalently to EnC and ANCA can 
bind to them resulting in endothelial injury. In vitro studies were logically extended by use 
of physiological flow studies to more closely mimic the in vivo environment in vitro. Our 
group has successfully used flow chambers to enumerate different aspects of endothelial 
recruitment of neutrophils following ANCA stimulation (David et al., 2000; Little et al., 
2005b; Nolan et al., 2008; Radford DJ, 2001). Thus, endothelial dysfunction is integrally 
coupled with the activation of endothelium during inflammatory events which conclude in 
vascular injury. However, EnC activation controlled by local chemokine expression is 
characterized by enhanced leukocyte adhesion and extravasation as part of a co-ordinated 
multi-step process.  
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Figure 2: Hypothetical scheme of neutrophil activation by ANCA resulting in 
the endothelial damage and vascular injury 
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1.1.5.2 Role of adhesion molecules and the multistep process of neutrophil 
extravasation 
The basis for neutrophil-endothelial interactions during inflammation involves three main 
steps. Step one involves selectin dependent tethering and rolling, step two involves 
chemoattractants to activate integrin adhesiveness and put on the brakes, and in step 
three, the immunoglobulin (Ig) family member binds integrins and causes cells to arrest 
from rolling.  
 
Selectin mediated leukocyte rolling 
Most leukocytes express L- selectin. E-selectin and P-selectin are expressed by activated 
EnCs while platelets also express P-selectin, which mediate early rolling events in the 
adhesion process. Ligands for L-selectin are CD34 and GLYCAM-1; E-selectin binds to 
ESL-1 and glycosylated CD44 (Hidalgo et al., 2007) and P-selectin binds to PSGL-1 
(Kalogeris et al., 1999). E-selectin, unlike P-selectin, has no preformed storage units in 
EnCs. Increased levels of cell surface expression occur by transcription-dependent protein 
synthesis in response to inflammatory cytokines. P-selectin is stored specifically in α-
granules in platelets and Weibel-Palade bodies in EnCs and is rapidly translocated to the 
cell surface in response to mediators of acute inflammation. The selectins interact with 
their ligands to enable leukocytes to adhere to inflamed endothelium under conditions of 
blood flow.   
Under inflammatory conditions VAP-1 is also translocated from Weibel-Palade bodies of 
EnCs  and supports leukocyte rolling, firm adhesion, and transmigration under shear 
stress (Koskinen et al., 2004).  In 1996, Salmi et al.,elucidated that mature VAP-1 
mediates carbohydrate-dependent, selectin-independent lymphocyte binding under shear 
 31 
stress (Salmi and Jalkanen, 1996). VAP-1 regulates the selectin bond dissociation, 
mediating tethering and rolling (Smith et al., 1998) and shares functional similarity to 
PECAM-1 (CD31) in regulating transmigration.  
 
Integrin-mediated firm adhesion 
Integrins mediates firm leukocyte adhesion, triggered by chemokines and 
chemoattractants that cause conformational changes within integrin molecules on the 
neutrophil surface. Leukocyte integrins bind to the immunoglobulin super family members 
ICAM-1 and VCAM-1, expressed by EnCs (Campbell et al., 1996; Henninger et al., 1997) . 
The α2 and β2-integrins are most relevant to leukocyte adhesion and arrest and are 
implicated in ANCA induced neutrophil recruitment (De Vriese et al., 1999a). Blocking of  
α2 integrin has been shown to prevent an adhesion response (De Vriese et al., 1999b) and 
blocking of β2-integrin completely inhibited ANCA-induced neutrophil-endothelial adhesion 
(David et al., 2000). β2-integrins, CD11a/CD18 (LFA-1) and CD11b/CD18 (macrophage 
antigen 1 [Mac-1]) bind to ICAM-1 on the endothelium and are reported to be involved in 
neutrophil crawling. Elevated levels of expression of ICAM-1 and VCAM-1 are observed on 
renal capillaries and small renal vessels in WG patients (Ledford, 1997).  
 
Crawling and trans-endothelial cell migration 
The final step in leukocyte emigration into inflamed tissue is the transmigration through 
venular walls. An adherent neutrophil crawls through the tissue towards chemoattractants 
by engaging the junctional adhesion molecules (JAM). Leukocyte membrane protrusions 
extend into the endothelial-cell body and cell junctions which are triggered by ligation of 
ICAM-1 by MAC-1 phillipson (Phillipson et al., 2006). Ligation is associated with enhanced 
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endothelial cell contraction and opening of inter-endothelial contacts promoting leukocyte 
migration through endothelial junctions (paracellular pathway) or through the body of the 
endothelium (transcellular pathway). The transmigration is mediated by CD31 and JAM’s 
A-C and may involve CD99 (Lou et al., 2007). 
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Figure 3: Neutrophil recruitment cascade  
 
 
 
Figure 3: Neutrophil recruitment cascade: Demonstration of interactions between the neutrophil and cytokine 
activated endothelium. Reviewed by (Pankhurst et al., 2009)  
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1.1.5.3 Choice of glomerular endothelial cells 
GEnC were used for the experiments due to their specialized role in glomerular function 
and the contribution that this may make to the pathophysiology of GN. As maintaining 
primary cultures of GEnC are difficult, conditionally immortalized human GEnC (ciGEnC) 
were used for these studies (Gift from Dr S Satchell, Bristol). ciGEnC were prepared from 
isolated primary cultures from glomeruli. GEnC were transduced with temperature-
sensitive simian virus 40 large tumour antigen (SV40LT) and telomerase using retroviral 
vectors.  ciGEnC proliferate at the permissive temperature (33oC with 5% CO2) and 
become growth arrested at the non-permissive temperature (37oC with 5% CO2). ciGEnC 
have been shown to retain early passage primary culture morphological features up to at 
least passage 41 (Satchell et al., 2006). Messenger RNA (mRNA) analysis confirmed 
expression of the endothelial markers platelet endothelial cell adhesion molecule-1 
(PECAM-1), ICAM-2, vascular endothelial growth factor (VEGF) receptor molecule-2 and 
vWF, validated by immunofluorescence and Western blotting (work by Pankhurst). 
 
1.1.6 Glomerular visceral epithelial cells  
Glomerular visceral epithelial cells or podocytes (GEpC) are complex, specialized, unique 
cells and play a critical role in health and disease of kidney. They have a cell body, major 
processes, and foot processes. The podocyte foot processes interdigitate and forms the 
slit diaphragm. Podocytes and GEnCs have a mutual glomerular basement membrane 
(GBM) and form the glomerular filtration barrier in the kidney which maintains filtration. 
Many in vitro studies support the notion that podocytes provide physical support for the 
GBM to counteract the hydrostatic pressure of the blood. Any small interference in this 
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complex system will lead to escape of protein, leading to proteinuria, a hallmark of 
glomerular disease, and in severe cases leading to morbidity and mortality of children and 
adults (Bernard et al., 1988). Functionally, podocytes are responsible for GBM turnover 
and regulation of glomerular filtration. In addition they also mediate some immunological 
functions and are injured in many immune mediated glomerular diseases (Mundel and 
Kriz, 1995). Podocytes were also shown to express cytokine and cytokine receptors 
making them fragile and vulnerable during inflammatory episodes (Huber et al., 2002; 
Moutabarrik et al., 1994a; Xing et al., 2006);(Moutabarrik et al., 1994c). 
 
Figure 4: Scanning electron micrograph of portion of glomerulus (Arakawa, 
1971) 
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Figure 4: Scanning electron micrograph illustrating Glomeular capillaries covered by visceral epithelial cell 
with its cell body and foot processes embracing capillary wall of glomerulus. 
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1.1.6.1 Podocytes as GEnC supporting cells:  
In glomerular capillaries, podocytes extend their foot process around the GEnCs, thus 
supporting through juxtacrine mechanisms (Vicki and David, 2005). Both the cells are 
shown to play a major role in the progression and regression of disease states such as 
glomerulosclerosis. Glomerular podocytes, despite having limited regenerative capacity, 
influence the growth, proliferation and regeneration of GEnCs (Liang et al., 2006). 
Podocytes abundantly produce and secrete VEGF A and angiopoietin-1 (ang-1) necessary 
survival factors required for GEnC (Hirschberg et al., 2008; Kitamoto et al., 1997). 
Hirschberg et al have shown that podocytes provide angiogenic support to GEnCs and 
regulate their maintenance and angiogenesis by secreting mediators (Hirschberg et al., 
2008). Podocytes lack VEGFR2 and Tie-2 receptors, but in contrast, GEnCs express high 
levels of the receptors (Fan L, 2002; Satchell et al., 2002; Simon et al., 1998). The barrier 
properties of glomerular endothelium were also shown to be mediated by mediators, 
including VEGF, from podocytes (Sugimoto et al., 2003). The requirement of podocyte 
derived VEGF in maintenance and organization of GEnC was studied in homozygous and 
heterozygous podocyte specific knockout mice (Eremina et al., 2003).  
 
1.1.6.2 New approaches to studying the integrated role of podocytes and 
GEnCs in glomerular inflammation 
The co-ordinated role of glomerular cells such as GEnC, mesangial cells and podocytes, 
and their roles in different processes such as inflammation and angiogenesis have been a 
subject of discussion since many years. With the latest advancements in the technology of 
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culturing the cells in vitro, and with the availability of propagative lines of glomerular cells 
which retain their morphological features and immunological properties (Saleem et al., 
2002; Satchell et al., 2006), in vitro co-culture systems can enable the glomerular 
microenvironment to be mimicked and enables the influence of different glomerular cells 
on each other to be studied. This encouraged us to study the intricate communication 
between podocytes and GEnCs and their role in neutrophil recruitment in response to 
cytokine stimulation during inflammation and the mechanisms involved. 
 
1.1.6.3 Influence of podocytes on the ability of endothelium to support 
leukocyte recruitment 
EnCs exist in close contact with organ specific stromal cells, such as pericytes, and the 
interactions with underlying stromal cells are known to modify responses of endothelial 
cells. During inflammation, stromal cells have a crucial role in regulation of neutrophil 
recruitment by EnCs as they exist in very close proximity (reviewed by (Ahmad et al., 
2002; Hirschi and D'Amore, 1996; Nash et al., 2004)). Previous studies have shown that 
EnCs co-cultured with alveolar EpCs showed increased recruitment of mononuclear 
leukocytes upon cytokine stimulation. Others have found that co-culture alone caused 
upregulation of mRNA for adhesion receptors ICAM-1, E-selectin and VCAM-1 (Hsiai, 
2008). Furthermore, endothelial co-culturing with smooth muscle cells and fibroblasts has 
shown a direct influence on leukocyte recruitment leading to EnC dysfunction. Recent 
studies examining the cross-talk between stromal fibroblasts and EpC have shown a 
defined site specificity (McGettrick, 2010). Similarly, it is possible that the podocytes in the 
kidney regulate inflammation and may play a role in the initiation and propagation of 
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glomerular damage, although most underlying cell biological mechanisms are not 
completely understood (Eremina et al., 2003; Patrakka and Tryggvason, 2009). It is clear 
that in vitro co-culture of EnCs with stromal cells is known to modify a range of endothelial 
responses to neutrophil recruitment, so the same may be true with GEnCs and podocytes. 
 
Figure 5: Schematic representation of neutrophil recruitment in the 
glomerular vasculature  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Neutrophil recruitment by the endothelium and their transmigration through the epithelial cells from 
blood into inflamed tissue. 
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1.1.6.4 Possible mediators released by podocytes and their 
pathophysiological role in inflammation. 
Podocytes and GEnCs are involved in many pathological processes of the kidney and the 
damage to these cells is a common occurrence during disease processes in several forms 
of GN. It is also evident that podocytes contribute to the initiation and propagation of 
disease by direct stimulation and inhibition of endothelial functions (Xing et al., 2006). 
Endothelium has been shown to produce potential mediators of inflammation some of 
which have autocrine factors and some paracrine and these are thought to stimulate the 
endothelium and other cells. There is increasing evidence that these factors are present in 
various forms of GN, regulating endothelial activation in vitro and in vivo. However, 
resident neighboring podocytes are also capable of producing soluble factors, thereby 
potentially stimulating endothelium in a paracrine manner.  
Several proinflammatory mediators play crucial roles in cell-cell interactions both in vitro 
and in vivo (Abe et al., 1990) and also mediate injury, for example, PAF augments 
glomerular injury by mediating inflammation and increasing vascular permeability 
(Camussi, 1986; Camussi et al., 1983; Camussi et al., 1984; Stewart et al., 1990; 
Zimmerman et al., 1990). Podocytes can respond to a variety of soluble mediators as they 
express cytokine and chemokine receptors which could alter the functions of neighboring 
cells during glomerular inflammation. Huber et al., (Huber et al., 2002)  detected the 
expression of functional active chemokine receptors CCR4, CCR8, CCR9, CCR10, 
CXCR1, CXCR3, CXCR4, and CXCR5 in human differentiated podocytes . Podocytes 
were also shown to produce the proinflammatory cytokines TNF-α, IL-1 and IL-6 in vitro 
(Hughes et al., 2001; Neale et al., 1995; Niemir et al., 1997; Timoshanko et al., 2003). 
They also demonstrated the ability of podocytes to produce and respond to chemokines 
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such as IL-8, since they express CXCR1/CXCR2 receptors, thereby participating in an 
autocrine loop. Podocytes were shown to respond to exogenous chemokines by producing 
ROS in vitro (Huber et al., 2002).  Pavenstadt’s group demonstrated that ROS released 
exogenously from  cultured differentiated mouse podocytes resulted in increased induction 
of GM-CSF mRNA as well as protein release (Greiber et al., 2002). GMCSF induced by 
ROS may activate mature leukocytes and play a role in prolonged inflammatory episodes. 
GMCSF also modulates cellular properties of GEnCs in a paracrine fashion. The release 
of ROS that accompanies the activation of CCRs and CXCRs may contribute to podocyte 
injury. Besides IL-8, undifferentiated rat podocytes in culture were demonstrated to release 
monocyte chemoattractant protein-1 (MCP-1), suggesting that they may actively 
participate in local inflammatory events during GN (Alon et al., 2003; Natori et al., 1997). 
Previous studies have demonstrated the active role of podocytes in inflammatory cell 
recruitment by up-regulating toll like receptor (TLR-4) expression (Rollins, 1997).  
Another important mediator involved in inflammation and in pathogenesis of the disease is 
IL-6. IL-6 is reported to be released by neutrophils and EnCs and has been shown to play 
a significant role in neutrophil retention. Renal over expression of IL-6 has been described 
in experimental GN. Xing et al., and Moutabarrik et al., reported production of IL-6 in both 
unstimulated and TNF-α stimulated podocyte culture supernatants (Moutabarrik et al., 
1994b; Xing et al., 2006). The expression of non-ubiquitous lL-6 receptor by cultured 
podocytes was also reported with inflammatory stimulation but the interaction of IL-6 with 
its receptor is not well documented. IL-6 may play a substantive role in the regulation of 
processes which appear critical to the initiation of progressive glomerular disease. 
Podocytes release angiopoetin-1 which can bind to its receptor Tie2 on endothelium and 
thereby regulate some of the actions of VEGF in stabilizing the endothelium and resist 
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increased permeability, inflammation, and angiogenesis in the mature endothelium 
(Thurston et al., 1999a; Thurston et al., 1999b). Podocytes are also capable of producing 
TGF-β and fibroblast growth factor 2 in various experimental models of GN, with potential 
for deleterious effects on podocytes themselves and on other intrinsic glomerular cells 
(Floege et al., 1995; Lee and Song).  However, the functional significance needs to be 
established. Even though the effects of the cytokines and/or chemokines are undescribed, 
soluble mediators of GEnC and podocytes clearly have the potential to play a part and 
respond to various soluble products during inflammation in the glomerulus either by 
autocrine or paracrine processes and play a major role in the pathophysiology of Vasculitic 
GN. 
 
1.1.6.5 Choice of Glomerular epithelial cells 
Culture of primary podocytes proved complex with regard to repetitive isolation and 
maintenance, so, conditionally immortalised podocytes were derived from primary 
podocytes by Saleem and his group in University of Bristol. The cell line was conditionally 
immortalised with a temperature sensitive mutant of immortalised SV40 T-antigen (Saleem 
et al., 2002). At the “permissive” temperature of 33o C (with 5% CO2) the SV40 T antigen is 
active, and allows the cells to proliferate rapidly. Thermo switching the cells to the “non-
permissive” temperature of 37o C (with 5% CO2) silences the transgene and the cells 
become growth arrested and differentiated. Cells were grown for a period of 14 days to 
ensure growth arrest and differentiation.  
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1.1.7 Hypothesis  
The hypothesis of this project is that the SP provoke the endothelium by initial activation 
and thereby alter neutrophil endothelial interactions leading to EnC damage and that the 
cross talking of podocytes with endothelium regulate its response in neutrophil recruitment 
to the inflammatory stimulus.   
 
1.1.7.1 Aims of the study 
The aim of the project is to address the following questions: 
1. Whether the SP activates the endothelium and promotes neutrophil recruitment. 
2. Determine whether SP mediate damage to the endothelium. 
3. Determine whether intercellular cross-talk occurs between the glomerular EnCs 
and podocytes and whether it affects the ability of activated endothelium to 
recruit neutrophils or other functional responses of endothelium. 
4. If cross-talk occurs, to determine whether it is cell-cell contact dependent or due 
to soluble mediators that are released. 
5. To determine the ANCA activated neutrophil response on GEnC in the presence 
of podocytes. 
6. To determine whether injury to podocytes disturb the symbiosis between the 
glomerular cells. 
 43 
Chapter-2:  Experimental procedures 
 
2.1 Cell culturing 
2.1.1 Propagation of ciGEnC 
ciGEnC were grown in endothelial basal medium 2 – microvascular (EBM 2-MV, Cambrex, 
Wokingham, UK) containing foetal calf serum (5%) (Sigma Aldrich) along with growth 
factors supplied (Table 1.1). Cells proliferate at the permissive temperature of 33°C (with 
5% CO2) and enter growth arrest and fully differentiate when transferred to 37°C. 
Confluent T75 cm2 flasks of cells were selected by phase-contrast microscopy 
(AXIOVERT 40C), washed with 0.02% EDTA (Sigma Aldrich), trypsinized with 0.05% 
trypsin (Sigma Aldrich), centrifuged at 1500rpm for 5mins, and reseeded in fresh flasks at 
a dilution of 1 into 3. Cells grown to confluence were switched to 37oC (with 5% CO2) 
incubator and could be used for experimental purposes. 
 
2.1.2 Culture of primary GEnC 
Primary cultures of GEnC (Cell Systems, USA) were grown using EBM-2 medium (as 
above) in tissue culture flasks pre-coated with fibronectin and placed in 37oC CO2 (5%) 
incubator. They were grown to confluence and are reseeded into fresh flasks at a dilution 
of 1 into 3 or grown in 96 well plates (20,000 cells / well) for use in experiments. The 
medium was changed every 2-3 days.  
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2.1.3 Isolation of HUVEC 
HUVECs were isolated from umbilical veins. Fresh human umbilical cords were collected 
with ethically approved permission from Birmingham Women’s Hospital (Ethics code 
5779). EnCs were isolated by collagenase 1mg/ml (Sigma Aldrich) digestion. Following 
isolation, HUVEC were seeded on 2% gelatin (Sigma Aldrich) coated T25 cm2 tissue-
culture flasks in medium 199 (Gibco) with supplements (shown in table 1.2). Confluent 
primary cultures were dispersed using 0.02% EDTA and 2X trypsin (Sigma Aldrich) and 
were seeded into 96-well flat-bottomed microtiter plates or T25 cm2 flasks at a 
concentration of 2x104cells/well and allowed to grow to confluence at 37oC. Each 
experiment was conducted with HUVEC’s from a different primary culture that was freshly 
isolated. 
 
2.1.4 Propagation of podocyte cell line 
Podocyte cell lines were grown to confluence at 33oC (with 5% CO2) in RPMI 1640 (Sigma 
Aldrich) with supplements (shown in table 1.3). Confluent T75 cm2 flasks of cells were 
selected by phase-contrast microscopy (AXIOVERT 40C), washed with 0.02% EDTA 
(Sigma Aldrich), trypsinized with 0.05% trypsin (Sigma Aldrich), centrifuged at 1500rpm for 
5mins, and reseeded in fresh flasks at a dilution of 1 into 4.  
The confluent podocytes were left to differentiate at 37o C (with 5% CO2) for 7 or 14 days 
for use in experiments Figure 6 (Saleem et al., 2002). 
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Figure 6: Immortalised podocytes in culture undergoing differentiation  
 
 
2.1.5 Propagation of Human Kidney Cell line -8 (HKC-8)  
Cells were grown in DMEM/Ham’s F-12 liquid with L-Glutamine (A & E Scientific (PAA)) 
and 5% FCS (Gibco). Cells were grown to confluence in T75 cm2 flasks at 37oC (with 5% 
CO2). Confluent cultures were dispersed using 0.02% EDTA/0.05% trypsin (Sigma Aldrich) 
and centrifuged at 1500rpm for 5mins, and reseeded in fresh flasks at a dilution of 1 into 4 
or seeded on the outer surface of transwell inserts at a seeding density of 60,000 cells / 
insert for co-culturing with GEnC.  
 
X40 images 
X20 images 
Cultures in flask  
Undifferentiated 
Podocytes from 33oC 
Podocytes from 37oC,  
7 day differentiated  
Podocytes from 37oC,  
14 day differentiated  
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2.1.6 Propagation of epithelial-like liver cell line (AKN-1 cells) 
AKN-1 cells are non-malignant biliary epithelial cells, and were grown in DMEM 1% GPS 
and 10% FCS (Gibco). Cells were grown to confluence in T75 cm2 flasks at 37oC (with 5% 
CO2). Confluent cultures were dispersed using 0.02% EDTA/0.05% trypsin (Sigma Aldrich) 
and centrifuged at 1500rpm for 5mins, and reseeded in fresh flasks at a dilution of 1 into 4 
or seeded on the outer surface of transwell inserts at a seeding density of 60,000 cells / 
insert for co-culturing with GEnC.  
 
2.1.7 Propagation of human retinal pigment epithelial cell line (ARPE-19 Cells) 
Cells were grown in DMEM/Ham’s F-12 liquid with L-Glutamine (A & E Scientific (PAA)) 
and 5% FCS (Gibco). Cells were grown to confluence in T75 cm2 flasks at 37oC (with 5% 
CO2). Confluent cultures were dispersed using 0.02% EDTA/0.05% trypsin (Sigma Aldrich) 
and centrifuged at 1500rpm for 5mins, and reseeded in fresh flasks at a dilution of 1 into 4 
or seeded on the outer surface of transwell inserts at a seeding density of 60,000 cells / 
insert for co-culturing with GEnC.  
 
2.1.8 Propagation of Hep-2 cells 
Cells were grown in DMEM/Ham’s F-12 liquid with L-Glutamine (A & E Scientific (PAA)) 
and 5% FCS (Gibco). Cells were grown to confluence in T75 cm2 flasks at 37oC (with 5% 
CO2). Confluent cultures were dispersed using 0.02% EDTA/0.05% trypsin (Sigma Aldrich) 
and centrifuged at 1500rpm for 5mins, and reseeded in fresh flasks at a dilution of 1 into 4 
or seeded on the outer surface of transwell inserts at a seeding density of 60,000 cells / 
insert for co-culturing with GEnC.  
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Medium Recipes: 
Table 1.1 – Constituents of Endothelial Basal medium(EBM-2) kit supplied by Lonza. 
 
Medium and Additives Volume Source 
Endothelial growth medium 500ml Lonza, Wokingham, UK 
hFGF-B - human Fibroblast 
Growth Factor-B 
2ml Lonza, Wokingham, UK  
GA-1000 - (Gentamicin Sulfate, 
Amphotericin-B)  
500l Lonza, Wokingham, UK  
Foetal Bovine serum (FBS) 25 ml Lonza, Wokingham, UK  
R3 – IGF – 1 Recombinant-long 
R-Insulin like growth factor-1 
500l Lonza, Wokingham, UK  
Hydrocortisone 200l  Lonza, Wokingham, UK  
VEGF – Vascular Endothelial 
Growth Factor  
500l Lonza, Wokingham, UK  
Human Endothelial growth 
factor 
500l Lonza, Wokingham, UK  
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Table 1.2 – Constituents of Medium199 
 
Medium and Additives Volume Final 
Concentration 
 
 
Source 
 Medium with Phenol red 100ml -  Gibco 
Hydrocortisone 10l 1 μg/ml  Sigma Aldrich, UK 
 Penicillin and 
 Streptomycin  
1ml 1 mM  Sigma Aldrich, UK 
Endothelial growth factor 10l 1 ng/ml  Sigma Aldrich, UK 
L-Glutamine 1 ml 20mM  Sigma Aldrich, UK 
Amphotericin 1 ml 2.5 μg/ml  Sigma Aldrich, UK 
FBS 20ml 20%  Sigma Aldrich, UK 
 
Table 1.3 – Constituents of Roswell Park Memorial Institute (RPMI)  medium 
 
Medium and Additives Volume  Final 
Concentration 
Source 
 RPMI-1640 Medium  100ml  - Sigma Aldrich, UK 
FBS 10ml  10% Sigma Aldrich, UK 
 Penicillin and 
 Streptomycin  
1ml  1 mM Sigma Aldrich, UK 
ITS (10ug/ml Insulin, 
 5.5ug/ml Transferrin, 
 5ng/ml Sodium selenite)  
1ml   Sigma Aldrich, UK 
L-Glutamine 1 ml  20mM Sigma Aldrich, UK 
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2.2 Viability assays 
 
2.2.1 Cell viability measured by a tetrazolium (MTT) assay  
Confluent monolayers of HUVEC, ciGEnC, podocytes and primary GEnC were treated for 
2 hours with different concentrations (0.5-15μg/ml as indicated) of PR3 (Athens 
Laboratories) or HNE (Calbiochem) or treated with different concentrations of PAN and 
incubated at 37oC. Cell viability was assessed using the tetrazolium assay in either 24 well 
or 96 well plates. Briefly, after treatments, wells were washed and incubated with MTT (3-
(4,5-Dimethylthiazol-2,5-diphenyltetrazolium bromide, 5mg/ml, Sigma Aldrich) in a 37oC 
shaking incubator for an hour. Mitochondrial dehydrogenases converted soluble yellow 
MTT into blue insoluble formazan. After 1 hour, the MTT was aspirated from the wells and 
the plate was dried on clean tissue to remove excess liquid. Formazan crystals were then 
solubilised with neat DMSO (Dimethyl Sulphoxide) (Sigma Aldrich) treated for 30 min at 
37oC and the absorbance was read at 540nm.  
 
2.2.2 Endothelial cell detachment measured by crystal violet assay 
After incubation of confluent layers of EnC’s with PR3 and HNE for 2 hours at 37oC, cells 
were fixed with 1% formaldehyde (Sigma Aldrich) for 15 minutes and stained with 0.1% 
crystal violet for 10 minutes to assess cell detachment. The cells were lysed with 1% triton 
X-100 (Sigma Aldrich) in dH2O and the absorbance of cell-associated crystal violet was 
then measured at 550nm.  
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2.2.3 Endothelial cell membrane integrity was assessed by Propidium iodide 
(PI) 
Confluent layers of EnCs were treated and incubated with 0.5 to 2 µg/ml PR3 (Athens 
Laboratories) or HNE (Calbiochem) for 2 hours and 1mM H2O2 (Sigma) used as positive 
control for 1 hour. Following treatments, cells were incubated with 20 μg/ml PI stain 
(Sigma Aldrich) for 20 minutes. PI staining locates the cells which have lost their 
membrane integrity. Cells were photographed under fluorescence microscopy on an 
Olympus inverted microscope. Cells were counted by using Image pro-analysis software 
(Media Cybernetics UK).   
 
2.2.4 Apoptosis Detection Assays 
2.2.4.1 Measurement of Apoptotic Cells by Ultraviolet (UV) Light Microscopy 
ciGEnC or HUVEC were seeded at 4x104 /well in 8 well chamber slides and grown to 
confluence. Wells were washed thrice with warm medium 199 (no phenol red) (GIBCO) 
containing 0.1% BSA (Sigma Aldrich). Cells were treated with PR3 (Athens Research & 
Technology Inc., USA) and HNE (Calbiochem, UK) in a dose and time dependent manner 
and incubated at 37oC.  After treatment, cells were fixed in 100% ethanol (Sigma Aldrich), 
air dried, and stained with 1μg/ml DNA-specific dye, 4',6-diamidino-2-phenylindole (DAPI; 
Sigma Aldrich) and incubated for 2mins. DAPI was washed off with PBS with Ca+2 (Gibco). 
Cellular morphology was assessed using a Nikon FXA research light microscope. 
Apoptotic cells were identified by chromatin condensation and fragmentation.  
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2.2.4.2 EnC apoptosis detection by flow Cytometry using Annexin V FITC and PI 
binding 
HUVEC or ciGEnC were grown to confluence in T25 flasks. The cells were treated for 2 
hours with 1ug/ml of PR3 or HNE at 37oC. A 24 hours treatment with cycloheximide (CHX; 
3µg/ml) (Sigma Aldrich) + TNFα (10ng/ml) (NIBSC) was used as a positive control. After 
incubation, the cells were harvested by gentle trypsinisation and centrifuged for 10min at 
1500rpm. Cells were washed with PBS containing calcium and centrifuged for 5min at 
1500rpm. The specific binding of annexin V- fluorescein isothiocyanate (FITC) and 
incorporation of PI (Invitrogen, UK) was performed by incubating the cells for 15 min at 
room temperature in binding buffer. After incubation, the cells were immediately analyzed 
using a FACS analyzer (Becton Dickinson, San Jones, CA, USA). Annexin V+/PI+ cells 
were defined as necrotic (or late apoptotic), while annexin V+/PI- cells were defined as 
apoptotic. The data obtained is analysed using the Cell Quest software. 
 
2.2.4.3 EnC apoptosis detection by caspase-3 activation using western blotting 
Confluent HUVEC or ciGEnC in T25 flasks were treated for 2 hours with 1ug/ml of PR3 or 
HNE and incubated at 37oC. Cells treated with cycloheximide (CHX) (3ug/ml) +TNF 
(10ng/ml) for 24 hours were used as positive controls. After incubation the cells were 
harvested by 0.02% EDTA (Sigma Aldrich) treatment, washed in 1X PBS (Sigma Aldrich) 
and lysed with 250ul of lysis buffer (recipe table 1.3) PBS with 10ul of Protease inhibitor 
cocktail (Calbiochem) for 15min on ice. Then the cell extracts were centrifuged for 15min 
at 1500rpm and the supernatants were collected. The cell lysates were reduced by adding 
55 µl of 6X sample buffer which contain 10% SDS and 5% β-mercaptoethanol to 250 µl of 
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sample and 20 µl loaded onto a 15% Tris-glycine gel (Severn Biotech limited, UK) (Gel 
receipe, table 1.4). 
The proteins were resolved by SDS-PAGE. The proteins were then transferred onto PVDF 
membrane (Hybond ECL, Amersham Biosciences) using a semi-dry transfer unit at 34 mA, 
shaking for 1h at 4 oC. The membrane was then blocked for 3-4 hours at room temperature 
in Tris Buffered Saline with 0.1% Tween-20, Sigma Aldrich (TBS-T) (24.2g of Tris base 
and 80g Sodium Chloride in 1L water) containing 5% (W/V) dried milk. This was followed 
by overnight incubation with polyclonal rabbit anticaspase-3 unconjugated primary 
antibody (Invitrogen) diluted at 1: 1000 in 5% dried milk, at 4oC. The membrane was 
washed thrice for 30min each time with TBS-T and incubated with horseradish peroxidise- 
conjugated goat anti-rabbit (Biosource) at 1:1000, for an hour at room temperature. The 
membrane was washed with TBS-T as before and the proteins were visualised using 
chemiluminescence using ECL plus substrate (GE) for 5min.  
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Table 1.4 – Constituents of Cell lysis buffer 
Additives Final Concentration Source 
Tris HCL pH 7.4 50mM Sigma Aldrich  
Nonidet-P40 (NP-40) 1 % Sigma Aldrich, UK 
Sodium deoxycholate 0.25% Sigma Aldrich, UK 
Sodium Chloride 150mM Sigma Aldrich, UK 
EGTA 1mM Sigma Aldrich, UK 
PMSF 1mM Sigma Aldrich, UK 
Sodium Fluoride 1mM Sigma Aldrich, UK 
Protease inhibitor cocktail 2% Calbiochem, UK 
 
Table 1.5 – Western Blotting Gel Recipe 
 
Resolving gel recipe 
 
15% 
 
 
Stacking gel recipe 
 
5 % 
 
Acrylamide 3.75 ml Acrylamide 1 ml 
Bis- Acrylamide 400 µl Bis- Acrylamide 520 µl 
1.5M Tris pH 8.8 3.73 ml Tris pH 8.8 1 ml 
10% SDS 100 µl 10% SDS 80 µl 
10% APS 67 µl 10% APS 80 µl 
TEMED 5 µl TEMED 8 µl 
Water 1.998ml Water 5.312 ml 
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2.3 EnC treatments 
Confluent EnC were treated in serum-free medium 199 (Invitrogen) with 0.05% BSA 
(Sigma Aldrich) with 1µg/ml of either PR3 (Athens Research & Technology Inc., USA, 
stock 100 µg/ml) or HNE (Calbiochem, UK, stock 100 µg/ml) for 2 hours or 24 hours or 
with 1 units/ml (0.01ng/ml) or 10 units/ml (0.025ng/ml)  or 100units/ml (2.5ng/ml) TNF-α 
(NIBSC) for 4 hours. The enzyme activity of PR3 and HNE was tested against 100µl of the 
synthetic substrate (2mM) N-methoxy-succinyl-Ala-Ala-Pro-Val-4nitroanilide (Sigma 
Aldrich) and incubated at room temperature protecting from light and the absorbance was 
read from 5 minutes to 4 hours at 405nm.  
In some experiments, serine protease inhibitor, Alpha 1  anti trypsin (prolastin, a gift from 
Telecris Biotherapeutics, USA, Stock 100mg reconstituted in 40ml sterile water) was 
added to the cultures along with the proteases diluted in M199 with 0.05% BSA to a 
working concentration of 140nM. 
2.4 Neutrophil Isolation from whole blood using percoll density gradient 
method 
Blood from consented healthy volunteers, was collected into tubes with anticoagulant, 10% 
acid citrate dextrose (ACD), containing disodium hydrogen citrate (Sigma Aldrich) and D-
glucose. Neutrophils were isolated using a two step density gradient. Whole blood was 
layered over percoll gradients (GE Health Care, UK) and centrifuged at 1500g for 30 
minutes. The middle neutrophil fraction was harvested and washed twice in phosphate 
buffered saline (PBS) with calcium and magnesium (Gibco). The neutrophils were then re-
suspended in 1 ml of PBS/BSA, count and cellular viability was assessed by trypan blue 
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exclusion using a hemocytometer and then re-suspended to a concentration of 1 x 106 
cells per ml in PBS/BSA. The preparations contained >98% neutrophils.  
2.5 Isolation of ANCA IgG and normal control IgG 
ANCA-positive IgG (WG or MPA active patient’s IgG) was isolated from plasma exchange 
fluid (PEX) collected from patients and normal control IgG (ANCA-negative IgG) was 
obtained from the serum of consented healthy volunteers. 50 ml aliquots of PEX samples 
were added with 1ml calcium chloride (1 molar) to remove clotting factors such as fibrin, 
heated in a water bath and then the precipitant was removed. The patient’s serum and 
normal serum was diluted with PBS in equal volumes and filtered separately using 0.2m 
and passed through a 5ml volume HiTrap Protein G column (Amersham Biosciences). IgG 
trapped in the column was eluted using 0.1 molar glycine, pH 2.6  and neutralised with 1 
ml of 1 molar Tris base (Sigma Aldrich), pH 9.0. The samples were placed into pre-boiled 
dialysis tubing (10-14kDa cut off) and dialysed in PBS overnight at 4ºC. The samples were 
collected into vivaspin concentrators (Vivascience, Hannover, Germany) and spun to 
concentrate to approximately 1mL volume with a 10,000 Da cut off, and stored at 4˚C for 
up to one month. 
The concentration of the eluted IgG was determined by spectroscopy. ANCA IgG samples 
were diluted 100X and the absorbance was measured at 280nm using PBS buffer as a 
blank in quartz cuvette. The protein concentration of the samples was determined using 
the following equation (derived from the Beer Lambert law): A =  x C x L (A = absorbance; 
 = molar extinction coefficient; C = concentration; L = length of the light path.) The molar 
extinction coefficient for IgG at 280nm is 1.43 and the light path of a 1ml cuvette is 1cm. 
Protein concentrations using this method are expressed in mg/ml. Therefore, the resulting 
equation is: 
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Concentration (mg/ml) = A x dilution factor 
                                      =  1.43 x 1 
2.5.1 Endotoxin removal from immunoglobulin preparations 
Endotoxin removing gel (Detoxi – gel from Pieree) was used to remove endotoxin from 
ANCA IgG and normal IgG preparations. The gel beads were washed in PBS with 1% 
sodium deoxycholate (Sigma Aldrich) in an eppendorf and spun at 13000RPM for 30 
seconds. The supernatant was discarded and the washing was repeated thrice. The IgG 
preparations were pipetted in 50% suspension with beads and left in rotation overnight at 
4oC. The samples were spun at 13000 RPM for 5 minutes and supernatants were 
collected. The beads were washed in PBS with 1% sodium deoxycholate as before and 
were stored in 25% ethanol at 4oC for future use. 
 
2.6 Adhesion assays 
2.6.1 EnC static neutrophil recruitment assay 
HUVEC and GEnC (primary and secondary) seeded at 2x104/well in 96 well plates were 
grown to confluence. Wells were washed with medium 199 (GIBCO) with 0.15% BSA prior 
to treatment for 2 hrs with 0 & 1 µg/ml PR3 or HNE and for 4 hrs with TNFα 100 units/ml 
(NIBSC, a positive control). Neutrophils, that were isolated using the Percolll gradient 
method (as above), were added at concentration of 2.5x105 cells/well and incubated at 
37°C for 1 hour. A standard curve plate was prepared in parallel to the experiment with 
2.5x105 neutrophils and then serial diluted. At the end of the incubation period, non- 
adhered neutrophils in supernatants were very gently sucked off and EnC monolayer was 
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washed thrice with warm PBS. The cells were lysed with 0.1% triton X-100 and 100ul of 
MPO substrate (SIGMA ALDRICHFAST™ OPD) was added and absorbance read at 
450nm after 1hr on a Thermo© Multiskan Ascent plate reader. The number of adherent 
neutrophils was determined by comparing the absorbance with a neutrophil standard curve 
(0-2.5x105 cells). 
 
2.6.2 Adhesion assay on TNF-α activated HUVEC under flow model 
2.2.6.2.1 Microslide preparation and testing using platelets 
Glass capillaries or microslides (rectangular cross-section, 0.3x3mm; length, 50 mm, 
Camlab, Cambridge, UK) were cleaned with nitric acid, washed with water followed by 
acetone and coated with 4% 3-aminopropyltriethoxysilane (APS). The microslides were 
allowed to dry and autoclaved. To check the effectiveness of APES coating, platelets were 
layered into the microslide. For the experimens the slides were coated again with 1% 
gelatin (type B from bovine skin, Sigma Aldrich) or 2µg/cm2 fibronectin (from human 
plasma, Sigma Aldrich). 
 
2.6.2.2 Transfer of EnCs into microslides 
The confluent cultures of HUVEC or primary GEnC grown in T25cm2 were harvested with 
trypsin and EDTA 0.2%. The cells were spun at 1500rpm for 5 minutes and the pellet was 
re-suspended in 0.4mls of medium. Endothelial cells were seeded into gelatinized 
microslides at a concentration of 1.5x105 cells per slide and incubated for 2-3 hours at 
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37ºC allowing adherence and spreading of the endothelial cells. The slides were then 
placed in a modified glass petri dish filled with medium and the slides were connected via 
rubber tubing to a pump which exchange medium at a speed of 15rpm through the slides 
every hour. The endothelium was cultured in this system for 24 hours or until the 
experimental treatments allowing maintenance of a healthy monolayer. 
 
2.6.2.3 The flow based adhesion assay 
The microslides with healthy confluent EnC monolayers were individually treated with 
different treatments, 4h TNF-α (2, 10, 100 Units) treatment on HUVEC or 2h PR3/HNE (1 
µg/ml) treatment on primary GEnCs and incubated at 37 ºC. After 4h incubation, flow 
adhesion experiments were performed in an enclosed Perspex chamber at 37ºC (XFigure X 7). 
Each individual microslide was glued onto a glass microscope slide mounted on a phase-
contrast microscope. One end of the microscope slide was attached via silicon rubber 
tubing to a syringe pump (set to 0.1Pa wall shear) allowing control of the rate of flow 
across the microslide surface. The other end of the microslide was connected by silicon 
rubber tubing to an electronic valve (Lee Products, Gerards Cross, UK), which allowed 
switching between a reservoir of wash buffer (PBS with calcium and magnesium/0.1% 
BSA) and a reservoir containing neutrophil suspension isolated by percoll method 
(1x106/ml diluted in PBS with 0.1% BSA). Flow was switched between wash buffer and 
neutrophil suspension and was perfused for 4 minutes, followed by a washout of 1 minute. 
The number of neutrophils rolled over the endothelial monolayer, adhered or transmigrated 
were viewed and recorded both in real time and on video. Video microscope recordings 
were then made in 4-5 fields, 5 minutes after the initial perfusion of neutrophils to look at 
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rolling neutrophils and at 10minutes for transmigration along the centre of the microslide in 
the direction of flow. Video recordings were analysed using Image Pro-Plus software 
(MediaCybernetics). 
Figure 7: Flow Model 
 
Figure 7: The flow model. All flow experiments were performed in a Perspex box at 37ºC. The microslide, 
mounted on a glass microscope slide was attached to a pump and to the sample and wash buffers. Events in 
the slide were viewed through the microscope, recorded on video and analyzed on the computer. (Image 
copied with permission from Dr Tanya Pankhurst) 
 
2.7 Immunostaining of podocytes for differentiation marker, Podocin 
The immunolabeling was done to identify the differentiation markers of Podocytes. 
Podocytes were grown in chamber slides and allowed to differentiate at 37o C (with 5% 
CO2) for 7 or 14 days. Briefly, slides were fixed with ice cold methanol for 10 min and then 
air dried at room temperature for 30 min. Nonspecific binding was blocked with 4% FBS 
with 0.1% Tween 20 (Sigma Aldrich) in PBS for 30 min. 1µg/ml of polyclonal rabbit anti 
 60 
NPHS2 primary antibody (Abcam) was added onto the slide and incubated overnight at 4o 
C. The slides were washed thrice with PBS with 2% FBS and 1% BSA and secondary 
antibody (Anti- Rabbit FITC, DAKO) was applied at the appropriate dilutions (1:10 to 1:40) 
and incubated for 1 hour protected from light. The slides were washed three times with 
PBS with gentle agitation. Cover slips were mounted on glass slides with slowfade 
(invitrogen). The pictures were taken using fluorescent imaging. 
 
2.8 Co-culturing of podocyte cell line and EnCs 
2.8.1 Seeding podocytes and EnCs on co-culture inserts 
The confluent flask of podocytes was washed with 0.02% EDTA (Sigma Aldrich), 
trypsinised (Sigma Aldrich), centrifuged at 1500rpm for 5mins. The cells were counted 
using a CASY® Technology Cell Counter. The cells were resuspended at a seeding 
density of 6x104 cells/ insert and seeded onto the external surface of the 3um porous 
polyethylene terepthalate transwell filter inserts (BD Pharmingen, UK) and allowed to settle 
for 2 hours adding medium after 1 hour. The inserts were placed in 24 well companion 
plates at 37oC and the podocytes were left to differentiate for 7 or 14 days.  Similarly, 
EnCs (6X104 cells/ insert) were seeded on the inner surface of inserts in complete RPMI 
medium and left to settle overnight at 37o C (adapted from (McGettrick et al., ; Rainger and 
Nash, 2001; Rainger et al., 2001)).   
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2.8.2 Electrical resistance (ER) measurement on inserts across cell cultures 
The ER across the monolayers of HUVEC and/or podocyte cell line cultured on filters was 
measured using the Millicell-ERS resistance meter according to the manufacturer’s 
instructions (Millipore, USA). 
 
Figure 8: The millicell-ERS resistance meter 
 
 
 
Initially the electrodes were immersed in fresh RPMI for 15 min followed by manually 
adjusting the resistance setting to zero. The filters were placed in a special electrode 
chamber, containing 700ul of culture medium, with centrally located electrodes to ensure 
reproducibility. The ER across the monolayer was measured and recorded. The electrodes 
were washed in fresh culture medium between resistance measurements. The resistance 
meter was stored according to manufacturer’s instructions. Cell monolayer resistance was 
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obtained by subtracting the resistance of a blank filter from the resistance of the sample 
filter. This was obtained by subtracting the area of the filter, to calculate resistance in ohms 
cm2. 
 
2.8.3 Transwell assay with endothelial and epithelial co-culture to assess 
neutrophil recruitment 
Podocytes were seeded onto the 3um porous transwell filter inserts (BD Pharmingen, UK) 
as described in section 2.7. EnCs were seeded on the inner surface of inserts in RPMI 
complete medium 24hrs prior to an experiment and left to settle overnight at 37o C.  For 
comparison, parallel cultures of EnCs alone and podocytes alone were seeded inside 
inserts as controls in RPMI complete medium. This assay is illustrated in figure 9 below.  
 
Figure 9: Illustration of co-culture 
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The viable confluent layers of cells on the inserts were stimulated with TNF-α (NIBSC) 
diluted in RPMI medium in a dose dependent manner (0 -100Units/ml) and added to both 
upper and lower chambers for 4 hours and incubated at 37oC. Following incubation, 
supernatants were collected from the upper insert and from the lower wells and stored at 
80oC for multiplex bead assay using LUMINEX (Invitrogen, UK).  
After stimulation with cytokines, the inserts were washed with fresh medium and were 
transferred into a fresh plate. Fresh medium (RPMI+0.1% Bovine serum albumin (BSA)) 
was added in the upper and lower chambers. The neutrophils isolated by percoll density 
gradient method (as described earlier) were added into the upper insert (2X105 cells/well in 
RPMI+BSA). Neutrophils were added either directly without priming or activating by TNF-α 
(2 and 10 units/ml) and IgG [normal or ANCA (200ug/ml)] before perfusion. Neutrophils 
were allowed to settle, adhere and migrate at 37o C for 1 hour. The experiment was 
stopped by transferring the filter into a fresh well. The neutrophils in the upper chamber 
were collected and the filter was washed twice. The cells from the washes were pooled 
with the upper sample and were taken to represent non-adherent neutrophils. The 
neutrophils in the lower chamber were collected and washed twice with fresh medium. The 
washes were pooled with the sample from the lower chamber; these pooled samples 
contained transmigrated neutrophils. The neutrophil counts from the samples collected 
(counted using Casy counter) represent the number of non-adherent and the 
transmigrated cells. From this data, the percentages of non-adherent, adherent and 
migrated neutrophils were determined.  
The results were represented as total recruited and transmigrated neutrophils. Total 
recruited neutrophils represent those that were adherent and those subsequently 
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transmigrated to the bottom chamber (% recruited = adherent + total transmigrated/total 
added neutrophil* 100) and the % transmigrated represent the total transmigrated 
neutrophils of total recruited neutrophils (% transmigrated = total transmigrated / total 
recruited * 100).  
The wells were examined microscopically to ensure that all cells are removed and washed 
further if necessary. The inserts were fixed in order to analyze the location of neutrophils 
on the insert by using 2% isotonic glutaraldehyde (Sigma Aldrich) containing 1ug/ml 
bisbenzimide (Sigma Aldrich) for 15 minutes in the dark followed by 4 washes in PBS to 
get rid of excess Fluorochrome from the pores. They were then cut out directly onto 
microscope slides, and cover slips were mounted using the mountant, Vectashield H1000 
(in the dark). 
Observations were made using UV fluorescent microscopy and images were recorded for 
analysis using Image pro-plus software package (Data Cell Ltd, UK). The total number of 
neutrophils were counted and converted to cells / mm2 using the known field dimensions, 
multiplied by the area of the filter, divided by the total number of neutrophils added, and 
then multiplied by 100 to express percentage neutrophil recruitment of total added. 
 
Number of Pictures in well area (X) = area of filter or insert 
                                                                  Area counted 
Neutrophil count/mm2 = average counts 
                                                   X                  
Area of a 24 well is 1.767cm2 (given by BD falcon), area of insert filter is 1.3cm2 (given by 
BD falcon). 
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Figure 10: Video images of cells on apical and basal surfaces of the filter 
  
 
 
2.9 Neutrophil recruitment assay to HUVEC and GEnC following conditioning 
with podocyte medium 
HUVEC and GEnC (primary and secondary) seeded at 6x104/well in 24 well plates were 
grown to confluence in EBM-2 (Lonza, UK). Cells were treated with conditioned medium 
from 14 day differentiated podocytes and incubated at 37o C for 24 hours. Endothelial 
monolayers were stimulated with 0–100 Units/ml of TNF-α (NIBSC) in podocyte 
conditioned medium for 4 hours, at 37o C. Neutrophils were isolated using the percoll 
gradient method (as previously described) and resuspended in RPMI+0.1% BSA, added to 
the wells at concentration of approximately 2x105cells/well and incubated for 1 hour. After 
Neutrophil recruitment on inserts with ciGEnC and ciGEC co-culture 
Neutrophil recruitment on inserts with ciGEnC 
alone 
Apical surface of the insert Basal surface of the insert 
Apical surface of the insert Basal surface of the insert 
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incubation, wells were washed with RPMI containing BSA thrice and non-adhered 
neutrophils were washed off. Cells were stained with 1ug/ml bisbenzimide (Sigma Aldrich) 
for 15 minutes in the dark followed by 4 washes in PBS to get rid of excess fluoro-chrome 
from the pores (in the dark). 
Observations were made using UV fluorescent microscopy and images were recorded for 
analysis using Image pro-plus software package (Data Cell Ltd, UK). The total number of 
neutrophils were counted and converted to cells/mm2 using the known field dimensions, 
multiplied by the area of the filter, divided by the total number of neutrophils added, and 
then multiplied by 100 to express percentage neutrophil recruitment of total added. 
 
2.10 Transwell assay with endothelial cells in the presence, but not in contact 
with epithelial cells to assess neutrophil migration by soluble mediators  
Podocytes were seeded onto the 24 well insert companion plates (BD Pharmingen, UK) at 
a seeding density of 60000/well and left to differentiate for 7 or 14 days in a 37o C 
incubator (with 5% CO2) (Figure 11). EnCs were seeded on the inner surface of inserts in 
RPMI complete medium 24 hours prior to use in an experiment and left to settle overnight 
at 37o C (as described in section 2.2.8.1).  For comparison, parallel cultures of EnCs alone 
as well as Podocytes alone were seeded inside inserts as controls in RPMI complete 
medium. The confluent layers of cells in the inserts were stimulated with TNF-α (NIBSC) in 
a dose dependent manner (0 -100Units/ml) for 4 hours in RPMI medium. The rest of the 
procedure was identical to Section 2.2.8.3. 
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Figure 11: Structure of co-culture with EnCs and podocytes with no direct 
contact 
 
 
 
 
 
 
 
 
 
 
 
2.11 Neutrophil recruitment assay following treatment with IL-6 on GEnC 
mono-cultures 
GEnC were seeded at 6 x 104 cells / well in 24 well plate insert. Cells were treated with 
10ng/ml of IL-6 incubated at 37o C for 24 hours. The concentration was chosen as this was 
the approximate amount of IL-6 that was detected in co-cultures by LUMINEX. Endothelial 
monolayers were stimulated with 0–100 Units/ml of TNF-α (NIBSC) in RPMI medium for 4 
hours, at 37o C. Neutrophils were isolated using the percolll gradient method (as previously 
described) and resuspended in RPMI+0.1% BSA, added to the wells at concentration of 
Podocytes
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approximately 2x105cells/well and incubated for 1h. After incubation, wells were washed 
with RPMI containing BSA thrice and non-adhered neutrophils were washed off. Cells 
were stained with 1ug/ml bisbenzimide (Sigma Aldrich) for 15 minutes in the dark followed 
by 4 washes in PBS to get rid of excess fluoro-chrome from the pores (in the dark). 
Observations were made using UV fluorescent microscopy and images were recorded for 
analysis using Image pro-plus software package (Data Cell Ltd, UK). The total number of 
neutrophils were counted and converted to cells / mm2 using the known field dimensions, 
multiplied by the area of the filter, divided by the total number of neutrophils added, and 
then multiplied by 100 to express percentage neutrophil recruitment of total added. 
 
2.12 Multiplex cytokine immunoassay and ELISA to detect soluble mediators 
Invitrogen’s multiplex bead immunoassay was used to detect cytokines and chemokines in 
the supernatants collected from co-cultures. Cytokines measured included IL-1β, IL-1α, IL-
2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 , IL-13, IL-15, IL-17, interferon-γ (IFN-γ), 
IFN- α, TNF-α, GM-CSF, MCP-1, CCL3 (MIP-1α), CCL4 (MIP-1β), GM-CSF, CCL11 
(eotaxin), CCL5 [regulated upon activation, normal T cell expressed and secreted 
(RANTES)], TNFRI and TNF-RII. A Quantikine ELISA kit for ENA-78 (R&D systems) was 
used as per manufactures instructions. 
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2.13 Blocking Studies 
2.13.1 CXC – chemokine receptor blocking in co-cultures and mono-cultures  
To investigate the role of neutrophil chemokines receptors CXCR1 and CXCR2 in 
neutrophil recruitment and migration, the receptors were blocked. Neutrophils were treated 
with function-blocking antibodies against CXCR1 and CXCR2 (IgG1, Biosource, Belgium, 
clones 501 and 19, respectively) and the antibodies used at 4 ug/ml (1ul of stock 
0.1g/0.1ml) in 100ul of neutrophils (up to 3x106 cells/ml) and incubated for 30 min prior to 
addition to the cultures. 4 ug/ml antibodies against CXCR1 & 2 were used after optimising 
the concentration, as preliminary studies with 2 ug/ml (concentration adapted from 
(Calderwood et al., 2005)) did not work in co-cultures. The function neutralizing antibodies 
against CXC chemokines were incorporated into the co-culture system to see the effect of 
anti CXCR1 & 2 antibodies on neutrophil recruitment to EnCs co-cultured with podocytes. 
 
2.13.2 Neutralization of IL-6 activity in culture supernatants 
IL-6 was measured in the supernatants from GEnC mono-cultures and GEnC Podocyte 
co-cultures using LUMINEX assay (Invitrogen, UK). To neutralize IL-6 activity, monoclonal 
anti IL-6 antibody (5ug/ml, R&D systems, clone 6708) was added to the medium with the 
establishment of co-cultures and maintained throughout the experiment. The concentration 
was chosen after optimising it with different concentrations ranging from 1-10µg/ml. In 
some experiments, antibody was removed with the addition of neutrophils, while other 
experiments were carried with the presence of neutralising IL-6 antibody along with 
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neutrophils as well. Static adhesion assay is carried as explained earlier with co and 
mono-cultures of ciGEnCs. 
 
2.13.3 Blocking of IL-8, ENA 78 and GRO-α in co-culture studies 
GRO-α and IL-8 were measured in the supernatants from GEnC mono-cultures and 
GEnC/Podocyte co-cultures using LUMINEX assay (Invitrogen, UK). To block GRO- α and 
IL-8 monoclonal anti GRO antibody (2ug/ml, R&D systems, clone 31716) and IL-8, 
monoclonal anti IL-8 antibody (10ug/ml, R&D systems, clone 6217) were added to the 
cultures after cytokine stimulation along with the addition of neutrophils. Static adhesion 
assay is carried as explained earlier with co and mono-cultures of ciGEnCs. 
ENA-78 was measured in the supernatants from GEnC mono-cultures and 
GEnC/Podocyte co-cultures using human ENA-78 immunoassay (R&D systems). ENA-78 
was blocked in cultures as described above using monoclonal anti ENA-78 antibody 
(5ug/ml, R&D systems, clone 33160). 
The concentration were used following optimisation with range of concentrations and 
picked the appropriate one to carry on further. 
 
2.14 Statistics 
All experiments were performed at least three times and presented as the meanSEM. 
Variation between multiple treatments was evaluated using ANOVA followed by bonferroni 
multiple comparison post-test or Dunnetts post-test and student T tests. P<0.05 were 
considered statistically significant. 
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Chapter 3: Investigating the role of SP on EnC activation and 
viability in VGN 
3.1 Introduction  
Neutrophilic SP have been identified as the targets of ANCA associated vasculitic 
diseases. Raised plasma levels of PR3 or HNE, either complexed with their inhibitors or 
alone, have been detected during active disease (Haubitz et al., 1997; Henshaw et al., 
1994). The SP mediated EnC damage is thought to play a very important role in the 
vasculitic process but the importance of SP in GEnC activation that occur during the 
development of VGN, has not been fully defined. Under normal conditions these SP assist 
in clearance of pathogens within phagolysosomes and in neutrophil migration across the 
endothelium as part of the immune response (Janoff, 1985a). The process of diapedesis 
does not generally result in EnC damage (Huber and Weiss, 1989), however, during 
disease states, ANCA against SP present in the sera of patients, are shown to be capable 
of activating cytokine primed neutrophils, resulting in degranulation and an oxidative burst 
resulting in endothelial damage (Charles et al., 1991; Ewert et al., 1991; Keogan et al., 
1992). Several mechanisms of EnC damage have been identified involving EnC 
detachment induced by SP that degrade a variety of matrix proteins including fibronectin, 
laminin, vitronectin, and collagen type IV (Ballieux et al., 1994; Varani et al., 1989; Westlin 
and Gimbrone, 1993). Under serum free conditions, increasing concentrations of PR3 or 
HNE can induce cleavage of thrombomodulin and detachment of EnC in vitro (Boehme et 
al., 2002). This proteolytic activity of SP is shown to be inhibitable by the presence of α1 
antitrypsin (α1-AT) (Ballieux BE, 1993; Rao et al., 1993), but in the circulation, the 
concentration of the inhibitors is generally low (approx. 60ng/ml) and are easily inactivated 
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by ROS produced during an oxidative burst, thereby enhancing damage mediated by SP 
(Janoff, 1985b; Kramps JA, 1984, 1988). The pathogenic significance of PR3 or HNE 
certainly needs further investigation.  
We hypothesized that PR3 or HNE provoke the endothelium by initial activation and 
thereby alter neutrophil endothelial interactions leading to EnC detachment and cytolysis 
during VGN. In this chapter the pathogenic role of SP on EnC is explored - by studying the 
activation, functionality and viability. My study also determined if the effects of SP are 
completely enzymatic and inhibitable by the role of protease inhibitor α1-AT. EnC cultures 
were incubated with an increasing range of concentrations of these inflammatory 
mediators in order to determine the time and concentration dependent effects on EnC 
stimulation or activation leading to the neutrophil recruitment or on EnC injury and whether 
the effects were independent of proteolytic effects.  
.  
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3.2 Methods 
Endothelial damage was tested following increasing concentrations of PR3 or HNE: 
 Following the treatments with SP, the cells were were tested for their mitochondrial 
activity using MTT assay.  
 EnC detachment was tested using crystal violet staining 
 PI staining was done to check the membrane integrity of the EnC 
 EnC apoptosis was measured using DAPI staining, Caspase -3 cleavage and 
Annexin V and PI binding. 
EnC stimulation or activation following SP treatment was measured by static neutrophil 
recruitment assay and physiological flow based neutrophil recruitment assay.  
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3.3 Results 
 
3.3.1 Effect of 2 hours treatment of PR3 or HNE on EnC survival:  
3.3.1.1 EnC viability was determined by measuring mitochondrial activity: 
 
Initially, we exposed EnCs (HUVEC, ciGEnC & Primary GEnC)  to a range of 
concentrations of PR3 or HNE (0.5 - 15 μg/ml) for 2 hrs to identify the point where viability 
slips away under serum-free conditions testing the mitochondrial activity using the MTT 
assay as described previously (Fig.12A). The results revealed that the treatments with 
PR3 (0.5-15 µg/ml) for 2 hours on all the cell types did not show any significant reduction 
in viability compared to untreated controls. Treatment with HNE (0.5-15 µg/ml) did not 
affect viability of ciGEnCs, but on HUVEC there was significant decrease in cell viability 
with increasing concentrations over 5µg/ml (Fig.12A). The viability of HUVEC was reduced 
significantly to 38.9%±15.15 of control values (**p<0.01 by one-way ANOVA with 
Dennett’s Post test with 11 data sets). This infers that at the 2 hours time point, 
concentrations of upto 5 μg/ml of PR3 or HNE do not reduce cell viability. The significant 
damage to HUVEC on treatment with concentrations over 5μg/ml of HNE may reflect the 
sensitivity of primary cultures. ciGEnC were not affected even with the higher 
concentrations. Primary GEnCs were treated only with lower concentrations of PR3 or 
HNE (0.5 - 2 μg/ml) and no loss in mitochondrial activity was observed following the 2 
hours treatment (Fig. 12B). The effect shown by HNE at higher concentrations (10µg/ml) 
on EnC viability was completely inhibited by α1-AT.  
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Figure 12: Mitochondrial activity measuresment following 2 hours SP 
treatment 
 
 
Fig 12: Effect of 2h treatment with PR3 or HNE on mitochondrial activity. Figure 12A ciGEnC and HUVEC 
were treated with 0.5-10µg/ml of PR3 (P) or HNE (E) for 2hours and cell viability was assessed using the 
MTT assay. α1-AT was used to determine any alterations in EnC viability were due to proteolysis. Figure 
12B shows the effect of treatments (0.5 – 2 μg/ml PR3 or HNE) on primary GEnC. 1mM H2O2 treatment was 
used as positive control. Statistics: One way ANOVA with Dunnett Post Test, protease treated vs controls 
**p<0.01 and One way ANOVA with Bonferroni post test. **P<0.01, ***P<0.0001. 
 76 
3.3.1.2 EnC monolayer detachment measured by crystal violet Assay 
 
Crystal violet assay was used to enumerate the percentage of adherent viable cells 
following SP treatments. HUVEC and ciGEnCs were treated with concentrations (0.5, 1, 2 
and 10 μg/ml) of PR3 or HNE and a crystal violet assay was performed. The results 
obtained confirmed results from the MTT assay, where PR3 did not affect cell attachment 
even at higher concentration of 10 μg/ml on both cell types, whereas HNE (10 μg/ml) 
treatment showed increased cell detachment significantly in HUVEC to 55.98%±2.27 of 
control values (**p<0.01 by one-way ANOVA with Bonferroni’s post test with 3 data sets), 
but in ciGEnCs it did not reach significance when compared to control (Figure 13).   
 
Figure 13: EnC attachment measured by crystal violet assay 
 
 
 
Figure 13:  Effect of 2h SP treatment on EnC attachment measured by crystal violet assay. GEnC and 
HUVEC were treated with 0.5-10µg/ml PR3 (P) or HNE (E) for 24 hours and cell attachment was assessed 
using the crystal violet assay. Statistics: One way ANOVA with Bonferroni post test, control vs SP. 
n=3-4 
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3.3.1.3 Membrane integrity assessed by PI staining following the treatment 
with PR3 or HNE  
 
The effect of SP on the membrane integrity of a healthy cell was determined by PI 
staining. Confluent monolayers of HUVEC, primary and secondary GEnCs were treated 
with different concentrations (0.5, 1, 2 μg/ml) of PR3 or HNE for 2 hours and tested for the 
loss in membrane integrity (Fig. 14). This assay showed no decrease in cell membrane 
integrity following these treatments and thus confirmed the MTT and crystal violet assay 
data.  
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Figure 14: Membrane integrity tested by propidium iodide staining 
 
 
 
 
 
 
 
 
 
 
Figure 14:  Membrane integrity of ciGEnC, HUVEC and primary GEnC detected by PI staining following 
treatment with PR3 or HNE (0.5 to 2 μg/ml) for 2 hours, 1mM H2O2 treatment for 1hr was used as a positive 
control. Figure 14A shows the counts of the PI positive cells and figure 14B shows the phase contrast 
images representing all cell types. Statistics: One way ANOVA with Bonferroni post test. 
 Endothelial cell membrane intregrity  
Control         PR3 
1µg/ml 
         HNE 
1µg/ml 
 
 
H202 
1mM 
) 
14A 
14B 
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3.3.1.4 Monolayer integrity assessed by phase contrast microscopy following 
treatment with PR3 or HNE  
 
Confluent monolayers of HUVEC, primary and secondary GEnC’s were treated with 
different concentrations (0.5, 1, 2 μg/ml) of PR3 or HNE (Fig. 15) and cell layers were 
observed for loss of monolayer integrity by using phase contrast microscopy. There was 
no loss of monolayer integrity with PR3 treatment, but HNE 2 μg/ml showed retraction of 
the monolayer following 2 hours treatment. A similar effect was observed with all cell 
types. 
Figure 15: The effect of PR3 or HNE on EnC monolayers following 2 hours 
treatment 
 
 
Figure 15 represents the damage caused to monolayers of EnCs following 2 hours treatment with 2µg/ml 
PR3 or HNE.  The phase contrast images (Fig 15) are representative for all cell types.  
2µg/ml HNE 2µg/ml PR3 
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3.3.1.5 Apoptosis detection following the treatment with PR3 or HNE 
 
Endothelial monolayers treated with PR3 or HNE at concentrations of 1 or 10 μg/ml for 2 
hours, were tested for apoptosis using different techniques  
(i)UV light microscopy using DNA specific DAPI staining to visualize intact nuclei (Fig 16)  
(ii) Caspase 3 dependent apoptosis by western blotting (Fig 17)  
(iii) FACS using annexin V and PI staining (Fig 18) to detect early and late apoptotic 
stages.  
The results have shown no detectable apoptosis at the concentration of 1 μg/ml with both 
the enzymes on HUVEC and ciGEnC. 10 μg/ml of PR3 or HNE treatment for 2 hours on 
both cell types resulted in reduction of monolayer integrity but no detectable apoptosis as 
visualized by DAPI staining. These changes were inhibited by treatment with α1-AT 
(Prolastin) at molar excess concentration (Figures 16 B,D,F,H).  
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Figure 16: DAPI staining to visualize nuclear fragmentation induced by SP on 
EnC in the presence and absence of alpha1- AT 
 
 
 
 
116BFigure 16: UV fluorescence photomicrographs of PR3 (P) or HNE (E) treated EnCs stained by DAPI. ciGEnC 
(Images A-D) and HUVEC (Images E-H) were incubated with 10μg/ml PR3 or HNE for 2 hours  and stained 
with DAPI to detect apoptotic morphology in the presence or absence of α1-AT.  
  PR3 (10µg/ml)                   PR3 +α1-AT   Elastase (10µg/ml)            Elastase +α1-AT  
A C
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Figure 17: SP induced caspase-3 activation in EnC 
 
Figure 17 represent western blots showing the effect of 1µg/ml PR3 or HNE on EnC apoptosis by cleaving 
active caspase 3.  Activation of caspase 3 is determined as marker of apoptosis and the activation was 
absent from these protease-treated EnC. Cells were treated with 3µg/ml CHX+10ng/ml TNF for 24 hours as 
a positive control. Representative images of 3 individual experiments. 
 
 
 
 
ciGEnC 
HUVEC 
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Figure 18: Apoptosis detection on EnC stained with annexin V and PI by 
FACS 
 
  
Figure 18 represents the effect of 1µg/ml of PR3 or HNE on EnC in inducing apoptosis by staining with 
Annexin V and PI. ciGEnC and HUVEC were treated with 1µg/ml of SP for 2 hours and then stained to 
detect apoptosis. The cells were treated with 1mM H2O2 as a positive control. Statistics: One way ANOVA 
with Bonferroni post test. 
Fig 6g 
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3.3.2 Effect of 2 hours treatment of PR3 or HNE on EnC activation:  
3.3.2.1 Time dependent effect of SP on GEnCs in inducing neutrophil 
recruitment under static conditions 
Having found the concentration of SP that did not disturb endothelium using viability 
experiments, we proceeded to determine the time point where the EnC favors neutrophil 
recruitment in the presence of PR3 or HNE at 1μg/ml. Time course was performed until 4 
hours on GEnC treated with SP. Greater level of neutrophil recruitment on GEnC was 
observed with 2 hours treatment  and later decreased rapidly (fig 19, +p<0.05 for PR3 
compared to control  by one-way ANOVA with Dunnett’s Post test with 4-8 data sets). 
 
Figure 19: Neutrophil recruitment to GEnC following PR3 or HNE treatment 
 
 
Figure 19 - Effect of PR3 or HNE (1µg/ml, 0-4 hr) on GEnC neutrophil recruitments under static conditions. 
EnC were incubated with PR3 or HNE and the neutrophils were allowed to adhere for 1 hour at 37ºC. 
Number of adherent neutrophils was determined from a neutrophil standard curve. Statistics: One- way 
ANOVA with Dunnetts Post Test, *protease vs. control. 
Time course (in hours) with PR3 and HNE 
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3.3.2.2 Effects of SP pre-treatment on EnC-neutrophil recruitment under static 
conditions 
 
The effect of SP in the activation of HUVEC and GEnC (primary and secondary) and in 
promoting endothelial-neutrophil interactions was assessed following treatment with 
1µg/ml PR3 or HNE for 2 hours under static conditions. The results revealed that pre-
treatment with PR3 or HNE significantly increased neutrophil recruitment on HUVEC and 
ciGEnC (figure 20A ***p<0.001 for PR3 or HNE treatment compared to control by one-way 
ANOVA with Dunnett Post test with 23 data sets) with 1µg/ml of either protease that was 
partly inhibitable with α1-AT under static conditions (figure 20B, +p<0.05 for either PR3 or 
HNE only compared to SP with α1-AT by one-way ANOVA with Bonferroni Post test with 6 
data sets).  In the case of primary GEnC (Fig. 20A), there was no significant increase in 
the adhesion in contrast to other cell types.  
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Figure 20: Neutrophil recruitment by EnC pre-treated with SP for 2 hours 
under static conditions and inhibition in the presence of alpha 1- AT 
 
  
Figure 20 – Adhesion of unprimed neutrophils under static conditions was observed by treating EnCs with 
PR3 or HNE (1µg/ml, 2 hours) and also in the presence or absence of α1-AT. EnC were incubated with PR3 
or HNE and the neutrophils were allowed to adhere for 1 hour at 37ºC. Number of adherent neutrophils was 
determined from a neutrophil standard curve and inhibition by α1-AT was carried out at molar excess 
concentration. Statistics:  One- way ANOVA with Dunnett Post Test, protease vs. control (n=3).    
(A) 
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3.3.2.2 Effects of SP pre-treatment on EnC-neutrophil recruitment under 
physiological flow conditions 
 
Under physiological flow conditions, the PR3 or HNE induced neutrophil recruitment was 
observed on EnC’s pre-treated with SP (1µg/ml) for 2 hours or TNF-α (100 Units) for 4 
hours. Increased neutrophil interactions were observed on HUVEC more with PR3 and to 
a much lesser extent with HNE (figure 21, **p<0.001 for PR3-treated cells compared to 
controls by one-way ANOVA with Bonferroni Post test with 5-6 data sets). However, 
GEnCs did not present a similar pattern of neutrophil recruitment and showed greater 
variation than HUVEC (data from 1- 4 data sets). 
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Figure 21: Neutrophil recruitment by EnC pre-treated for 2 hours with SP 
under physiological flow conditions 
 
 
 
Figure 21 – Adhesion of unprimed neutrophils under flow conditions was observed by treating EnCs with 
PR3 or HNE (1µg/ml, 2 hours) or TNF-α (100 Units) for 4 hours. EnC were incubated with PR3 or HNE and 
a bolus of neutrophils was perfused over the surface of EnCs under wall shear rate of 0.1Pa and the effects 
were observed by phase contrast microscopy. Number of adherent neutrophils was determined by counting 
using Image Pro Plus software (Media Cybernetics, USA).    
U 
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3.3.3 Effect of post treatment incubation (2 hours treatment followed by 22 
hour incubation) of PR3 or HNE treated EnCs: 
 
3.3.3.1 Mitochondrial activity tested with MTT Assay  
 
EnCs (HUVEC, ciGEnC) were tested for their mitochondrial activity following treatment 
with different concentrations (1 - 15 μg/ml) of PR3 or HNE for 2 hours and left for 22 hours 
incubation at 37oC and observed post treatment for any chronic effects of the enzymes 
(Fig.22). The results revealed that the treatments showed significant reduction in 
mitochondrial activity especially with HNE treatments. HUVEC demonstrated significantly 
reduced mitochondrial activity with HNE treatment even with lower concentration 
treatments. GEnCs also lost their mitochondrial activity significantly with higher 
concentrations of HNE. However, PR3 also showed reduction in activity on HUVEC and 
ciGEnC with higher concentrations, which did not reach statistical significance in all 
instances.  
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Figure 22: Long term effects of PR3 or HNE treatment on mitochondrial 
activity measured by MTT assay following 2 hours treatment 
 
 
Figure 22 represent the ciGEnC and HUVEC treated for 2 hours with PR3 (1-15 μg/ml) or HNE (1-10 μg/ml) 
and incubated for another 22 hours at 37
o
C to see the chronic effects of the enzymes. Cell viability was 
assessed using the MTT assay. Statistics: *p<0.05, **p<0.01, ***p<0.0001 by one-way ANOVA with 
bonferroni post test, treatment compared to control. 
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3.3.3.2 Apoptosis detection with 2 hours treatment of PR3 or HNE followed 
by 22 hours post treatment incubation: 
 
EnC monolayers treated with PR3 or HNE at lower and higher concentrations for 2 hours 
and then incubated for 22 hours in serum (20%) containing medium, were tested for 
apoptosis using different techniques (i) UV light microscopy using DNA specific DAPI 
staining to visualize intact nuclei (Fig 23), (ii) caspase 3 dependent apoptosis by western 
blotting (Fig 24).  
UV light microscopy images of DAPI staining shows the signs of apoptosis on cultures of 
ciGEnC and HUVEC following the treatment with 10μg/ml of PR3 or HNE. The 
demonstrated apoptosis was clearly inhibitable in the presence of α1-AT at molar excess 
concentration.  
Western blots of active caspase 3 dependent apoptosis detection have shown that 
HUVEC and ciGEnC treated with lower concentrations (1μg/ml) of PR3 or HNE for 2 hours 
and following incubation for 22 hours in normal medium treatment did not undergo 
apoptosis when compared to the positive control (CHX (3ug/ml) +TNF (10ng/ml) treatment 
for 24hours). The serum starved cells were used as positive control and demonstrated 
apoptosis. 
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Figure 23: Detection of nuclear fragmentation of EnC induced by longer 
incubations following 2 hours SP treatment  
 
 
Figure 23 UV fluorescence photomicrographs of PR3 or HNE treated EnCs stained by DAPI in the presence 
or absence of α1-AT. Apoptotic cells depict nuclear fragmentation and homogeneous DNA staining in 
granules of different sizes. The images are representation of 3 individual experiments and were 
demonstrated by HUVEC as well as ciGEnC.             
 
  PR3 (10µg/ml)            PR3 +α1-AT         Elastase (10µg/ml)          Elastase +α1-AT
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Figure 24: Caspase 3 cleavage in EnC induced by longer incubations 
following 2 hours SP treatment at 37oC  
 
 
 
Figure 24 represent western blots testing for caspase 3 dependent apoptosis following the treatment of EnCs 
with PR3 or HNE (1μg/ml) for 2 hours and post incubation in the presence of 20% serum medium for 22 
hours at 37
o
C.  The blots show no signs of caspase 3 cleavage following the treatments compared to 
positive control (3µg/ml CHX+10ng/ml TNF for 24 hours) (lane 5). Lack of serum did cause detectable 
apoptosis (lane 1) in both cell types. 
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3.3.4 UEffect of 24 hours treatment of PR3 or HNE on EnCs:U  
 
3.3.4.1 Mitochondrial activity tested with MTT Assay  
 
Following the treatment for 24 hours, there was loss of mitochondrial activity of GEnC 
following treatment with 10µg/ml of PR3 and in HUVEC with concentrations as low as 
2µg/ml, compared to untreated controls (Fig 25A). Treatment with 2µg/ml of HNE impaired 
viability in both GEnC and HUVEC compared to untreated controls (Fig 25A). The effect of 
higher concentration was significantly nullified by the presence of α1-AT (Fig 25B). 
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Figure 25: Measurement of mitochondrial activity following 24 hours SP 
treatment in the presence and absence of α1- AT 
 
Figure 25 A,B -Effect of 24 hours treatment with SP and in the presence of  α1–AT on EnC mitochondrial 
activity.  GEnC or HUVEC were treated with 0.5-10µg/ml PR3 (P) or HNE (E) for 24 hours and mitochondrial 
activity was assessed in the presence and absence of protease inhibitor using the MTT assay.  
Statistics: One way ANOVA with Dunnetts Post Test from 6 data sets, control vs SP.  
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3.3.4.2 Apoptosis detected using DAPI staining by UV light microscopy 
 
EnC monolayers treated with PR3 or HNE at lower and higher concentrations for 24 hours 
were tested for apoptosis using UV light microscopy using DNA specific DAPI staining to 
visualize intact nuclei (Fig 26). DAPI staining on 24 hours SP treated cells revealed that 
PR3 or HNE at 10 µg/ml caused maximum chromatin condensation of EnC after 24 hours 
and these changes were inhibitable in the presence of α1-AT at molar excess 
concentration.  
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Figure 26: Nuclear fragmentation in EnC induced by 24 hours SP treatment 
 
 
 
 
 
 
 
 
Figure 26 UV fluorescence photomicrographs of PR3 or HNE treated EnCs stained by DAPI in the presence 
or absence of α1-AT. Apoptotic cells depict nuclear fragmentation and homogeneous DNA staining in 
granules of different sizes. The images are representation of 3 individual experiments.              
             1 µg/ml SP            1 µg/ml SP+α1-AT        10µg/ml SP           10µg/ml SP 
+α1-AT  
PR3 
HNE 
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3.4 Discussion 
 
 
ANCA induced neutrophil-derived inflammation pathophysiologically leads to EnC injury 
caused by proteolytic SPs as well as oxygen radicals and by neutralisation protective 
antiproteinase shield at inflammatory sites (de Bono and Yang, 1995; Varani et al., 1989; 
Weiss, 1989). The initiation of vascular damage starts with activation of endothelium 
upregulating adhesion molecules carried on to leukocyte infiltration further proceeding 
towards damage (Pall and Savage, 1994; Yamada et al., 1981; Zeck-Kapp G, 1990). SPs 
are the second source of cell injury and our study investigated the ability of SP to induce 
damage EnC in dose dependent manner and have shown the transition from health to 
proadhesive phenotype enhancing neutrophil adhesion and eventually leading towards 
damage. It is conclusive that the lower concentrations of SP and shorter incubation 
periods do not cause any significant damage to the endothelium; instead they do induce 
the endothelium to express a weak adhesive phenotype which supported neutrophil 
capture. This may be due to a limited degree of endothelial activation since parallel studies 
from my colleague have demonstrated increased expression of P-selectin (Bevins 
unpublished). Our work demonstrated that neutrophil adhesiveness to endothelium was 
enhanced by mobilising endothelial P-selectin expression and stabilising this adhesion by 
inducing IL-8 signalling. This could be due to initial EnC stimulation which does not require 
de novo protein synthesis and occurs rapidly as described by Hunt and Jurd (Hunt and 
Jurd, 1998). This would be compatible with the likely mobilization of Weibel-Palade bodies 
to the endothelial cell surface resulting in the release of P-selectin and von Willebrand 
factor (vWF) by the action of SP. Our data also suggests that PR3-induced neutrophil 
capture under flow conditions may require a threshold endothelial P-selectin level, as 
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neutrophil recruitment only occurred under conditions which significantly increased P-
selectin expression. Alternatively, the adhesion observed might be charge dependent.  
Under static conditions, SP being cationic proteins, bind covalently to the anionic 
endothelium and might be damaging the vascular endothelium by digesting the matrix 
proteins and junctional proteins, thus facilitating the adhesion of neutrophils (Campbell et 
al., 2000). However, only partial inhibition of adhesion by α1-AT, suggests that the effect is 
only partly dependent on the enzymatic actions of SP. 
We have also documented the stages of EnC damage in a concentration and time 
dependent manner and have confirmed the previous observations that high levels of both 
proteases can induce cell retraction and detachment (Bart, 1994). All the cell types 
(HUVEC, Primary and secondary GEnC) had showed similar effect with no significant 
difference. Lower concentrations and shorter durations of exposures showed minimal or 
no evidence of EnC apoptosis, loss of membrane integrity or cell viability. At 2 hour time 
point, PR3 and HNE (1 μg/ml) induced neutrophil recruitment by both HUVEC and ciGEnC 
but not primary GEnC under static conditions.  Under flow conditions, PR3 but not HNE 
induce neutrophil recruitment. EnCs were susceptible to damage with HNE even at lower 
concentrations disturbing monolayer integrity with no detectable apoptosis. Indeed, HNE 
has been linked to endothelial cell injury more so than PR3 (Carden et al., 1998; Nakatani 
et al., 2001; Smedly et al., 1985). In addition, we also found protease treatment was not 
directly correlated with immediate cell destruction and thus observed activation of EnCs. 
However, exposure of EnC to higher concentrations (10 and 15 μg/ml) of SP demonstrated 
a significant decrease in mitochondrial activity.  
Further, our studies proceeded to looking at the effects of long term exposure to proteases 
on endothelial monolayers. At 24 hours treatment with lower concentrations up to 1µg/ml, 
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PR3 did not cause any considerable damage to the cells. However, HNE 1µg/ml caused 
considerable damage to monolayer integrity but no significant reduction in mitochondrial 
activity was observed. These findings indicate that 24 hours time point is long enough for 
1µg/ml HNE in starting to digest the matrix proteins and reduce the monolayer integrity, 
but did not decrease the cell mitochondrial activity that further leads to death. Higher 
concentrations of 10µg/ml did cause detachment, significant reduction in viability and 
apoptosis. Yang et al., 1996 have shown the induction of apoptosis by PR3 treatment on 
endothelial cells following 24 hours treatment (Yang et al., 1996). Other in vitro studies 
have demonstrated the direct detachment and cytolysis of EnCs by the effect of SP 
(Ballieux et al., 1994);(Westlin and Gimbrone, 1993) and inducing emphysematous lesions 
upon intratracheal instillation in vivo (Janoff et al., 1977). It has been demonstrated that 
treatment with PR3 and HNE resulted in the degradation of several constituents of the 
glomerular basement membrane, including fibronectin, laminin and collagen type IV and 
heparan sulfate leading to detachment of GEnCs which further effects cell metabolism and 
activate the process of cell death and thus glomerular injury (Klebanoff et al., 1993; Re et 
al., 1994). Yang et al., (Yang et al., 2001), resolved the confusion whether detachment 
triggers apoptosis or vice versa, by showing the percentage of apoptotic cells proportional 
to the degree of cell detachment indicating that detachment of EnCs from the matrix 
correlates with the apoptosis induced by PR3/HNE and our results corroborate the above 
findings. Our data also demonstrates that HNE when compared to PR3 was more effective 
inducer of endothelial cell damage. Thus, the analysis of studies using concentrations from 
0.5 - 15 μg/ml of PR3/HNE, suggest that exposure of EnCs to low levels of neutrophil-
derived proteases activated the EnCs without causing any damage to the monolayer and 
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higher concentrations for 2 hours might be the initiative to the damage of endothelial 
monolayer by digesting the matrix proteins.  
Accumulation of neutrophils at focal sites is involved with acute inflammation which was 
observed with the presence of SP along with the damage that they cause to endothelium. 
Later our interest was directed to observe the chronic effects of SP where we looked at 
post treatment effects as these proteases were shown to have equal contributions to 
chronic inflammation, as monocytes are also a source of PR3 and HNE. The results have 
shown that there are chronic effects of treatments at higher concentrations of PR3 where 
as HNE decreased mitochondrial activity following even 1 µg/ml. Western blotting did not 
show any caspase-3 cleavage with treatment of 1ug/ml of either PR3/HNE. However 
treatment with higher concentrations demonstrated detachment of cells and apoptotic 
bodies with DAPI staining. The actions of α 1 antitrypsin, at a molar excess concentration, 
outlasted the 2 hour incubation period and nullified the effect of SP on EnCs, thereby 
acting to protect the cells from post-treatment effects. Both HUVEC and ciGEnC showed 
similar effects. These results indicate that the damage to the endothelial surface occurs 
not only in the presence of the enzyme but also post effects leads to increased damage.  
 
U 
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Prolastin - Therapeutic target of Vasculitis: 
Our work also demonstrated that all the effects were inhibitable by the presence of 
prolastin suggesting the balance between SP and their inhibitors and protease-
independent mechanisms. The presence of protease inhibitors in plasma and tissue fluid 
offer some defense against elevated protease concentrations, however, in some 
occasions this balance can be disturbed (Bank et al., 1999). It has been reported that the 
deficiency of protease inhibitors in some individuals due to heterozygosity for alpha 1 anti 
trypsin is associated in systemic vasculitis (Segelmark et al., 1995). Under experimental 
conditions, Prolastin seems to diminish the damage caused to EnCs by PR3/HNE, and 
thus confirms that the proteolytic activity of the enzymes is causing the damage and partial 
inhibition of neutrophil recruitment to the endothelial monolayers represents the 
mechanisms independent to the enzyme activity. Prolastin is currently in use for chronic 
replacement therapy of individuals with congenital alpha-1 antitrypsin deficiency. The 
series of experiments suggests that SP may represent a viable target for the inhibition of 
inflammation. This work contributes to our understanding of the mechanism of endothelial 
injury in vasculitis. Learning more about the functional capabilities of these SP might result 
in the development of manipulative methods of the inflammatory process. 
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Chapter 4: Podocytes modulates neutrophil recruitment by 
cytokine activated GEnCs 
4.1 Introduction: 
 
Being major detoxicating and osmo-regulative units, glomeruli are exposed to many 
disturbing stimuli that can trigger inflammatory episodes. Recruitment of neutrophils by 
glomerular endothelium mediates the first stage of defence during health and disease. 
Circulating neutrophils marginate towards glomerular endothelial cells (GEnC) under the 
influence of cytokines and inflammatory agonists, which stimulate the cell surface 
expression of pro-adhesive molecules and activate adhesive interactions (Brady et al., 
1992);(Mulligan et al., 1993). The role of several adhesion molecules and their ligands in 
the recruitment process has been elucidated (Bishop and Hall, 1989; Brady et al., 1992; 
Kawasaki et al., 1993; Mulligan et al., 1993; Seron et al., 1991; Tang et al., 1997; Tipping 
et al., 1994). The involvement of neighbouring cells in the regulation of physiological and 
immunological processes by vascular endothelium is of great interest. Previous in vitro 
studies have shown that when EnCs are co-cultured with other stromal cells, such as 
fibroblasts or smooth muscle cells, their ability to recruit leukocytes following cytokine 
stimulation is altered (Gerhardt H, 2000; Helen et al., 2009; Hsiai, 2008; Lally et al., 2005; 
McGettrick, 2010; McGettrick et al., ; Rainger and Nash, 2001). Similarly, in glomerular 
capillaries, the communication between neighbouring cells might be crucial for regulating 
different physiological functions. Glomerular podocytes, despite having limited 
regenerative capacity, influence the growth, proliferation and regeneration of GEnCs. The 
symbiosis between these cells is well explained by the exclusive expression of VEGF and 
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angiopoietin-1 by podocytes, while GEnCs express high levels of the cognate receptors 
VEGFR2 and Tie 2, thereby ensuring the normal maintenance functions and angiogenesis 
(Fan L, 2002; Hirschberg et al., 2008; Kitamoto et al., 1997; Liang et al., 2006; Satchell et 
al., 2002; Simon et al., 1998). Both the cells have been shown to play a major role in the 
progression and regression of many disease states (Liang et al., 2006). The cross talk 
between GEnCs and podocytes mediated by soluble factors has been studied and 
reviewed (Camici, ; Hirschberg et al., 2008; Satchell et al., 2002; Vicki and David, 2005).  
There is evidence for a possible role of podocytes in regulating glomerular inflammation 
and in the initiation and propagation of glomerular damage (Eremina et al., 2003) although 
the underlying cell biological mechanisms are not completely understood 
In order to demonstrate the importance of the physical relationship between the glomerular 
cells and their ability to communicate during inflammatory episodes, we recreated 
glomerular micro-environment in vitro and studied neutrophil recruitment by GEnCs in the 
presence of podocytes and inflammatory stimuli, and defined the molecular mechanisms 
involved.  
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4.2. Methods: 
 
1. Characterisation of podocytes: Immunostaining of podocytes for the differentiation 
marker, podocin. 
2. Co-culturing of podocytes and EnCs: 
 Electrical resistance (ER) measurement on inserts across cell cultures. 
 Transwell assay to assess neutrophil recruitment in endothelial and epithelial cell 
co-culture. 
 Neutrophil recruitment assay to HUVEC and GEnC following conditioning with 
podocyte derived medium 
 Transwell assay with endothelial cells co-cultured, but not in contact with epithelial 
cells to assess neutrophil migration by soluble mediators  
3. Detection of Soluble mediators: Multiplex cytokine immunoassay & ELISA 
4. Neutrophil recruitment assay following IL-6 treatment of GEnC mono-cultures. 
5. Blocking Studies: 
 CXC – chemokine receptor blocking in co-cultures and mono-cultures.  
 Neutralization of IL-6 activity in culture supernatants. 
 Blocking of IL-8, ENA 78 and Gro-α in co-culture studies. 
 106 
4.3 Results: 
4.3.1 Expression of the podocyte specific marker, podocin, by differentiated 
podocytes 
 
One of the specific markers for differentiated podocytes is podocin which is localized on 
podocyte foot process membranes at the insertion site of the slit diaphragm. Based on the 
previous work by the Saleem group (Saleem et al., 2002), Podocin was used as a specific 
differentiation marker to compare the phenotype of the cells under permissive (33oC) and 
non-permissive temperatures (37oC). Podocin was not expressed by undifferentiated 
podocytes and was expressed at comparable levels in all cells at non-permissive 
temperatures following 7 days and 14 days differentiation at 37oC. These findings also 
provide evidence that the differentiated cell lines are of primary podocyte origin.  
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Figure 27: Immunofluorescence images of podocytes expressing the 
differentiation marker, podocin 
 
 
 
 
 
Figure 27: Immunofluorescence microscopy of the podocyte differentiation marker, podocin: Little or no 
expression in (A) undifferentiated podocytes from 33
o
C and (D) control cells, HUVEC. Podocytes 
differentiated at 37
o
C for 7 and 14 days expressed podocin on intracellular filaments and on the cell surface 
(B, C). Left panel are isotype controls showing no non-specific staining for podocin antibody. Magnification, 
X40 
 
(A) Podocytes from 
 33oC 
(B) Podocytes 37oC 
7 days 
(C) Podocytes 37oC 
14 days 
(D) HUVEC Control 
Isotype control 
antibody 
Podocin antibody 
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4.3.2 Trans-culture electrical resistance (ER) testing of co-cultures and 
monocultures 
 
Electrical resistance across the podocyte monolayer grown on the basal side of a 3µm 
insert was tested, following the seeding of podocytes from differentiation up to 14 days. 
The podocyte monolayer on the insert following 1 day differentiation showed ER values of 
7.61 Ωcm2. Following the differentiation process up to 14 days, the ER was checked on 
days 3, 6, 10 and 14, and the ER decreased to a minimum of 1.109 Ωcm2 by day 14 
(Figure 28A). The ER of EnC mono-cultures (HUVEC or GEnC) cultured on the apical side 
of the transwell insert was also measured along with co-cultures. The EnC & podocyte co-
cultures showed no difference when compared to the inserts with single endothelial 
cultures. The ER of HUVEC and podocyte co-cultures was 4.95 Ωcm2 and HUVEC alone 
showed an ER of 4.29 Ωcm2; similarly the ER of ciGEnC and podocyte co-cultures was 
11.22 Ωcm2 and ciGEnCs alone showed an ER of 10.23 Ωcm2 (Figure 28B).  HUVEC 
cultures showed a lower ER than ciGEnC cultures. 
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Figure 28: Electrical resistance tested across EnC and podocyte monolayers 
and co-cultures on the inserts 
 
 
 
 
Figure 28: ER measured on mono-cultures and co-cultures. (A) Podocytes cultured on the insert over period 
of differentiation (14 days) after initial seeding of the monolayer and was tested on all inserts used for 
experiments. (B) Represent the ER on filters with co-cultures and single cultures of EnCs and 
podocytes.Stats:  the monocultures were compared to co-cultures by Mann-Whitney test and *P<0.05 was 
considered significant. 
 
(A) 
(B) 
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4.3.3 Culture medium effect on neutrophil recruitment by HUVEC 
 
Neutrophils were suspended in different types of medium (M199+0.1 % BSA, RPMI+0.1% 
BSA, RPMI complete medium (described in previous section)) and the neutrophil 
recruitment pattern by HUVEC monolayers was examined. Neutrophils that were 
suspended in RPMI with 0.1% BSA showed an increase in adhesion by 5-10% on HUVEC 
monolayers treated with higher concentrations of TNF-α (10 and 100 Units/ml), when 
compared to the neutrophils suspended in other types of medium. Hence, future 
experiments were carried out by resuspending the neutrophils in RPMI with 0.1% BSA. 
 
4.3.4 Co-culture of EnCs and podocytes allowing direct contact 
 
The effect of podocytes in regulating EnC neutrophil interactions was studied in a co-
culture system using 3µm pore filters enabling direct cell-cell contact between the cell 
types. We analysed whether direct intercellular contact in the co-cultures generated 
different neutrophil recruitment patterns compared to EnCs grown alone inside the filters. 
Both the cultures were subjected to cytokine (TNF-α) treatments for 4 hours in a dose 
dependent manner (0 – 100Units/ml).  
 111 
 
4.3.4.1 Optimisation of co-culture technique: 
4.3.4.1.1 Effects of seven- day differentiated podocytes on neutrophil recruitment 
by ciGEnC and HUVEC 
 
EnC that had been co-cultured with podocytes that in turn had been differentiated for 7 
days (podocytes7 day) were subjected to TNF-α treatments in a dose dependent manner (0-
100 Units/ml). In this experiment TNF-α was only added to the upper chamber of cultures. 
EnC mono-cultures supported greater neutrophil recruitment compared to co-cultures of 
EnCs and podocytes.  
Following 100Units/ml TNF-α treatment, ciGEnC mono-cultures showed a 2-fold increase 
in neutrophil recruitment compared to ciGEnC and podocytes7 day co-cultures (figure 29A).  
On the other hand, HUVEC co-cultures did not show a significant increase compared to 
monocultures presenting neutrophil recruitment of 31762 cells/mm2/5x105 neutrophils 
added when compared to HUVEC co-cultured with podocytes7day 18794cells/mm
2/5x105 
neutrophils added (figure 29B). There was no significant difference in transmigration of 
neutrophils following increasing concentrations of TNF treatments except at TNF 100 U/ml 
on ciGEnCs as shown in figure 29 C&D.   
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Figure 29: Effect of 7-day differentiated podocytes on neutrophil 
recruitment by EnCs 
 
Figure 29; Neutrophil recruitment and migration to EnCs (ciGEnCs and HUVEC) cultured alone or with 7- 
day differentiated podocytes stimulated with TNF-α at 0-100U/ml. (A) Total recruited neutrophils by ciGEnC 
co-cultured with podocytes or cultured alone. (B) Total recruited neutrophils by HUVEC co-cultured with 
podocytes or cultured alone. (C) Total transmigrated neutrophils in co-cultures or mono-cultures. (D) Total 
transmigration by HUVEC co-culture with podocytes or cultured alone. Data shown is mean of n=7 
independent experiments. In all experiments, co-cultures were compared with mono-cultures. Data 
expressed is normalized to control. Statistics:  ***P<0.001 or *P<0.05 represents significance of the 
treatment compared to the control by one way ANOVA. 
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These findings suggest that EnCs and podocytes have the ability to influence each other’s 
behavior and that the presence of podocytes7 day suppressed neutrophil recruitment.   
 
4.3.4.1.2 Drawbacks with the seven-day culture experiments and representation 
of the data: 
 
 In these experiments, the upper and lower chambers of the co-culture system had 
equal volumes of medium which would possibly increase the hydrostatic pressure in 
the system. 
 The cultures were treated in a dose dependent manner with TNF-α only in the 
upper chamber facing EnCs and the lower chamber facing podocytes were left 
untreated. This diluted the treatments due to the exchange of medium between the 
chambers.  
 The number of neutrophils added to the system during static adhesion assay was 
approximately 500,000/well, and they were not re-counted after adding into the well, 
so it was assumed that the counts were exactly 500,000/well. This did not provide 
perfect counts to calculate the percentages of neutrophil recruitment and 
transmigration. So, the counts were normalized to controls. 
 
The later experiments were corrected and counted exactly after collecting all the washes 
containing neutrophils from the wells. 
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4.3.5 Effects of 14-day differentiated podocytes on neutrophil recruitment by 
ciGEnC and HUVEC 
 
Covering the previous issues, EnCs co-cultured with podocytes that have been 
differentiated for 14 days (podocytes14day) were subjected to treatment with TNF-α in a 
dose dependent manner (0-100 Units/ml). The cultures demonstrated dose dependent 
increase in neutrophil recruitment with TNF-α treatments, when compared to their 
individual controls in both co-cultures and mono-cultures (Figure 30 & 31).  
Interesting finding was that, similar to 7-day differentiated podocytes and ciGEnC co-
cultures, the ciGEnCs co-cultured with 14-day differentiated podocytes also demonstrated 
reduced neutrophil recruitment when compared to ciGEnC mono-cultures. In these 
cultures, the reduced neutrophil recruitment by co-cultures was observed with and without 
TNF-α treatment. The reduction was significant at higher concentrations of TNF-α (10 & 
100 Units/ml). 
There was 12% reduction in neutrophil recruitment in unstimulated co-cultures compared 
to mono-cultures. Following 10U/ml TNF-α treatment, ciGEnC co-cultured with 
podocytes14 day showed a reduction in neutrophil recruitment by upto 33%. Neutrophil 
recruitment (% of total neutrophils added) in co-cultures vs mono-cultures was 20.36 U+U 
2.9% and 34.27 U+U 4.8%, n=14. At 100U/ml TNF-α treatment, co-cultures of GEnC in direct 
contact with podocytes demonstrated significant reduction in neutrophil recruitment by up 
to 50% when compared to GEnC mono-cultures. Neutrophil recruitment (% of total 
neutrophils added) in immortalised co-cultures vs mono-cultures was 23.93 U+U 1.8% and 
49.7 U+U 4.3%, n=38 (Figure 30A).  
 115 
Figure 30: Effect of 14-day differentiated podocytes on neutrophil 
recruitment by ciGEnCs 
  
 
Figure 30: Neutrophil recruitment by ciGEnC mono-cultures or ciGEnC co-cultured with podocytes stimulated 
with TNF-α at 0 (none) to 100 Units/ml. (A) Percentage of the total recruited neutrophils to unstimulated and 
TNF stimulated co-cultures of ciGEnC and podocytes or ciGEnC cultured alone. (B) Percentage of 
neutrophils that demonstrated transmigration from the total recruited neutrophils across ciGEnC co-cultured 
with podocytes or cultured alone. In all experiments, co-cultures were compared with mono-cultures, and 
were run in parallel.  
Statistics: The symbols (* P<0.05, ** P<0.01 & *** P<0.0001 by one way ANOVA) represents significance of 
TNF treatments compared to the control by one way ANOVA in cultures. The symbols (
ϕϕ
P<0.01 & 
ϕϕϕ
P<0.0001 by two way ANOVA) represents significance of TNF treatments between cultures by Dunnet’s 
and Bonferroni’s multiple comparison test. 
 
(B) 
(A) 
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In contrast, HUVECs when co-cultured with podocytes14day demonstrated no significant 
reduction in neutrophil recruitment when compared to HUVEC mono-cultures (Figure 31A) 
despite increasing TNF-α concentrations.  
With both the cell types, the majority ( U>U80%) of total recruited neutrophils were observed to 
transmigrate through the cell layers and only a small sub-population were left firmly 
adherent at the EnC surface at the time the assay was terminated (3.61–5.19% of 
adherent cells on EnC co-cultured with podocytes14 day) with both ciGEnC (Figures 30 B) 
and HUVEC cultures (figures 31 B).  
All the above data suggests that ciGEnCs and podocytes are capable of cross talk 
resulting in suppression of neutrophil recruitment. Comparable crosstalk between HUVEC 
and podocytes was not observed. 
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Figure 31: Effect of 14-day differentiated podocytes on neutrophil 
recruitment by HUVEC 
 
Figure 31: Neutrophil recruitment by HUVEC mono-cultures or HUVEC co-cultured with podocytes 
stimulated with TNF-α at 0 (none) to 100 Units/ml. (A) Percentage of total recruited neutrophils to 
unstimulated and TNF stimulated HUVEC co-cultured with podocytes or cultured alone. (B) Percentage of 
neutrophils that demonstrated transmigration from the total recruited neutrophils across HUVEC co-cultured 
with podocytes or cultured alone. In all experiments, co-cultures were compared with mono-cultures, and 
were run in parallel.  
Statistics: The symbols (* P<0.05 & *** P<0.0001 by one way ANOVA) represents significance of TNF 
treatments compared to the control by one way ANOVA. 
(A) 
(B) 
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4.3.6 Effects of primary podocytes on neutrophil recruitment by primary 
GEnC 
Primary GEnCs were co-cultured with primary podocytes and were subjected to 
TNF-α treatment in a dose dependent manner (0-100 Units/ml). The cultures 
demonstrated a dose dependent increase in neutrophil recruitment when compared 
to their individual controls in both co-cultures and mono-cultures. Primary GEnCs 
co-cultured with primary podocytes also demonstrated reduced neutrophil 
recruitment as was observed with cell line cultures. In these cultures, the reduced 
neutrophil recruitment by co-cultures was observed with and without TNF-α 
treatments and the reduction was significant at higher concentration of TNF-α (100 
Units/ml).  
There was 5% reduction in neutrophil recruitment in unstimulated co-cultures compared to 
mono-cultures. Following 10U/ml TNF-α treatment, primary GEnC co-cultured with primary 
podocytes showed a reduction in neutrophil recruitment by up to 14%. Neutrophil 
recruitment (% of total neutrophils added) in co-cultures vs mono-cultures was 8.6 U+U 1.3% 
and 15.07 U+U 5.4%, n=4. At 100U/ml TNF-α treatment, co-cultures of GEnC in direct contact 
with podocytes demonstrated significant reduction in neutrophil recruitment by up to 30% 
when compared to GEnC mono-cultures. Neutrophil recruitment in primay co-cultures vs 
mono-cultures was 18.8 U+U 4.8% and 31.3 U+U 5.5%, n=4 (Figure 32A). Similar to the cell line 
cultures, the majority of total recruited neutrophils were observed to be transmigrated 
through the cell layers (figures 32B). The above data also suggests that primary GEnCs 
and podocytes have the ability to cross talk and play a collaborative role in regulating 
neutrophil recruitment.  
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Figure 32: Neutrophil recruitment by primary cultures of GEnC and 
podocytes 
 
 
 
Figure 32: Neutrophil recruitment by primary GEnC mono-cultures or co-cultured with primary podocytes 
stimulated with TNF-α at 0 (none) to 100 Units/ml. (A) Percentage of total recruited neutrophils to 
unstimulated and TNF stimulated GEnCs co-cultured with podocytes or cultured alone. (B) Percentage of 
neutrophils that demonstrated transmigration from the total recruited neutrophils across GEnCs co-cultured 
with podocytes or cultured alone.  
Statistics: The symbols (* P<0.05 & *** P<0.0001 by one way ANOVA) represents significance of TNF 
treatments compared to the control by one way ANOVA. The symbol (
δ
P<0.05 by two way ANOVA) 
represents significance between cultures by Dunnet’s multiple comparison test. 
(A) 
(B) 
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4.3.7 Co-culture of EnCs and podocytes in the absence of direct contact 
 
Previous experiments showed that podocytes in direct contact could reduce endothelial 
dependent neutrophil recruitment. In order to examine whether the effects observed were 
contact based or due to soluble mediators released by the cells, we cultured podocytes 
and EnCs such that no cellular contact was possible as in figure 10, ensuring that the 
cross talk could only occur via mediators. 
The results observed showed a similar pattern to that seen previously with the contact 
based co-cultures of ciGEnC with podocytes14 day. ciGEnC that had been in the presence of 
podocytes bound neutrophils less efficiently in the system when compared to ciGEnC 
mono-cultures, although this did not reach significance except at 100 U/ml TNF-α 
treatment. The effect of TNF-α treatment was significant in individual cultures; there was 
dose dependent increase in neutrophil recruitment with increasing TNF-α concentration (0-
100Unitsml). 
Following 100U/ml TNF-α treatment, there was 40% reduction in neutrophil recruitment in 
co-cultures compared to mono-cultures which reached significance. Neutrophil recruitment 
(% of total neutrophils added) in co-cultures vs mono-cultures was 28.5 U+U 7% and 47.3 U+U 
15.2%, n=3. At lower concentrations of TNF-α treatment and in unstimulated cultures there 
was no reduction in neutrophil recruitment (Figure 33A).  
In the case of HUVEC co-cultured with podocytes14day without direct contact, the neutrophil 
recruitment was similar in both co-culture and HUVEC mono-cultures. The effect of TNF-α 
treatment was significant in individual cultures; there was dose dependent increase in 
neutrophil recruitment with increasing TNF-α concentration (0-100Unitsml). This suggests 
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that HUVEC are not affected by the soluble mediators released by podocytes (Figure 
33B). 
The presence of podocytes that had no direct contact with ciGEnCs had significant effect 
on neutrophil recruitment. In contrast, podocytes only reduced neutrophil recruitment to 
HUVEC by 0.5%, when compared to control mono-cultures of HUVEC. However, the 
magnitude of the responses induced in the absence of direct contact tended to be 10% 
less than those observed where cells were only separated by a porous filter. Thus, close 
juxtaposition of podocytes with EnC may potentiate the activity of putative soluble 
mediators.  
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Figure 33: Neutrophil recruitment by ciGEnCs and HUVEC co-cultured 
with podocytes with no contact, compared to mono-cultures 
 
 
Figure 33: Neutrophil recruitment to ciGEnCs & HUVECs cultured alone or with podocytes, assuring no 
direct contact between the cell types and the cultures were stimulated with TNF-α at 0-100U/ml. (A) 
Percentage of the total recruited neutrophils to ciGEnC co-cultured with podocytes or cultured alone. (B) 
Percentage of the total recruited neutrophils to HUVEC co-cultured with podocytes or cultured alone. 
Statistics: The symbols (* P<0.05, ** P<0.01 & *** P<0.0001 by one way ANOVA) represents significance of 
dose dependent TNF treatments compared to the control by one way ANOVA. The symbol (
δ
P<0.05 by two 
way ANOVA) represents significance between cultures by Dunnet’s multiple comparison test. 
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4.3.8 Effects of soluble mediators released into podocyte medium on EnC-
neutrophil recruitment 
 
The effect of conditioned media from 14-day differentiated podocytes on neutrophil 
recruitment following treatment with different concentrations of TNF-α was examined.  The 
physical presence of podocytes in close contact with EnCs significantly reduced neutrophil 
recruitment by EnCs particularly at higher concentrations of TNF-α. Interestingly, the 
supernatants from podocytes treated for 24 hours had a suppressing activity on neutrophil 
recruitment by ciGEnCs reaching significance especially with TNF 1Unit/ml treatment 
(Figure 34A). Similarly, HUVEC treated with podocyte conditioned medium for 24hrs also 
showed a decrease in endothelial responses with TNF 100Units/ml treatment although 
there was a lot of variation between the experiments and so this effect did not reach 
statistical significance (Figure 34B). The above data complements the results from 
previous experiments which suggested that mediators produced in the presence of 
podocytes do influence recruitment of neutrophils by ciGEnCs but not HUVEC cultures 
and may be suggesting organ specific cross talk between the cells. 
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Figure 34: Effect of soluble mediators released into podocyte 
conditioned medium on neutrophil recruitment by EnCs 
 
 
Figure 34: Neutrophil recruitment by ciGEnCs and HUVEC treated with and without podocyte conditioned 
medium for 24h and stimulated with TNF-α at 0-100U/ml. (A) Total number of neutrophils recruited by 
ciGEnC cultured with and with out podocyte conditioned medium where conditioned medium is the medium 
collected from 14-differentiated podocytes cultures. (B) Total number of neutrophils recruited by HUVEC 
cultured with and without podocytes conditioned medium. HUVEC and ciGEnC experiments were run in 
parallel. Statistics: The symbols (* P<0.05, ** P<0.01 & *** P<0.0001 by one way ANOVA) represents 
significance of dose dependent TNF treatments compared to the control by one way ANOVA and the symbol 
(
δ
 P<0.05 by two way ANOVA) represents significance of TNF 1unit/ml treatment between cultures by 
Bonferroni’s multiple comparison test.  
(A) 
(B) 
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4.3.9 Detection of cytokine and chemokine profiles from the supernatants 
collected from EnC and podocytes co-cultures and single cultures following 
TNF-α treatment and neutrophil recruitment 
 
Samples were subjected to multiplex bead assay by LUMINEX to detect levels of a panel 
of cytokines and chemokines that had a potential mechanistic relation to neutrophil 
recruitment by ciGEnC and HUVEC. The results showed detectable amounts of neutrophil 
specific ELR positive CXC chemokines, including IL-8 and GRO-α in ciGEnC co-cultured 
with podocytes. There was significant release of IL-6 release in co-cultures of ciGEnC and 
podocytes compared to single cultures, suggesting its possible involvement.  
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Figure 35: Soluble mediators released into culture supernatants by 
ciGEnC and podocytes in mono-cultures and co-cultures by Luminex 
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Figure 35: Cytokine and chemokine levels obtained by subjecting the supernatants from mono-cultures of 
ciGEnC or podocytes or from ciGEnC co-cultured with podocytes by LUMINEX.  
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4.3.10 Detection of Angiopoeitin-2 in supernatants from co-culture and mono-
cultures 
 
In the process of detecting the molecules involved in neutrophil recruitment by GEnC in 
co-culture with podocytes and in mono-cultures, the supernatants collected from the 
unstimulated and stimulated cultures were tested for the presence of angiopoietin-2 using 
quantikine ELISA kit from R & D systems. The results revealed no significant difference in 
release from the cultures of GEnC in co-culture with podocytes and in mono-cultures.  
 
Figure 36: Detection of angiopoeitin-2 in supernatants from co-culture 
and mono-cultures  
 
 
Figure 36: Angiopoeitin-2 levels in culture supernatants from mono-cultures of ciGEnC or podocytes or from 
ciGEnC co-cultured with podocytes by ELISA.  
 129 
4.3.11 Detection of tumor growth factor (TGF)-β in supernatants from co-
culture and mono-cultures 
 
In the process of detecting the molecules involved in the neutrophil recruitment by GEnC 
in co-culture with podocytes and in mono-cultures, the supernatants collected from the 
unstimulated and stimulated cultures were tested for the presence of TGF-β using 
quantikine ELISA kit from R & D systems. The results revealed no significant difference in 
release from the cultures of GEnC in co-culture with podocytes and in mono-cultures.  
 
Figure 37: Detection of active TGF- β in supernatants from co-culture 
and mono-cultures  
 
Figure 37: TGF-β levels in culture supernatants from mono-cultures of ciGEnC or podocytes or from ciGEnC 
co-cultured with podocytes by ELISA.  
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4.3.12 Involvement of CXC receptors in neutrophil recruitment by ciGEnC in 
mono-culture and in co-culture with podocytes 
 
We dissected the involvement of CXC chemokine receptors in neutrophil recruitment by 
testing antibodies against the CXC receptors 1 & 2 (CXCR1 & CXCR2). CXCR1 & 2 are 
the receptors that are expressed on the surface of neutrophils and recognise CXC 
chemokines with an ELR motif. CXCR1 displays greater ligand specificity than CXCR2 and 
binds with high affinity to IL-8 and granulocyte chemotactic protein. CXCR2 binds multiple 
CXC chemokines in addition to IL-8, including epithelial neutrophil-activating peptide 78 
(ENA-78), neutrophil-activating peptide-2, growth-related oncogene (GRO)- , -ß, - , and 
LPS-induced CXC chemokines.  
In co-cultures, the neutrophil recruitment was significantly reduced with CXCR2 blockade 
but not with CXCR1 blockade. This trend was evident at all the TNF-α concentrations, but 
reached significance in cultures treated with TNF-α 100U/ml (Figure 38). As IL-8 is specific 
to CXCR1, this shows that the transmigration is not mediated by IL-8 alone, indicating the 
involvement of molecules other than (or in addition to) IL-8 that signal through the CXCR2 
receptor (Figure 38).   
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Figure 38: Role of CXC chemokine receptors in neutrophil recruitment 
by EnCs in co-cultures and mono-cultures 
 
 
Figure 38: Effect on neutrophil recruitment on blocking CXC receptors 1 & 2 in both co-cultures and mono-
cultures treated without (A) and with TNF-α 10U/ml (B), TNF-α 100U/ml (C). Mouse IgG used as isotope 
control. Statistics: ANOVA followed by bonferroni post test showed significant effect of blocking on neutrophil 
recruitment in TNF-α stimulated (*<0.05) co-cultures and mono-cultures (**P<0.001). 
(A) (B) 
(C) 
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4.3.13 Mechanism of neutrophil recruitment in EnC - podocyte co-cultures; 
the role of CXC chemokines 
 
Following the data obtained by LUMINEX and ELISA, the mechanism by which the 
neutrophils are recruited by the ciGEnCs in both co-cultures and mono-cultures has been 
evaluated. 
The levels of certain CXC chemokines including IL-8, GRO-α and ENA-78 were measured 
in the supernatants of ciGEnC and podocyte co-cultures and mono-cultures by 
multiplexing and ELISA.  Co-culture supernatants showed significantly increased levels of 
IL-8, GRO-α and ENA-78 (Figure 39A to C respectively). The amount of IL-8 released in 
co-cultures was higher (29087 pg/ml) compare to ciGEnC mono-cultures (25,363 pg/ml) 
and significantly more compared to podocyte mono-cultures (9236pg/ml). This data 
suggested a role of IL-8 in enhancing recruitment of neutrophils in cultures (Figure 39A).  
There was also a prominent and significant increase in soluble GRO-α in the co-culture 
supernatants (142pg/ml) compared to mono-cultures of either ciGEnC (80.3pg/ml) or 
podocytes (36pg/ml) (Figure 39B).  Detection of soluble ENA-78 also showed similar 
findings. There was a significant increase in soluble ENA-78 in the co-culture supernatants 
(281pg/ml) compared to mono-cultures of either ciGEnC (128.3 pg/ml) or podocytes (18.5 
pg/ml) (Figure 39C).   
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Figure39: Detection of IL-8, GRO-α and ENA-78 in culture supernatants 
 
Figure 39: Detection of CXC chemokines (IL-8, GRO-α, ENA-78). (A) Detection of soluble IL-8 in 
supernatants collected from co-cultures and mono-cultures of ciGEnC and podocytes. (B) Detection of 
soluble GRO-α in supernatants collected from co-cultures and mono-cultures of ciGEnC and podocytes. (c) 
Detection of soluble ENA-78 in culture supernatants collected from co-cultures and mono-cultures of ciGEnC 
and podocytes. Data shown is the mean from 3 independent experiments. Statistics: The significance * 
P<0.05, ** P<0.01 & *** P<0.0001 between the cultures is by two way ANOVA. 
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UBlocking the CXC chemokines:  
 
Blocking antibodies against IL-8, GRO-α and ENA-78 were incorporated in the co-culture 
system to determine the chemokines mediating the neutrophil recruitment in co-cultures. 
Blocking of IL-8 in both mono-cultures and co-cultures revealed that neutrophil recruitment 
in ciGEnC mono-cultures was significantly mediated by IL-8, whereas in co-cultures the 
effect did not reach significance (Figure 40A). Interestingly, despite detecting significantly 
increased levels of GRO- α in co-cultures, blocking did not show any effect on neutrophil 
recruitment (Figure 40B). However, blocking of ENA-78 in cultures revealed that ENA-78 
operates through CXCR2 and is playing a significant role in recruiting neutrophils in co-
cultures (Figure 40C). 
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Figure 40: Blocking of chemokines to detect their involvement in 
neutrophil recruitment 
 
Figure 40: Blocking of CXC chemokines (GRO-α, ENA-78 & IL-8) to detect their role in neutrophil 
recruitment. (A) Blocking of IL-8 in co-cultures and mono-cultures. (B) Blocking of GRO-α in mono-cultures 
and co-cultures. (C) Blocking of ENA-78 in both co-cultures as well as mono-culture. Data shown is the 
mean from 5-6 independent experiments, using different blood donors for each experiment. Mouse IgG used 
as isotope control and all the three antibodies were raised in mouse. Statistics: The significance * P<0.05, ** 
P<0.01 & *** P<0.0001 between the treatments by one and two way ANOVA. 
 
Blocking of ENA-78 
  Blocking of GRO-α 
Blocking of IL-8 
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4.3.14 Effect of IL-6 neutralisation on neutrophil recruitment in co-cultures  
IL-6 was detected by multiplex assay as a principle soluble mediator since it was present 
at significant levels in co-culture supernatants (up to 10,000pg/ml), and it appeared to be 
released by podocytes in the cultures (Figure 41A). To determine the involvement of IL-6 
in neutrophil recruitment, a function neutralising antibody was added at the 
commencement of co-cultures and maintained all the way through the experiment making 
sure that there was no IL-6 exposure to ciGEnCs. The results showed significant recovery 
of neutrophil recruitment in both unstimulated and cytokine stimulated GEnC co-cultured 
with podocytes (Figure 41B & C). Hence, suggesting the possible role of IL-6 in the 
reduction of neutrophil recruitment in co-cultures of ciGEnC and podocytes. 
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 Figure 41: Detection and neutalisation of IL-6 in cultures 
 
Figure 41: Detection and neutralising IL-6 on neutrophil recruitment on co-cultures and mono-cultures: (A) 
Detection of IL-6 in supernatants collected from co-cultures and mono-cultures. (B) Neutralisation in 
unstimulated ciGEnC and podocytes co-cultures, and ciGEnC mono-cultures; (C) neutralisation in TNF–α 
stimulated cultures. Data shown is the mean from 4-8 independent experiments, using different blood donors 
for each experiment. Statistics: One way and two way ANOVA followed by bonferroni post test showed 
significant effect of IL-6 blocking on neutrophil recruitment in both unstimulated (** P<0.01) and stimulated 
(***P<0.001) co-cultures when compared to mono-cultures. 
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4.3.15 Recapitulation of the co-culture response in response to TNF with 
exogenous IL-6 (10ng/ml) in glomerular endothelial cell cultures 
 
The role of IL-6 was further elucidated by adding exogenous IL-6 into mono-cultures of 
ciGEnC. IL-6 (10ng/ml) was added exogenously into the mono-cultures, using a 
concentration similar to that observed in co-culture supernatants and maintained 
throughout the experiment in order to recreate the co-culture response. Reduction in 
neutrophil recruitment was observed in both the cultures of unstimulated and cytokine 
stimulated cultures. Significant reduction in neutrophil recruitment was observed in the 
cultures stimulated with 100Units/ml TNF-α when compared to the ciGEnC mono-cultures 
with no exogenous IL-6 (Figure 42).  
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Figure 42: Recapitulation of co-culture effect by exogenous IL-6 in 
ciGEnC mono-cultures 
 
 
 
 
 
Figure 42: ciGEnC mono-cultures with and without exogenous IL-6 maintained for 24hrs prior and throughout 
the experiment. Data is represented as percentage of the neutrophils added in each experiment.  
Statistics: Two way ANOVA followed by bonferroni post test showed significant effect in cultures with and 
without IL-6. 
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4.3.16 Co-culture of ciGEnC with different epithelial cells of other origins 
 
Podocytes in co-cultures were replaced with other epithelial cells like renal tubular 
epithelial cells (HKC), Epithelial like liver cell line (AKN) and human retinal pigment 
epithelial cell line (ARPE-19), in order to test whether the replacement of podocytes with 
other epithelial cells mediate the similar response that was observed in co-cultures of 
podocytes and GEnCs. When compared to podocyte co-culture, HKC cell line presented 
similar reduction in neutrophil recruitment (Figure 43A). The other cell lines from liver and 
retina showed dramatic decrease in neutrophil recruitment. Testing the ER of these co-
cultures showed that co-cultures of ciGEnC & podocytes as well as ciGEnC & HKC 
presented similar ER value of 20 Ωcm2, where as other co-cultures showed increased ER 
values up to 60 Ωcm2 (Figure 43B). 
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Figure 43: Effect of different epithelial cells in co-culture with ciGEnC - 
Podocytes replaced by HKC (renal tubular epithelial cells), AKN 
(epithelial-like liver cell line) and ARPE-19 (human retinal pigment 
epithelial cell line) 
 
 
Figure 43: (A) ciGEnC were co-cultured with epithelial cells of different origins and maintained for 24hrs prior 
to the experiment and a static neutrophil recruitment assay was performed. (B) Electrical resistance 
measured in ciGEnC co-cultured with different epithelial cells and epithelial mono-cultures Statistics: Two 
way ANOVA followed by bonferroni post test showed significant effect between cultures. 
(A) 
(B) 
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4.3.17 Does Endothelial/endothelial co-cultures and epithelial/epithelial co-cultures 
reduce the neutrophil recruitment compared to GEnC mono-cultures? 
 
Podocytes in co-cultures were replaced with ciGEnC or GEnC were replaced by podocytes 
having endothelial co-culture and epithelial co-culture, in order to test whether the double 
layer of cells can reproduce the reduced effect of neutrophil recruitment as was seen in 
GEnC co-cultured with podocytes. When compared to podocyte co-culture with ciGEnC, 
endothelial co-culture increased neutrophil recruitment similar to ciGEnC mono-cultures. 
The epithelial co-culture showed increased neutrophil recruitment compared to podocytes 
in mono-culture.  
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Figure 44: Co-culture of ciGEnC with ciGEnC and podocytes with 
podocytes  
 
 
 
Figure 44: ciGEnC were co-cultured with ciGEnCs forming endothelial co-culture and similarly podocytes 
were cultured with podocytes forming podocyte co-culture and maintained for 24hrs prior to the experiment 
and a static neutrophil recruitment assay was performed.  
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4.3.18 Detection of IL-6 in HUVEC supernatants 
 
IL-6 was detected by multiplex assay in podocyte and HUVEC co-culture supernatants 
(Figure 41A). HUVEC culture supernatants from HUVEC mono-cultures had increased 
levels of IL-6, in response to TNF-α along with increased levels in co-cultures (upto1700 
pg/ml). The levels in HUVEC cultures were lower to that GEnC co-culture supernatants 
(upto10,000 pg/ml). The effect of IL-6 released in these cultures had no effect in regulation 
of neutrophil recruitment when HUVEC were co-cultured with podocytes. 
 
Figure 445: Detection of IL-6 in HUVEC co-culture supernatants 
 
 
 
Figure 45: IL-6 levels in culture supernatants from mono-cultures of HUVEC or from HUVEC co-cultured with 
podocytes by LUMINEX.  
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4.4 Discussion 
 
In glomeruli, the maintenance of vascular endothelial functions depends on a symbiosis 
between the podocytes and GEnCs. However, little is known about the involvement of 
podocytes in immune regulation. Thus, it was of interest to elucidate the role of podocytes 
in inflammation in particular to determine whether they could help protect GEnCs from 
various forms of glomerular injury.  
Previous in vitro studies on leukocyte recruitment have been largely limited to endothelial 
monolayer models that have provided key information regarding the involvement of 
different adhesion molecules, cytokines and chemo attractants (reviewed by (Adams and 
Shaw, 1994; Alon et al., 1996; Baggiolini, 1998; Springer, 1995)). However, the in vivo 
situation is more complex since infiltrating leukocytes need to pass through the basement 
membrane and will likely contact stromal cells. Thus we developed an in vitro co-culture 
experimental model to mimic the complex glomerular micro-environment and to investigate 
neutrophil infiltration in the context of glomerular inflammation. Monolayers of glomerular 
endothelial and epithelial cells, both primary cells and cell lines that were separated by a 
semi permeable membrane allowing cell-cell contact enabled us to study the interactions 
between these glomerular cells. A key observation was significantly reduced level of 
neutrophil binding to TNF-α activated GEnCs in the presence of podocytes particularly at 
higher concentrations of TNF-α treatment that was indicative of a more activated 
inflammatory environment. Interestingly, these findings may be specific to renal glomerular 
cells as similar findings were not observed in the co-cultures of HUVEC with podocytes.  
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The reduction in neutrophil recruitment was apparent whether the podocytes and GEnC 
were in juxtaposition or separated within the same well. However, effects were more 
marked when cells were in juxtaposition such that cell to cell contact was possible.  
Observations of transepithelial ER over time might suggest loss of compact monolayer 
integrity in podocyte cultures, but phase contrast images provide evidence of presence of 
podocytes on the insert and nuclear staining confirmed this. Similar findings have been 
observed by other investigators (Coers et al., 1996; Van Den Berg et al., 2000). 
Observations from our cultures also suggest that they do not show monolayer integrity as 
they become differentiated, as shown in the picture of differentiating podocyte monolayer 
(Figure 5). These observations support the results of the co-cultures with GEnCs, in that 
the reduced neutrophil recruitment is not due to the presence of two monolayers across 
the filters but instead, it is the presence of podocytes and their soluble mediators that are 
playing a role in the reduction. These observations point to an important role for soluble 
mediators, as well as a mechanistic role for direct cell to cell contact.  
Usually within the glomerulus the inflammatory processes are switched off by the release 
of anti-inflammatory mediators that oppose the actions of proinflammatory mediators.  
Niemir et al., showed concomitant expression of IL-1 receptor type I and II (IL-1 RI) as well 
as IL-1 RA in podocytes which suggests a protective mechanism within glomeruli to 
counteract the effects of intrinsic glomerular production of IL-1 against continuing injury 
(Lovett and Sterzel, 1986; Niemir et al., 1997). IL- 10, also known as human cytokine 
synthesis inhibitory factor (CSIF), has also been shown to be greatly involved in 
suppressing glomerular inflammation due to its strong anti-inflammatory effects. Podocytes 
were shown to have an activated phenotype in two-dimensional cultures releasing 
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cytokines which affect the function of surrounding cell types [2, 29]. Podocytes have 
previously been shown to be a potential source of IL-6 that could play role in the regulation 
of processes critical to the initiation of progressive glomerular disease (Moutabarrik et al., 
1994b; Osawa et al., 1994). Given a potential role for soluble mediators in our cultures, we 
were interested to observe that higher levels of IL-6 was detected both in co-cultures, as 
well as in supernatants derived from podocytes alone. Addition of exogenous IL-6 in GEnC 
mono-cultures led to reduced neutrophil recruitment, when compared to cultures with no 
IL-6, supporting a role for IL-6 in regulating the neutrophil recruitment. Furthermore, IL-6 
blocking antibodies reversed the reduction in neutrophil binding. These observations are 
consistent with previous reports where IL-6 was shown to be responsible for the inhibition 
of neutrophil recruitment to EnC co-cultured with dermal fibroblasts from individuals with 
rheumatoid arthritis (Helen et al., 2009; Lally et al., 2005). In vivo studies have 
demonstrated the attenuation of LPS induced pulmonary neutrophil infiltration in the 
presence of exogenous IL-6 and also complete abolishment of the over reactivity of 
cytokine responses (Ulich et al., 1991b; Xing et al., 1998). Interestingly, IL-6 has also been 
shown to have opposing effects in vitro and so its effects may be dependent on the exact 
milieu (McGettrick et al.).  
Podocytes express IL-6R and transduces the IL-6 signal (Moutabarrik et al., 1994b), in 
contrast, there is no evidence that GEnCs express IL-6R on their surface. IL-6 interaction 
with EnCs that express only the gp130 signal transducing chain occurs via the involvement 
of soluble IL-6R and subsequent negative trans-signalling (Heinrich et al., 1998; Taga et 
al., 1989). It is notable that the soluble IL-6R (sIL-6R) was not detectable in the podocyte 
culture supernatants harvested from either unstimulated or cytokine-stimulated cultures, 
findings that were confirmed in the present study (Moutabarrik et al., 1994b). However, the 
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presence of sIL-6R (data not shown) in the supernatants of the cultures following the 
addition of neutrophils suggests that sIL-6R from neutrophils consequently mediates 
signalling that might contribute to the previously described effects of IL-6 on neutrophil 
recruitment (Ulich et al., 1991b; Xing et al., 1998). 
 Thus, sIL-6R along with IL-6 in the cultures may have induced the reduction in neutrophil 
recruitment observed in our studies (Modur et al., 1997). Alternatively, IL-6 may have 
stimulated IL-6 receptors expressed by podocytes with generation of secondary mediators 
responsible for inhibiting neutrophil recruitment. Previously, IL-6 has been demonstrated to 
suppress LPS induced TNF-α and IL-1 in macrophages both in vivo and in vitro (Aderka et 
al., 1989; Bode et al., 1999; Ulich et al., 1991a). Thus, it is conceivable that the low 
release of soluble mediators from GEnC that were observed following treatment with 
podocyte conditioned medium may reflect direct suppressive properties of IL-6. Further 
studies are needed to establish the pathophysiological implications of IL-6 in inhibition of 
inflammatory responses by TNF-α in co-cultures and signalling events involved in the 
process.  
There was enhanced neutrophil transmigration across the layers in both mono and co-
cultures. The chemotactic and chemokinetic signals which regulate neutrophil recruitment 
by the GEnC were explored in the co-cultures and mono-cultures. Here, we show that 
blockade of CXCR2 (IL8RB) was sufficient to reduce neutrophil recruitment in co-cultures 
while blocking of both CXCR1 (IL8RA) and CXCR2 affected neutrophil recruitment on 
GEnC in monocultures. This suggested the possible involvement of chemokines other than 
IL-8 in co-cultures since CXCR1 only binds IL-8 while CXCR2 binds all the ELR 
chemokines. (Ahuja and Murphy, 1996; Imaizumi et al., 1997; Luster, 1998).  In co-
cultures, interactions of ENA-78 with CXCR2 seems to be playing a dominant role despite 
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the increased levels of IL-8 and GRO- α expression in the cultures, since recruitment was 
significantly reduced by blocking ENA-78 activity. Previous studies have shown that trans-
signalling of IL-6 not only blocks pro-inflammatory cytokines and suppresses IL-8 and 
GRO- α, but also promotes release of ENA-78 and CXCL-6 (Hurst et al., 2001; McLoughlin 
et al., 2004; McLoughlin et al., 2003; Modur et al., 1997), which is analogous to the 
findings with the co-cultures shown here. The increased transmigration in the co-culture 
system may be due to the hydrostatic pressure with in the system and the dedifferentiated 
appearance of podocytes. Coers et al., investigated the effect of basolateral hydrostatic 
pressure on podocyte biology in vitro and found cell-cell contacts were often found more 
basally and intercellular spaces are widened (Coers et al., 1996). These spaces might 
have supported enhanced transmigration. However, when considering total neutrophil 
recruitment, the percentage of neutrophil recruitment in co-cultures is significantly reduced 
compared to mono-cultures. Thus, we conclude that TNF-α treated GEnCs in co-culture 
capture neutrophils through CXCR2 to ligate to CXC-chemokine(s) and there by induce 
neutrophil retention in these cultures.  
The model described here appears relevant to the healthy glomerular environment and 
offer a means to study physiological processes regulating inflammation in human tissues. 
In conclusion, these studies reveal that podocytes can protect and modulate the 
inflammatory response mediated by GEnCs particularly during inflammatory insults via 
mechanisms that involve cell-cell contact and soluble mediators. These observations once 
again highlight the anti-inflammatory paracrine and autocrine actions of IL-6. The 
importance of organ specific cross talk is well documented within these renal cell 
populations.  
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Chapter 5: Superimposing a disease inflammatory insult on co-
cultures of glomerular cells 
 
5.1 Introduction 
 
Infiltration of phagocytic leukocytes in kidney glomeruli is a pathological finding in many 
kidney diseases  (Eddy et al., 1990). Both circulating inflammatory cells and resident 
glomerular cells can mediate acute glomerular injury. The acute injury can transition 
towards a chronic state by the release of various cytokines and growth factors which result 
in deposition of extracellular matrix leading to scarring and sclerosis of the kidneys 
(reviewed in (Couser, 1998)).  
During VGN, neutrophils activated by ANCA interact with glomerular endothelium and 
sometimes leads to its damage. Neutrophils are the major cell type involved in the 
antibody-induced glomerular injury and ANCA were shown to promote neutrophil 
recruitment to cytokine activated endothelium provoking endothelial damage within 
glomerular capillaries (Charles et al., 1991; Ewert et al., 1995; Ewert BH, 1992; Falk et al., 
1990b; Keogan et al., 1992; Little et al., 2005b). The ANCA activated neutrophils localize 
in glomeruli and undergo degranulation, respiratory burst  followed by the release of SP 
and toxic oxygen metabolites, particularly hydrogen peroxide which reacts with MPO 
(Johnson et al., 1988; Johnson et al., 1987; Shah, 1989) inducing glomerular damage and 
our previous work stands as a possible proof (Kuravi and Bevins publication in press) (Lu 
et al., 2006; Lu et al., 2004). The recruitment of ANCA activated neutrophils could promote 
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a dynamic interplay between resident tissue cells which ultimately contributes to the 
pathophysiology of renal inflammation.  
Very little is known about podocyte involvement in immune mediated injury and about their 
active involvement in regulation of inflammation. Podocyte apoptosis and their detachment 
from basement membrane was shown to contribute to glomerular injury and podocytes 
were also shown to be part of the formation of glomerular crescents in crescentic GN 
(Thorner et al., 2008). Evidences highlight the importance and contribution of podocytes in 
normal physiological functions, as well in disease states. Under pathological conditions, 
failure of the podocytes certainly results in the initiation of progressive renal diseases 
leading to proteinuria and progressing to end-stage renal failure. The inability of terminally 
differentiated podocytes to proliferate and repair or replace damaged podocytes in an 
injured glomerulus may be pivotal in chronic and end-stage renal disease.  Foot process 
effacement is a hallmark of glomerular injury leading to proteinuria in the vast majority of 
human glomerulopathies and animal models of proteinuric glomerular disease, with rare 
exceptions (reviewed by shankland (Shankland, 2006) ). Podocyte dysfunction can be due 
to genetic, congenital and acquired causes leading to disruption of the slit diaphragm and 
filtration barrier (Debiec et al., 2004; Kestilä et al., 1998; Kim et al., 2003; Ronco and 
Debiec, 2005; Tryggvason K, 1999).  Podocyte effacement as described by Farquhar et al 
in 1957 (Farquhar, 1957), is an extensive process observed in biopsies of patients with 
nephritic syndrome. Effacement constitutes fusion or retraction and is a stereotypical 
reaction of podocytes to injury or damage caused by disruption of components of the slit 
diaphragm, deregulation of the actin cytoskeleton and alteration of the negatively charged 
apical domain of podocytes (Reidy and Kaskel, 2007). This dramatic alteration of podocyte 
complex cellular architecture is followed by cell hypertrophy, vacuolisation and detachment 
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from the basement membrane leading to the apoptosis of the podocytes and thus 
progression of glomerular diseases.  
Thus, our studies explored the role displayed by podocytes in regulating inflammation and 
we have investigated ANCA associated inflammation in a co-culture system to further 
explore the importance of podocytes in the resolution of inflammation. We also injured 
podocytes and studied the effect on the inflammatory response which might be a leading 
cause of chronic and intensive inflammatory states as in VGN. 
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5.2. Methods: 
 
1. Isolation of ANCA from plasma exchange fluid of patients. 
2. Endotoxin removal from ANCA IgG. 
3. Co-culturing of podocytes and GEnCs and neutrophil recruitment assay introducing 
ANCA activated neutrophils.  
4. MTT assay on PAN treated podocytes. 
5. Co-culturing of PAN treated podocytes and GEnCs and neutrophil recruitment assay.  
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5.3 Results: 
 
From previous chapter, it was clear that the presence of podocytes along with GEnC 
modulate the inflammatory stimuli with reduced neutrophil retention. This current chapter 
further elucidates the protective role displayed by podocytes under disease conditions, by 
adding ANCA activated neutrophils to TNF-α stimulated GEnC in mono-cultures and in co-
culture with podocytes that were in healthy state or otherwise injured by PAN. 
 
5.3.1 Effects of ANCA activated neutrophils in co-culture with podocytes in 
contact with ciGEnC and HUVEC 
 
EnCs co-cultured with podocytes that had been differentiated for 14 days were subjected 
to treatment with TNF (2 Units/ml). Static neutrophil recruitment assays were performed, 
adding neutrophils activated by ANCA in the cultures for 1hr. As observed with 14-day 
podocyte co-cultures, ciGEnCs showed reduced recruitment of ANCA activated neutrophil 
recruitment in the presence of podocytes, when compared to ciGEnC mono-cultures in 
cultures stimulated even with lower concentrations of TNF-α (2U/ml) (Figure 37 A). The 
data shows that normal IgG activate neutrophils in the cultures whilst reduction in 
neutrophil recruitment seems to be prominent in co-cultures. 
Following 2U/ml TNF-α treatment, ciGEnC co-cultured with podocytes showed a significant 
reduction in total neutrophil recruitment of U>U50% of neutrophil recruitment observed with 
ciGEnC mono-cultures and MPO ANCA activated neutrophils. In the presence of PR3 
ANCA, the co-cultures presented reduced neutrophil recruitment up to 50% which did not 
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reach significance (Figure 45A). The neutrophils that were adherent, transmigrated away 
from the endothelium more in co-cultures than in mono-cultures (Figure 45B).  
In contrast, HUVEC co-cultured with podocytes did not show any reduction in neutrophil 
recruitment with the presence of PR3 ANCA compared to mono-cultures (Figure 45C). The 
majority ( U>U80%) of total adherent neutrophils were observed to be transmigrated through 
the cell layers and only a small sub-population were left firmly adherent at the EnC surface 
at the time the assay was terminated similar to GEnC cultures (Figure 45D).   
These findings also suggest that podocytes have the ability to suppress neutrophil 
recruitment even at low concentrations of TNF stimulation in the presence of ANCA by up 
to 60% via direct contact. The cross talk was again shown to be specific to glomerular 
cells, as HUVEC in co-culture did not present similar response. Thus, close juxtaposition 
of podocytes with ciGEnC may promote an anti-inflammatory phenotype that suppresses 
neutrophil recruitment to a certain extent.  
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Figure 45: Recruitment of ANCA activated neutrophils in co-cultures of 
ciGEnC and podocytes 
 
Figure 45: ANCA activated neutrophil recruitment by endothelium in co-culture with podocytes stimulated 
with TNF-α (2 U/ml). (A) Percentage neutrophil recruitment by ciGEnC co-cultured with podocytes or cultured 
alone in the presence and absence of ANCA IgG. (B) Percentage transmigrated neutrophils across ciGEnC 
co-cultured with podocytes or cultured alone. (C) Percentage neutrophil recruitment by HUVEC co-cultured 
with podocytes or cultured alone in the presence and absence of ANCA IgG. (D) Percentage transmigrated 
neutrophils across HUVEC co-cultured with podocytes or cultured alone. Statistics: The significance by one 
way ANOVA, comparing to the control in co-cultures. 
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5.3.2 Effects of ANCA activated neutrophils in co-culture of podocytes in 
contact with ciGEnC (using IgG without endotoxin) 
 
As previous studies from section 5.3.1 had shown responses with normal IgG, we 
suspected the activity of endotoxin in the IgG. Endotoxins are unique glycoproteins such 
as lipopolysaccharides (LPS) of gram negative bacteria which can induce 
pathophysiological effects by inducing cytokine release and are thought to trigger flares of 
vasculitis  (Mandell, 1998; Young, 1995). These endotoxins were shown to be 
contaminating some serum samples previously from our lab (unpublished data) and 
removal of endotoxin from the IgG samples provided a clear role of ANCA in activating 
neutrophils. Thus, previous results from 5.3.1 were repeated with endotoxin removed IgG, 
both normal and ANCA IgG as discussed in methods sections previously in chapter 2. 
GEnC co-cultured with podocytes that had been differentiated for 14 days were subjected 
to treatment with TNF (2, 10 &100 Units/ml). Static neutrophil recruitment assays were 
performed, adding neutrophils activated by ANCA (without endotoxin) to the cultures. As 
observed with 14-day podocytes co-cultures, EnCs showed reduced ANCA activated 
neutrophil recruitment in the presence of podocytes when compared to EnC mono-
cultures, but only in cultures stimulated with 2U/ml TNF-α (Figure 46A). With increasing 
concentration of TNF-α (10 & 100U/ml) in culture, the neutrophil recruitment was equal or 
even greater than in mono-cultures (Figure 46C&E). 
Following 2U/ml TNF-α treatment, we have observed that ciGEnC co-cultured with 
podocytes showed significant reduction in total neutrophil recruitment of >50% of the 
neutrophil recruitment by ciGEnC mono-cultures with MPO ANCA activated neutrophils 
similar to previous findings of section 5.3.1 with the presence of endotoxins. In the 
presence of PR3 ANCA, the co-cultures presented reduced neutrophil recruitment of up to 
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30% which did not reach significance (Figure 46A). Increasing the TNF concentration to 
10U/ml has altered the protective barrier thereby increasing the neutrophil recruitment in 
co-cultures to a similar extent as with ciGEnC mono-cultures. Further increasing the TNF 
concentration to 100U/ml resulted in upregulated neutrophil recruitment by ciGEnC in co-
cultures by up to 24% compared to ciGEnC mono-cultures especially in the presence of 
ANCA. 
 The neutrophils that were adherent, transmigrated away from the endothelium more so in 
co-cultures than in mono-cultures, using cells stimulated with TNF 2 & 10 U/ml (Figure 46 
B, D). When stimulated with TNF 100U/ml, the transmigration of neutrophils was less in 
co-cultures when compared to ciGEnC monocultures in the presence of ANCA (Figure 
46F).  
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Figure 46: Recruitment of ANCA activated neutrophils in co-cultures of 
ciGEnCs and podocytes - IgG without endotoxin 
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Figure 46: ANCA activated neutrophil recruitment by endothelium in co-culture with podocytes stimulated 
with different concentrations of TNF-α (2, 10 & 100 U/ml). (A, B) Percentage neutrophil recruitment and 
transmigration in co-cultures or mono-culture of ciGEnC stimulated with 2U/ml TNF-α concentration in the 
presence and absence of ANCA IgG. (C, D) Percentage neutrophil recruitment and transmigration in co-
cultures or mono-cultures of ciGEnC stimulated with 10U/ml TNF-α concentration in the presence and 
absence of ANCA IgG. (E, F) Percentage neutrophil recruitment and transmigration in co-cultures or mono-
cultures of ciGEnC stimulated with 100U/ml TNF-α in the presence and absence of ANCA IgG.  
Statistics: The significance by two way ANOVA, comparing the treatment between the cultures. 
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5.3.3 Viability of podocytes treated with puromycin aminonucleoside (PAN)- 
determined by measuring mitochondrial activity 
 
Podocytes were exposed to PAN of increasing concentrations (5 - 500 μg/ml) for 6 -24 hrs  
to identify the point where viability slips away by testing the mitochondrial activity using the 
MTT assay, as described previously. The results revealed that the treatment with PAN 
(500 µg/ml) is toxic even after only 6hrs, whereas 100 µg/ml PAN treatments of podocytes 
were toxic after 24hours of incubation (Fig. 47 A-C). The concentrations 50, 10 & 5 µg/ml 
of PAN treatment did not affect viability of podocytes even with incubation times up to 24 
hrs.  
The determination of PAN toxicity by MTT assay was confirmed by studying changes in 
cell morphology observed by inverted and fluorescent microscopy. The results revealed 
PAN induced dysregulation of the actin cytoskeleton with morphological changes like 
podocyte foot process effacement and cell elongation, induced by PAN, progressing in a 
concentration and time dependent manner. The progression of foot process effacement is 
gradual and progressive with concentrations at 16 hours treatment   (Fig. 48). 
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Figure 47: Effect of PAN on podocyte viability 
 
 
 
 
 
Figure 47: Effect of PAN treatment on podocyte mitochondrial activity. Podocyte cell viability was assessed 
using the MTT assay treated with concentrations of PAN ranging from 5 to 500 µg/ml for 6 hours (A), 16 
hours( B) and 24hours (C). 
 
 
 
 
 
 
 
(A) (B) 
(C) 
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Figure 48: Effect of PAN on podocyte cell morphology 
 
 
 
 
Fig 48: Effect of PAN treatment on podocyte cell morphology. Podocytes treated for 16 hours with a range of 
concentrations of PAN, present a changing morphology with increasing concentrations of PAN and severe 
damage at 500µg/ml.  
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5.3.4 Effect of PAN injured podocytes on neutrophil recruitment by ciGEnC in 
co-culture 
 
Following the previous studies involving PAN treatment of podocytes, injured podocytes 
were used in co-cultures along with ciGEnC and TNF-α, so that the effect on neutrophil 
recruitment could be studied. The results revealed that presence of injured podocytes in 
the co-culture shows no protection towards cytokine stimulation and increased neutrophil 
recruitment occurred over and above that observed with ciGEnC mono-cultures, with 
increasing concentrations of PAN (Fig. 49). The results were compared to neutrophil 
recruitment by ciGEnC co-cultured with healthy podocytes that were subjected to TNF-α 
100U/ml treatment. The neutrophil recruitment in co-cultures with injured podocytes 
treated with 10, 50, 100μg/ml PAN, was significantly different from co-cultures with healthy 
podocytes. Co-cultures with 10μg/ml PAN treated podocytes showed increased neutrophil 
recruitment over ciGEnC mono-culture on stimulation with 100U/ml TNF-α (Fig.49). 
 165 
Figure 49: Effect of PAN injury to podocyte on neutrophil recruitment by 
ciGEnC in co-culture 
 
 
 
 
Figure 49: Neutrophil recruitment by TNF-α (100U/ml) stimulated and unstimulated co-cultures of ciGEnC 
with PAN injured podocytes. Podocytes were injured using different concentrations of PAN – 5, 10, 50, 100 
µg/ml treated for 16hrs.  The data expressed is a mean of 5 individual experiments. Statistics: One way 
ANOVA with bonferroni post tests compared to the healthy co-cultures stimulated with TNF-α. 
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5.3.5 Recruitment of ANCA activated neutrophils by GEnC in co-culture 
with injured podocytes 
 
To determine the effect of podocyte injury on ANCA activated neutrophil recruitment by 
ciGEnC stimulated with TNF (2 &100 Units/ml), podocytes were injured by treating with 
10µg/ml PAN and co-cultured with ciGEnC on transwell inserts. Static neutrophil 
recruitment assays were performed by adding neutrophils activated by ANCA (without 
endotoxins) in the cultures.  
As seen in the previous studies, the results revealed that presence of injured podocytes in 
the co-culture shows no protection towards cytokine stimulation and increase the ANCA 
activated neutrophil recruitment over and above that observed with ciGEnC mono-cultures 
with increasing concentrations of TNF-α (Figure 50). The results were compared to ANCA 
activated neutrophil recruitment by ciGEnC co-cultured with healthy podocytes that were 
subjected to TNF-α treatment. The neutrophil recruitment in co-cultures with injured 
podocytes treated with 10μg/ml PAN, in the presence and absence of ANCA, was 
significantly different from co-cultures with healthy podocytes. Co-cultures with injured 
podocytes showed an increase in neutrophil recruitment over ciGEnC mono-culture on 
stimulation with 100U/ml TNF-α (Figure 50). 
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Figure 50: ANCA activated neutrophils in the co-culture of ciGEnC with 
PAN injured podocytes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 50: ANCA activated neutrophil recruitment by endothelium in co-culture with PAN injured podocytes 
stimulated with different TNF-α concentrations (2 & 100 U/ml). (A) Percentage neutrophil recruitment in co-
cultures with healthy or PAN injured (10μg/ml) podocytes or mono-cultures of ciGEnC stimulated with TNF-α 
concentration (2 U/ml) in the presence and absence of ANCA IgG. (B) Percentage neutrophil recruitment in 
co-cultures with healthy or PAN injured (10μg/ml) podocytes or mono-cultures of ciGEnC stimulated with 
TNF-α (100 U/ml) in the presence and absence of ANCA IgG. Statistics: The significance by one and two 
way ANOVA comparing treatments and between the cultures. 
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5.4 Discussion:  
Glomeruli of kidneys are frequent targets of inflammatory and immune processes which 
threaten their functional ability to clear the body of toxins, and often resulting in kidney 
failure. ANCA are involved in inappropriate activation of the neutrophils in renal vasculitis 
and infiltration of these immune cells is well documented within the glomerulus (Suh et al., 
1999). The role of glomerular cells during inflammatory episodes and how they regulate 
the inflammatory cell influx has been explored in this study. This work demonstrates novel 
findings about the protective role displayed by podocytes by dramatically reducing ANCA 
activated neutrophil recruitment by GEnC with mild TNF stimulation of the cultures. The 
balance between health and disease is well documented by increasing TNF concentration 
which induced elevated levels of neutrophil recruitment in co-cultures. Further, the cross-
talk between acute and chronic inflammation is being explored. This work also highlighted 
the importance of the state of podocytes in maintaining a subtle transition from health to 
disease and demonstrating that injured podocytes lose their protective ability and cannot 
play a role in resolving the inflammatory episodes.  
Bacterial infection is often observed prior to the onset of vasculitis and is accompanied by 
elevated TNF levels which play a role in activating the endothelium, while the presence of 
circulating ANCA escalates neutrophil recruitment by the endothelium (Grau, 1989).  
Previous studies from our lab have already shown the pathogenicity of ANCA and 
upregulated neutrophil recruitment by EnCs in the presence of secondary stimulus with 
ANCA (Calderwood et al., 2005; Radford DJ, 2001). In an effort to create disease 
inflammatory stimuli, ANCA activated neutrophils were added to cytokine stimulated 
cultures. Minimally activated co-cultures (TNF-α 2 U/ml) did not support ANCA- activated 
neutrophil recruitment and reduced it by > 50% compared to mono-cultures, but when the 
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cultures were highly activated (TNF-α 100U/ml), there was increased neutrophil 
recruitment with untreated and ANCA treated neutrophils. Previous results from our lab 
demonstrated similar results where minimally activated endothelium in mono-culture 
presented increased ANCA activated neutrophil recruitment similar to the current findings 
and were contrary in co-cultures (Calderwood et al., 2005; Radford DJ, 2001). The 
presence of ANCA in the cultures stimulated with higher concentrations of TNF-α (10 & 
100U/ml), neutrophil recruitment in co-cultures was similar or even more to that of mono-
cultures and in all cases,  rapid transmigration of neutrophils away from the endothelium  
was observed. The ANCA activated neutrophil response in co-cultures demonstrates that 
these effects could be relevant to injury in VGN.  
The podocyte is a complex cell with a critical role in maintaining glomerular architecture 
and function. There is an increasing body of evidence that loss or damage to this 
terminally differentiated cell will contribute to development of proteinuria, leading to loss of 
glomerular function. However, it appears that podocytes associated with chronic 
inflammation cannot defend themselves, as they get injured due to ROS and other 
mediators released, thereby further promoting an inflammatory environment. The 
involvement of ROS in podocyte damage is well documented . Non inflammatory lesions 
such as minimal change nephropathy/focal sclerosis or membranous nephropathies result 
from podocyte disorders, whereas inflammatory lesions are generally induced by 
circulating inflammatory cells. There is a possibility that these inflammatory lesions could 
also be included with podocyte disorders and damage. ANCA induced neutrophil-EnC 
interactions were considered to be important in the disease process involving 
inappropriate molecular processes resulting in untimely secretion of superoxide and 
proteases proceeding towards cellular destruction (Falk et al., 1990b). Podocyte injury has 
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been reported to be the initiating cause of many renal diseases progressing to end-stage 
renal failure with podocyte effacement being the initial response towards injury. We have 
thus hypothesized that podocyte injury could promote the disease process by enhancing 
ANCA mediated neutrophil responses.  
Using a PAN induced podocyte injury model (Diamond et al., 1986; Fishman and 
Karnovsky, 1985; Lannigan et al., 1962), we have described podocyte injury and its effects 
neutrophil recruitment in the presence and absence of ANCA. PAN toxicity also involves 
overproduction of ROS (Marshall et al., 2006; Rincon et al., 2004; Vega-Warner et al., 
2004). PAN was found to injure podocytes specifically leading to effacement of foot 
process, disorganization of actin cytoskeleton and affecting slit diaphragm proteins, 
nephrin and podocin (Guan et al., 2004; Mundel et al., 1997; Oh et al., 2004). We also 
investigated whether such injury to podocytes reduces their ability to cross talk with 
endothelial cells and affects podocyte regulation of neutrophil recruitment by glomerular 
endothelium during inflammatory episodes. Our injury model has shown that injury to 
podocytes result in increased neutrophil recruitment by GEnCs, while podocytes that are in 
healthy state can fight off minor inflammatory insults and can regulate the cytokine 
sensitivity of the glomerular endothelium. In contrast, podocytes associated with chronic 
inflammation bypass this and promote an inflammatory environment. Thus the model 
described here appears relevant to the glomerulus in both health and disease. Previous 
evidence has shown that injured podocytes were shown to be inefficient in mediating 
angiogenesis, proliferation and migration of GEnC (Liang et al., 2006).  
In conclusion these studies reveal that podocytes can modulate the inflammatory response 
mediated by GEnC, and that this modulation may itself depend on the state of the 
podocytes. The exact molecular mechanisms and mediators involved in modulating the 
 171 
glomerular diseases needs to be fully delineated. This will allow therapies to be focused 
towards repair mechanisms that would address the inflammatory insults targeting the 
glomerular cells. 
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Chapter 6: Discussion and Conclusions 
 
VGN is a feature of ANCA associated vasculitis and the presence of ANCA activates 
neutrophils inappropriately resulting in increased infiltration and infiltrated immune cells 
along with the resident cells have been found in the crescents of crescentic GN (He et al., 
2006; Thorner et al., 2008). During active vasculitis, increased levels of SP have been 
detected in patient’s plasma (Haubitz et al., 1997; Timothy et al., 1994). The importance of 
SP in the GEnC activation and/or injury that occurs during the development of VGN and 
the role of glomerular epithelium in regulating the inflammatory episodes during both 
health and disease were presented clearly in this study. Targeting SP, as well as podocyte 
recovery from injury, could potentially be amenable to therapeutic manipulation. In this 
current study, we have investigated four models of inflammation that might mimic different 
inflammatory conditions. Firstly, the role of SP in activating the EnC mono cultures and 
looked at neutrophil recruitment under static and flow conditions. Secondly, the cultures 
were stimulated with TNF concentrations from 0-100U/ml, mimicking an inflamed state in 
which there is an elevated level of cytokine and chemokine release. Thirdly, in addition to 
an inflammatory stimulus, a secondary stimulus was added to the situation by adding 
ANCA representing the ANCA associated vasculitic condition. Lastly, an injury model was 
hypothesized on the basis of the state of podocytes, where they were injured by using 
PAN and recreated both inflammatory and disease states in an effort to model the 
inflammation occurring in vivo in vasculitis. The results revealed clear transition between 
health and disease.  
 173 
Differences in SP effects on different EnCs: 
 
We have used primary GEnC as well as immortalised cell line cultures in these studies as 
GEnCs are the target cells in VGN. We couldn’t use primary cells all the time due to the 
complexity of their isolation process and/or cost involved in buying them commercially. The 
cell line cultures were developed from primary cells to over come similar problems and are 
successfully achieved by Dr Satchell group. The cell line GEnCs were shown to share 
similar morphological and phenotypic features compared to primary cells. We have also 
used HUVEC in our studies as a large vessel endothelial comparitive and primary GEnCs 
to confirm major findings.  
Whilst investigating the mechanisms by which SP affected the endothelial cell phenotype, 
cell line GEnC were stable compared to primary cultures of GEnC or HUVEC following the 
SP treatments. Our findings also confirmed previous finding that HNE is more damaging 
compared to PR3. Previous findings have shown that HNE in particular was linked more 
towards EnC disruption (Carden et al., 1998; Nakatani et al., 2001; Smedly et al., 1985) 
and was found to be deposited on glomerular endothelium in renal biopsies of patients 
with crescentic GN (Kuzniar et al., 2007). The neutrophil adhesion pattern was also 
different between the cell types, where HUVEC and ciGEnC demonstrated significantly 
increased levels of neutrophil adhesion under static conditions, following 1μg/ml protease 
treatment, whilst primary GEnCs did not show any response. The primary GEnCs were 
more sensitive to the protease treatment despite them being viable as demonstrated by 
MTT assay. Under physiological flow conditions, significant increase in neutrophil capture 
was observed by HUVEC only with PR3 treatment and not with HNE and none by GEnC 
(both primary and cell line cultures), and they completely blocked neutrophil recruitment. 
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The reason could be that the endothelium might not be armed with adhesion molecules. 
The transient neutrophil interactions that were demonstrated under static conditions were 
not mediated by adhesion molecules as absence of classical adhesion molecules was 
demonstrated by a colleague (unpublished data). The lack of selectin or integrin 
upregulation in the cultures mitigated against capturing neutrophils under flow conditions. 
The presence of surface P-selectin (unpublished data) might have played a role in the 
neutrophil recruitment by HUVEC since PR3 induced P-selectin expression was 
significantly lower in GEnC than HUVEC.   
The differences in the response with these cell types was previously documented in our 
laboratory by Dr Pankhurst while looking at neutrophil capture in the presence of ANCA. 
Her data also demonstrated the fragility of the primary GEnCs which could be due to 
differences in the environment in vitro and in vivo. The difference between HUVEC and 
GEnC is explainable as they are from completely different types of vessels and are 
functionally different as well.  
 
Importance of co-culture model: 
 
Co-culture systems mimic in vivo tissues and allow the study of cell–cell interactions. This 
system is widely used currently to study different aspects of health and disease conditions 
which are found within different organ systems (Helen et al., 2009; Hermanns et al., 2004; 
Lally et al., 2005; Ma et al., 2005; McGettrick, 2010; Rainger and Nash, 2001; Wang and 
Takezawa, 2005). In vitro studies have previously been attempted to study glomerular 
inflammation and to characterise glomerular cell behavior in order to provide insights into 
the mechanism of interactions of neutrophils under different conditions. Availability of cell 
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line podocytes and GEnCs brought it a step close and putting these cells together in co-
culture made it easy to interrogate the intricate details about glomeruli. At the same time, 
the system is limited and may not mimic the exact role of GEnC and the support or 
provocative effects they receive from neighboring cells, but it did enable us to study some 
mechanisms in greater detail than in their real environment. This system also provided the 
flexibility for the cells to behave similarly to in vivo conditions and also can overcome some 
of the limitations of single culture models. It allowed us to study interactions of the 
neighboring cells and to determine how the interactions help in mediating the functions of 
the system. Neutrophil recruitment by GEnCs and also interactions of ANCA were studied 
in the presence of podocytes and the recruitment pattern was directly observed.  
 
Disadvantages of the co-cultures: 
PET membrane: 
 
PET (polyethylene terephthalate) is a carbon polymer based membrane which is a 
hydrophilic thin film and is translucent or microscopically transparent for cell visualization 
and monitoring of the cell monolayer using light microscopy techniques. 
Many in vitro studies were successful in delivering knowledge about the intricate 
communication between cell types of different tissue systems (Hermanns et al., 2004; Ma 
et al., 2005). The transwell insert compared to glomerular filtration barrier functions is 
questionable as the mean GBM thickness is between 300-350 nm and alters in disease 
states.  The thickness of the TES membrane on the insert is 10μm. The thickness of PET 
membrane is greater, but nevertheless, most of adherent neutrophils transmigrated 
rapidly. The neutrophil recruitment also increased with the presence of ANCA and injured 
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podocytes which demonstrates that the thickness of the membrane was not a critical factor 
for reduced neutrophil recruitment. However, having a thicker membrane might have 
affected the proximity of the cells and might have reduced the responses mediated, while 
at the same time the pore size might have promoted cell interactions. Despite the 
challenges with the membrane and efforts to generate alternative forms of porous support 
by other groups (Abbott et al., 1992; Daley et al., 2008; Matthews et al., 2002; Slater et al., 
; Wang et al., 2008), the model is widely accepted and other forms of membrane 
structures might still need work to establish them as a successful model. 
 
 
Differences in neutrophil recruitment in the co-culture of HUVEC with podocytes 
and GEC with podocytes: 
 
              HUVEC co-cultured with podocytes presented different findings to that of GEnC. The 
primary reason could be the fundamental differences in their origins. Physiologically GEnC 
and podocytes sit next to each other, whereas HUVEC were isolated from umbilical vein 
conduit vessels. Hence the cross talk that we have seen could be organ specific. Further, 
there are likely to be basic physiological and functional differences of EnCs from 
microvasculature and macrovascular EnCs. There is considerable evidence in the 
literature of differing phenotypes of endothelial cells in different vascular beds (Lim et al., 
2003);(Franzen et al., 2003; Murakami et al., 2001; Vora et al., 1996). GEnC are of 
capillary origin and are exposed to increased numbers of circulating cells as the glomeruli 
are exposed to 180L of blood per day and thus armed to prevent inflammation. Despite 
these issues, both cell types were compared and were shown to be expressing selectins, 
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ICAM1 and P-selectin (unpublished data) and therefore to have a similar potential to 
recruit neutrophils.  
The other difference that we observed in our cultures was the production of IL-6 in co-
cultures of HUVEC or GEnC with podocytes as shown in figure 53. GEnC in mono-cultures 
did not release any IL-6 into culture supernatants. The IL-6 that was released in GEnC co-
cultures was by the podocytes as shown previously. This was different with HUVEC 
cultures, where supernatants from HUVEC mono-cultures also had increased levels of IL-6 
in response to TNF-α along with increased levels in co-cultures (upto1700 pg/ml). The 
levels in HUVEC cultures were lower to that GEnC co-culture supernatants (upto10,000 
pg/ml). 
  
The electrical resistance of filters with podocytes: 
 
The ER of the membranes with monocultures and co-cultures were not significantly 
different. The integrity of the podocyte monolayer was tested by microscopy and its growth 
on the underside of the filter did not change the cell morphology or alter the growth of the 
second cell type inside of the filter. Despite formation of intact monolayers, the ER of 
podocytes was similar to that of a blank filter which could be due to the podocyte finger-
like projections that spread around the cell body of the podocyte which might have allowed 
the electrical conductivity. Similar results were observed in other studies as well (Satchell 
et al., 2006; Slater et al.). This data also suggests that the reduction is not due to the two 
monolayers being in close proximity but is due to the involvement of soluble molecules 
released by podocytes. To prove this, we have replaced podocytes with other epithelial 
cells or with EnCs (shown in a previous chapter) and have observed increased neutrophil 
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recruitment in the case of GEnC with GEnC or AKN with GEnC or ARPE with GEnC. In all 
these cases, the electrical resistance was twice that of single cultures and could have 
reduced the neutrophil recruitment. Whilst in the co-cultures of GEnC with HKC, reduced 
neutrophil recruitment was observed as was with podocytes and also showed similar ER 
resistance. This could possibly be due to the fact that they are renal tubular cell line and 
are from same organ and thus could possibly be mediated in cross talk which could be 
another project and needs futher investigation. 
 
 
ANCA responses in co-cultures: 
 
Previous findings have shown the effect of ANCA in promoting neutrophil recruitment 
(Calderwood et al., 2005; Radford DJ, 2001; Radford et al., 1999). ANCA presents 
variable pathogenicity as observed in previous studies and some studies suggest that PR3 
ANCA are less effective in vitro compared to MPO ANCA (Harper et al., 2001b). ANCA 
variability was not clearly explained and it is also unclear about underlining factors 
responsible for varying responses of ANCA in various assays and also the variability in 
inducing degranulation and respiratory burst of neutrophils from different donors. There is 
also the difficulty of quantifying the amount of specific ANCA IgG within the total IgG 
preparation. Differences inl ANCA concentration could vary between patients which would 
contribute to the differences in ANCA responses. Despite testing several ANCA IgG 
preparations and selecting the ones that worked in degranulation assays and superoxide 
assays, it was difficult to predict the effects of each ANCA preparation and such 
differences may also extend to real variation in ANCA pathogenicity. Furthermore, there 
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may be variability in pathogenicity related to subclasses of IgG. This concern led to the 
development of chimeric ANCA of different IgG subclasses in order to investigate the 
importance of Fc binding by different IgG subclasses in ANCA-IgG pathogenicity (Hussain 
et al., 2009; Rachel Colman, 2007). Pankhurst et al recently reported that IgG3 is the most 
potent IgG, followed by IgG1 and IgG2 and last IgG4, in terms of capturing flowing 
neutrophils (Pankhurst et al.).   
Another problem in the IgG experiments was activation of neutrophils by control IgG. 
Again this was another problem with no clear explanation but could be the result of cross 
linkage of IgG resulting in neutrophil activation. Other technical issues include usage of the 
same columns for both patient and normal samples which might cross-contaminate the 
samples despite cleaning columns between samples by acid elution. The presence of 
endotoxin appeared to cause the activation of neutrophils by normal IgG in some cases. 
Bacterial lipopolysaccharides can activate immune cells and removal of the endotoxin 
resulted in reduced activation. 
 
 
Effects of SP on neutrophil recruitment by endothelium in the presence of 
podocytes: 
 
As primarily designed, my work could not proceed to demonstrate the effects of PR3 or 
HNE on GEnC in the presence of podocytes in the co-culture system. Our preliminary data 
on testing the viability of podocytes treated with SP did not show any reduction in viability 
at the lower concentrations (1µg/ml) following 7 day differentiation of podocyte cell line 
cultures (i.e. the same concentration as we observed increased neutrophil adhesion to 
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EnC under static conditions, as shown in the previous section). Viability was not checked 
for podocytes that were completely differentiated for 14 days. The fully differentiated 
podocytes were more sensitive to toxic treatments and could be sensitive to SP treatments 
as well.  On the other hand, despite no loss in viability, there is a possibility for the 
podocytes to be injured by SP which will further activate the EnC there by promoting 
neutrophil recruitment in the cultures as was seen in my injury model. It will be difficult to 
dissect the details of SP effects on endothelial activation in the presence of podocytes. 
Also the complexity of the co-culture system and time and funding restrictions did not 
permit elucidation of the effects of SP and the molecules and processes that could be 
involved in mediating the effects.  It would be interesting to find out how PR3 and HNE 
effect fully differentiated podocytes and their effect on the cells in co-culture. If the cells 
sustain the treatments in co-culture, then it would be interesting to further elucidate the 
role of podocytes in modulating the neutrophil recruitment by GEnCs and also 
investigating the mechanistic side of the effects. If the podocyte foot processes get injured 
as was observed with PAN, this will be most relevant to the in vivo situation, which would 
make endothelium sensitive to further SP treatments, thereby enhancing neutrophil 
retention and escalating the injury process which is relevant to the disease process of 
VGN. 
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Major conclusions of this study: 
SP damage endothelium in a time and dose dependent manner. At the concentrations 
where they do not damage endothelium, they stimulate the endothelium in a way that 
recruits neutrophils, with PR3 than with HNE.  HNE is more damaging compared to PR3. 
The presence of α1-AT along with the SP in the cultures nullified the effects of SP. This 
could be relevant to the disease process of VGN and thus SP are the potential therapeutic 
targets.   
The vulnerability of the glomerulus to an inflammatory insult is due to its anatomical 
specialisation. Podocytes not only maintain vessel architecture, but also regulate the 
actions of glomerular endothelial cells, modulating the inflammatory conditions. Healthy 
podocytes mediate IL-6 dependent cross talk and regulate neutrophil recruitment by GEnC 
under stimulated conditions, thereby demonstrating an endogenous mechanism by which 
the glomerulus is protected against an inflammatory insult.  This negative regulation could 
be organ specific as podocyte cross talk was not observed with HUVEC, thus 
demonstrating the specificity of the renal vasculature. 
Most importantly we have also addressed the relevance of podocyte-glomerular 
endothelial cell crosstalk by superimposing two disease models on the co-culture 
microenvironment. Podocytes were able to dramatically reduce the endothelial recruitment 
of neutrophils activated with ANCA IgG, even at lower TNF-α concentration and increasing 
TNF-α stimulation escalated neutrophil recruitment. Finally, injury to the podocytes by PAN 
disturbs the balance. Thus the state of podocytes is important in regulating the glomerular 
responses.   
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Figure 52: Conclusions of co-culture work. 
 
 
 
Figure legend: Illustration of complete Coculture work  
Inflammatory stimuli: mechanism of neutrophil recruitment on GEnC in the presence of 
podocytes with an inflammatory stimulus (tumor necrosis factor TNF-α) and the 
interactions of CXCR2 and its ligand ENA-78 in the mechanism of neutrophil recruitment. 
Podocytes regulate the inflammatory process by IL-6 mediated cross talk with the GEnC 
and resolve the inflammation.  
ANCA vasculitis model represents the inflammation in disease model, ANCA specific for 
PR3 or MPO bind to the molecules expressed on the surface of the neutrophil leading to 
the activation of neutrophil and resulting in intensive inflammation. The release of reactive 
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oxygen intermediates and other mediators results in the injury of the podocytes resulting in 
retraction of foot process of podocytes there by enhancing the neutrophil recruitment 
during inflammatory episodes. 
Injury model to test the hypothesis that podocyte injury could be initiating point for the 
glomerular dysfunction and PAN injured podocytes resulted in increased neutrophil 
recruitment.  It appears that podocytes from inflamed glomeruli cannot regulate the 
cytokine-sensitivity of vascular endothelium to other agonists.  
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Future work 
 
1. SP in co-cultures. 
2. Adding patient neutrophils with and without ANCA.  
3.  Investigating co-cultures under flow conditions. 
4. Examining how presence of platelets in co-culture system attracts 
neutrophils, or other inflammatory cells such as monocytes. 
5. Introducing PAN in vivo and looking at neutrophil adhesion by intravital 
microscopy. 
6. Targeting podocyte recovery by adding steroids such as dexamethasone to 
the cultures with injured podocytes.  
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Solutions and Buffers  
 
1. Reagents for Neutrophil preparation: 
 
Acid Citrate Dextrose 
 
 
 4.2g Disodium hydrogen citrate 
5.0g D-glucose 
200ml pyrogen-free water 
 
2% Dextran 
 
 
 
 
 
9g NaCl 
20g Dextran T500 
1 Litre pyrogen-free water 
FILTER STERILISE  
Store 4oC 
 
  HBH 
 
 
 
500ml Hanks buffered salt solution 
5ml 1M Hepes 
 
1.5M Saline 
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2. Reagents for western blotting: 
 
 
Coomassie      
 
 
 
 
 
 
 
400ml Methanol 
 500ml dH20  
 100ml Acetic acid 
 1g Brilliant Blue dye 
 
10x Running buffer 
 
 
 
 
 
30.2G Tris Base (Sigma Aldrich) 
100ml 10% SDS  
187.6g Glycine 
1L dH2O 
 
1x Running buffer 
 
 
 
 
 
 
12.11G Tris Base 
2g SDS  
57.65g Glycine 
2L dH2O  
 
 
10X TBS - PH 7.6 
 
 
 
 
24.2 G Tris Base 
80g NaCl 
1L dH2O 
 
 
1 X TBS-T 
 
 
 
 
100ml  10X TBS 
900ml dH2O 
1ml Tween 20 
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Transfer buffer 
 
2.93g Glycine 
5.81g Tris 
0.375g SDS 
200ml Methanol 
 
 
 
                        
 
6x SDS -page loading buffer 
 
10ml 
 
0.35M Tris                                                                         
10.28% SDS 
36% Glycerol 
5% β-mercaptoetanol 
Bromophenol blue 
 
3.5ml  
1.28g   
 4.8ml    
0.5ml 
Unitil blue            
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